Pneumovax VAERS
[back] VAERS
[back]
Pneumovax
PNEUMO, 23-VALENT (PNEUMOVAX)
Learn about PNEUMO, 23-VALENT (PNEUMOVAX) serious adverse events reported to
Food and Drug Administration (FDA).
Total reports: 2651
Reported hospitalizations: 1294 Reported deaths: 40
http://patientville.com/vaccine/pneumo31_side_effects.htm
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from MD, USA. Female patient, 68 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 28. On 12-29-05 patient stated that
he was unable to move his left arm. On Friday, a nurse at the senior center
looked at his arm and said that it was warm to touch and reddened from his
shoulder to his elbow..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 28. Pt developed 2-3 blister reaction within
24 hr. pain swelling. Pt was seen rx with Prednisone, Claritin. Pt was seen
again drained the tense blister clear serous fluid drained..Patient was
receiving Aspirin Oral 81mg (1 tablet qd), Glucophage 500mg (1 tab po bid),
Keflex 500mg (1 tab po tid), Lipitor 20mg (1 QD), Prednisone 10mg (40 MG PO ONCE
DAILY X 5 DAYS), Vicodin 5-500mg (1 tablet po q 6 hours-prn pain), Zoloft 50mg
(1 tab po qd).Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from ID, USA. Female patient, 67 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 09. Client had pain in arm in the evening
after shot given. Took 2 Tylenols before going to bed. Awoke to fine arm
reddened, warm and a little sore.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Dec 2005, 19. Information has been received from a office manager in a
physicians office concerning an adult male with asthma who on Dec 19 2005 was
vaccinated intramuscularly in the left arm with a 0.5 ml dose of Pneumococcal
23v polysaccharide vaccine (lot 650329/0747P). Concomitant therapy included
unspecified inhalers for the treatment of asthma. On Dec 21 2005, the patient
presented to the physicians office with left arm tenderness to touch, slight
swelling, and a rash that encircled the arm like a bracelet. It was.Paient has
the following illness history - Asthma.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a 92 year old female
who in approximately 1978 (at age 65) was vaccinated with Pneumococcal 23v
polysaccharide vaccine (pneumococcal 23v polysaccharide vaccine was approved Jul
07 1983). On Dec 20 2005, the patient contracted pneumonia and was hospitalized.
Chest x ray and unspecified labs indicated that streptococcal pneumoniae may be
involved. The patients pneumonia was reported as not recovered. Pneumonia was
considered to be immediately life thre.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from an office nurse concerning a patient who was
vaccinated with Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P).
Subsequently the patient experienced injection site tenderness, injection site
redness and also fluid collection which progressed down arm. Subsequently. the
patient recovered from injection site tenderness, injection site redness and
fluid collection which progressed down arm. Injection site tenderness, injection
site redness and fluid collection which.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from an office nurse concerning a patient who was
vaccinated with Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P).
Subsequently the patient experienced injection site tenderness, injection site
redness and also fluid collection which progressed down arm. Subsequently, the
patient recovered from injection site tenderness, injection site redness and
also fluid collection which progressed down arm. Injection site tenderness,
injection site redness and also fluid collect.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from an office nurse concerning a patient who was
vaccinated with Pneumococcal 23v polysaccharide vaccine (649695/0512P).
Subsequently the patient experienced injection site tenderness, injection site
redness and also fluid collection which progressed down arm. Subsequently, the
patient recovered from injection site tenderness, injection site redness and
fluid collection which progressed down arm. Injection site tenderness, injection
site redness and fluid collection which prog.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from an office nurse concerning a patient who was
vaccinated with Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P).
Subsequently the patient experienced injection site tenderness, injection site
redness and also fluid collection which progressed down arm. The patient
received antibiotic treatment. Subsequently, the patient recovered from
injection site tenderness, injection site redness and fluid collection which
progressed down arm. Injection site tenderness, injecti.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from an office nurse concerning a patient who was
vaccinated with Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P).
Subsequently the patient experienced injection site tenderness, injection site
redness and also fluid collection which progressed down arm. The patient
received antibiotic treatment. Subsequently, the patient recovered from
injection site tenderness, injection site redness and fluid collection which
progressed down arm. Injection site tenderness, injecti.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NE, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 09. Case received form another manufacturer
on Dec 22 2005 under the reference number WAES0511USA01987. It was initially
reported by a health care professional that a 66 year old female patient
received a dose of Fluzone no preservative 2005-2006, lot number U1825EA, intra
muscularly in the left deltoid and a dose of Pneumovax 23, lot number
651318/1006P, intra muscularly in the right deltoid. The next day, the patient
developed a fever of 102 degrees F. In addition, she had redness, swelling, pain
and warmth o.Patient was receiving Crestor.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NE, USA. Female patient, 62 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 10. Initial report received on Dec 22 2005
from another manufacturer, report WAES0511USA03324. A 62 year old female patient
with a history of hypertension was vaccinated in the left deltoid with her first
dose of Fluzone no preservative 2005-2006, lot number U1825EA and in the right
deltoid with a 0.5 ml first dose of another manufacturers Pneumovax 23 vaccine,
lot number 650082/0691P on Nov 10 2005. On Nov 12 2005 at 8:30 the patient was
seen by a physician and presented with redness and swelling at the inject.Paient
has the following illness history - The patient has a pre existing condition of
hypertension..Patient was receiving Lipitor, Plavix..Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from SC, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 21. Patient received Fluzone and Pneumovax in
left deltoid at 11:00am on 10/21/05. Later that evening her left arm became very
painful, red and swollen. She sent to the ER that evening and then x2 on
10/22/05 with continued pain.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 27 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 14. Right upper arm erythema and induration
with extension to the axilla, associated with axillary adenopathy. Fevers and
chills noted at onset of symptoms. PCP prescribed Keflex.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 58 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 04. Left arm is very swollen and red. Pt c/o
7/10 left arm pain. C/o limited ROM of left arm.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 51 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 29. Hives and itching symptoms. Seen by
doctor and given Zyrtec..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 74 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 28. Pt states 2 days after vaccine
administered had redness, swelling, itching, cellulitis in area Pneumococcal
vaccine administered..Paient had Well Adult.Paient has the following illness
history - Sulfa.Patient was receiving Hyzarr 50/12.5mg Crestor 10mg. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 06. Information has been received from a registered nurse concerning a
female patient who on 06-Oct-2005 was vaccinated with pneumococcal 23v
polysaccharide vaccine (lot # 650087/0815P). On 07-Oct-2005 the patient
experienced injection site reaction with an extremely high fever (103 F),
soreness/body aches, nausea and vomiting. The patient was treated with
cephalexin. Subsequently, the patient recovered from the injection site
reaction, fever, soreness/body aches, nausea and vomiting on an unspecified
date. The.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Dec 2005, 19. Information has been received from an office manager concerning
a 29 year old female with a drug allergy to acetaminophen (+) oxycodone
hydrochloride (TYLOX) and asthma who on 19-Dec-2005 was vaccinated
intramuscularly in the left arm with a 0.5 ml dose of pneumococcal 23v
polysaccharide vaccine (lot #650329/0747P). Concomitant therapy included
fluticasone propionate (FLOVENT). On 21-Dec-2005 the patient presented to the
office with left arm swelling from the shoulder to the bend of her elbow, hive
type bum.Patient was receiving Flovent.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WY, USA. Female patient, 40 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 28. 4 inch band around arm approximately 2
inches below injection site, red hot, swollen. Neck swollen under chin area,
tender to touch, no fever. During time for reporting in office, arm decreased in
color and temperature. Patient states she received a pneumonia shot in
1994..Paient has the following illness history - Anemia, Spinal cord tumor, many
severe allergies, TMJ, Chronic Fatigue Syndrome, Carpal Tunnel Syndrome,
Migraines, Endometriosis..Patient was receiving Ritalin, Allegra, Vanconase,
Benadryl, Nexium. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IA, USA. Female patient, 37 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 28. Within about 4-24 hours the patient noted
her arm becoming red, painful and swollen down to her finger tips. She had
difficulty getting dressed due to the pain and edema today..Paient has the
following illness history - Patient denied. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 77 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 11. Patient received pneumonia vaccine
10/11/05 on 10/12/05 area (L deltoid) was painful and red. Patient noted
"streaks"; reported to Health Department. I referred him to his physician. Upon
follow-up with patient, I found his physician had him take "allergy medicine"
and redness and pain subsided.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 67 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 19. 12-21-05 erythemia at injection site and
pain on axilla-clarinex 5mg x 7day on Amoxicillin for dental infection..Paient
had Dental infection. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient, 60 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 28. Redness and swelling at injection site.
Swelling extended to the elbow from the shoulder.Paient had Diabetes.Paient has
the following illness history - Kearne-Sayre Syndrome; Diabetes; Elevated
Cholesterol. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, child 6 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 28. A slight red area appeared on 12/29/05 on
upper L arm. Area is 2.5 x3. Not warm to the touch but is tender. Patient having
no problems with movement in the extremity. Dad of patient not sure if she is
receiving Tylenol or Benadryl. Advised to use Tylenol for the soreness and warm
compresses.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 56 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 10. Patient developed redness and swelling at
injection site into armpit/lymph nodes and up shoulder lasting for 2 days. No
fever developed. Area felt hot to touch..Paient has the following illness
history - Allergy-nuts.Patient was receiving Bromide 1cc SC right arm given
since day received IV Glutathione 7cc and 10cc phospholipid choline IV. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 15. Within 24 hours of injection patient
reported increased swelling, increased pain left arm and redness to entire body.
No itching, no difficulty breathing. On return to clinic pain and swelling had
improved, no redness seen to body. Very slight swelling of injection arm - well
below injection site with slight warmth - no redness to site. Within 2 days no
symptoms..Paient had NO.Paient has the following illness history - Allergy to
IVP dye.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a pharmacist concerning a female who was
vaccinated IM in the deltoid with a standard 0.5 nl dose of pneumococcal 23v
polysaccharide vaccine (lot 647661/0055R or 650083/0746P). Subsequently the
patient developed arm swelling and pain. The pain in her arm caused the patient
to fall and break her hip. Unspecified medical attention was sought the patients
outcome was unknown. There was no product quality complaint involved. Upon
internal review, the patient's hip fracture was.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 10. After 24 hrs-next day: 1)L arm slight
swollen and red at the site; 2)Arm moved only with difficulty and pain; 3)Lymph
glands in axilla swollen and painful; 4)pain across back and down L breast when
movement of arms..Paient has the following illness history - Metamucil,
Penicillin, Phenobarbital.Patient was receiving Vitamins, Quinine Sulfate,
Estrogen patch. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 83 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 27. Information has been received from a
health professional concerning an 83 year old female with hypertension, high
cholesterol and a shellfish allergy who on Dec 27 2005 was vaccinated IM in the
left arm with a second 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine
(lot 651329/1047P). Concomitant therapy included lisinopril (Zestril), warfarin
sodium (Coumadin), potassium chloride (K Dur), furosemide (Lasix Furosemide),
metoprolol succinate (Toprol XL Tablets), atorvastatin calcium (Lipitor),
sertrali.Paient has the following illness history - Hypertension, Cholesterol
high, shellfish allergy..Patient was receiving Xanax;Lipitor;Nexium;Lasix (Furosemide);Imdur;Zestril;Toprol
XL Tablets; K-DUR;Zoloft;Coumadin.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from WA, USA. Female patient, 65 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 09. Vaccine given SQ left lateral
inferior arm, 10cmx 7 cm redness, induration 4x4cm. Tx to include Benadryl ,
warm pack and f/u 1-12-06 in clinic for re-eval..Paient has the following
illness history - Advil-rash.Patient was receiving Aricept, Celebrex, Oxybutynin.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NJ, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Dec 2005, 14. Information has been received from a nurse concerning a 57 year
old white female (previously reported as 72 year old female) with asthma and no
history of adverse drug reactions or allergies. On Dec 14 2005, the patient was
vaccinated intramuscularly with a 0.5ml dose of Pneumococcal 23v polysaccharide
vaccine (lot 651318/1006P). Concomitant therapy included levothyroxine (Levoxyl),
pirbuterol acetate (Maxair), fluticasone propionate + salmeterol xinafoate (Advair)
and bupropion HCL (Wellbutrin). On Dec 15.Paient has the following illness
history - Asthma.Patient was receiving Wellbutrin, Advair, Levoxyl,
Maxair.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from GA, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 03. L arm and erythema distal to and at site
of injection with warmth or tender to touch. Patient states that 2 o'clock after
injection L arm began to be sore and red and progressed through the day and
night. Patient given Allegra 60mg, Medrol Dose Pack-offered pain med-pt declined
pain medicine.Paient has the following illness history - NFDA, Hyperlipidemia,
Prostate CA-stable.Patient was receiving Lipitor 40mg 1/2 qid.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 74 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 09. Numbness and weakness in legs progressed
to arms, face about 1 week before presenting to physician 12/27/05. Tx: IVIG.
Diagnosed GBS..Paient has the following illness history - Asthma; GERD; S/P knee
replacement.Patient was receiving ASA; Nexium; Pulmicort; Singulair; Milk
thistle. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 10. Fluzone vaccine administered by accident.
Patient had local reaction at age 19. She has never had the flu vaccine since.
Patient reacted with redness and itchiness..Paient had Arthritis flare.Paient
has the following illness history - NIDDM, HTN, GERD, CVA, Asthma, Allergies,
Diverticulosis, Gastric bypass.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 35 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 20. Patient received pneumococcal vaccine,
lot# 0877R, right deltoid in clinic 12/20/05. Called office 12/22/05 to report
right deltoid pain, itching, redness, swelling at injection site, et syncope on
12/20/05. Advised to go to ER. 12/23/05 notified patient at ER with fever 103,
severe body myalgias, HA, suspects meningitis. Work up for meningitis was
negative. WBC 20,000. Patient was discharged 12/27/05..Paient has the following
illness history - No known allergies. Congenital Heart Disease - ASD..Patient
was receiving Elidel PRN, Klonopin 0.5 mg PRN anxiety, Lexapro 20 mg
daily..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 39 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 20. Patient received Pneumococcal Pneumovax
vaccine IM right deltoid lot #0605R. Called 12/22/05 to report right arm
swelling, heat, itching, underarm pain. Advised patient to take allegra and
ibuprofen. 12/23/05 called patient. Patient doing better, pain gone, swelling
improved..Paient has the following illness history - No known allergies.
Congenital Heart Disease.S/P coarctation repair..Patient was receiving Paxil 20
mg PO Daily, Albuterol inhalation daily, Allegra D PO Daily PRN, Xanax PRN,
Tenormin 25 mg PO BID. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 71 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 28. Patient went to ER with local reaction to
left arm from pneumovax 23 lot #0740R. Swelling, pain at site..Paient has the
following illness history - CAD, HTN, hyperlipidemia..Patient was receiving
diprolene 0.05mg, lisinopril 20 mg, lisinopril/HTCZ 20/25, allergra 180 mg
daily, toprol XL 125 mg daily, zocor 20 mg qhs, colace 100 mg bid, ASA 325 mg
daily..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 15. Patient Recieved Pneumovax for pneumonia
vaccine and was a little nervous because of her severe allergy to different
types of nuts. 5 - 10 minutes after her vaccination she felt fine. About 20 - 25
minutes later, the patient felt a bit warm and felt like she was itching all
over. She described it as wearing wool. She was a little red and felt like she
had a couple of red marks on her. She otherwise felt fine. She was administerd
50 mg of oral Benadryl and rested in a chair for 30- 40 minutes. The patient
fe.Paient has the following illness history - nut, erythromycin, penicillin,
sulfa allergy. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 12. PT REPORTED RASH FROM SHOULDER TO ELBOW,
SLIGHTLY ITCHY, TX'D WITH BENADRYL 25MG, RASH GONE IN 4 DAYS..Paient has the
following illness history - HTN, GERD, SEASONAL ALLERGIES, MILD OA.Patient was
receiving HCTZ, METOPROLOL, NEXIUM, RANITADINE, ALLEGRA, CALCIUM, FOLIC ACID,
GLUCOSAMINE, FLAXSEED. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 22. Vaccine administered in left deltoid 11am
12/22/05. Patient states arm swelled, red, painful to touch by 8pm on 12/22/05.
Reported to Dr. on 12/23/05. States arm is improving and will use Benadryl for
reaction.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WV, USA. Female patient, 38 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 09. Swollen, red, hot L arm.Paient has the
following illness history - armpit/hot-rash. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CO, USA. Female patient, 52 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Aug 2005, 29. This patient who was hospitalized for
endometrial cancer was administered a pneumococcal vaccine on 08/29/2005. On
08/30/2005 she noticed increased pain and swelling at the pneumococcal injection
site. The inflamed area around the injection site was 2 inches. The affected
area was warm to the touch and was treated with ice packs. The patient was
prescribed Benadryl orally 25-50 mg as needed..Paient had endometrial
cancer.Patient was receiving dalteparin, lorazepam, oxycodone, Coumadin, Colace.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CO, USA. Female patient, 83 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 21. Information has been received from a
physician concerning an 83 year old female patient with an iodine allergy who in
21-Dec-2005 was vaccinated in the left deltoid with a dose of pneumococcal 23v
polysaccharide vaccine. At the time of vaccination the patient had "PMR", low
back pain, atrial arrhythmias, and hypertension. On the same day, 21-Dec-2005,
following vaccination, the patient experienced a systemic reaction "following
revaccination" and became completely white and stiffened up. Unspecified
medical.Paient has the following illness history - Iodine Allergy.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 74 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 26. Information has been received from a
Registered Nurse concerning a 74 year old male consultant with an allergy to
penicillin who on 26-Oct-2005 at 11:00 a.m. was vaccinated IM in left deltoid
with his first dose of pneumococcal 23v polysaccharide vaccine (lot
#651539/6607R). The patient was ill with chronic sinusitis at the time of
vaccination. There was no concomitant medication. On the same day, the patient's
left arm became sore. On 27-Oct-2005 the patient felt fatigued and developed
redness over left ar.Paient has the following illness history - Penicillin
Allergy;Chronic Sinusitis. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 47 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 22. On 12/23 patient developed fever up to
104 at home. Presents to hosp ER and noted document that left arm demonstrates
an area of erythema about the size of a silver dollar, tender to touch and
indurated. Fever continued per patients about 12 days. Admitted on 12/31 for
evaluation meningitis..Paient has the following illness history - Hx of
Pneumonia. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 15. Night of vaccine arm was very painful;
shoulder and upper arm next morning noticed very swollen and warm. No
intervention done lasted about 3-4 days.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 49 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 13. R deltoid. Circular red raised, warm,
tender to touch, 3x4 circular area..Paient has the following illness history -
Yellow dye MSO4-tye#3. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OR, USA. Female patient, 35 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 06. Within 1/2 hour arm became painful and
swollen at site. The swelling continued and spread from shoulder to elbow over
the next 24-48 hours. Patient contacted an on-call physician and was prescribed
Omnicef with 3 doses. About 18 hours the swelling almost totally resolved still
had muscle tenderness. No fever..Paient had URI.Paient has the following illness
history - No allergies or birth defects. Anorexia nervosa.Patient was receiving
Celexa 40mg. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 59 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 10. Patient presents 1/11/06 with L arm
swollen, red, hard, warm in large area distal to vaccination sites. No
streaking, margins of induration uneven. Denies itching, reports fever.
Prescribed Keflex, Motrin and Benadryl..Paient had Abdomen tenderness.Paient has
the following illness history - Adult onset diabetes mellitus,
Osteoarthritis.Patient was receiving Prilosec, Naprosyn, Tylenol #3,
Glipizide.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 73 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 14. L deltoid to elbow red, warm and tender
to touch.Paient has the following illness history - PCN, erythromycin. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NE, USA. Female patient, 51 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 31. Inflamed, hot, hard, fever 101, achiness
and neck stiff..Paient has the following illness history - Asthma Gout.Patient
was receiving Inderal LA;Allopurinol;Albuterol Inhaler;Flonase;Claritin. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 12. Patient received a pneumonia
polysaccharide vaccine on 01/12/2006 at 2:30pm. Patient reports that left arm
became sore and could not use arm about 3 hours after receiving vaccine. Patient
also reports pain in left shoulder and elbows and weakness in knees. Patient
also reported having a fever that night with nausea and reporting having
flatulence. Patient evaluation on 01/13/2006. Temperature of 99.2 degrees. No
swelling in left arm, but tenderness noted in the left bicep and tricep. Patient
reports.Paient has the following illness history - Hypertension, Heart
Disease.Patient was receiving Vitron, Niacin, Lopressor, Hydrochlorothiazide,
Calcium, Aspirin, Potassium, Multivitamin, Ibuprofen.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NE, USA. Female patient, 77 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 22. Chills and sore arm, not sure how long
lasted, but did resolve..Paient had No.Paient has the following illness history
- Hypertension, Hyperlipidemia, Arthritis, Claudication..Patient was receiving
ASA, Celebrex, Plavix, Zocor, HCTZ, Terazasin, Toprol, Zetia, MVI. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 46 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 09. Information has been received from a
registered nurse concerning a 46 year old female who on 09-Jan-2006 was
vaccinated intramuscularly in the right arm with a 0.5 ml dose of pneumococcal
23v polysaccharide vaccine (lot 649914/0578P). Later that same day on
09-Jan-2006, the patient developed redness, pain, swelling, and hardness to her
right arm. On 10-Jan-2006, the patient contracted the office to report the
symptoms and that she could not lift her right arm. The physician started the
patient on therapy wi.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 07. Information has been received from a physician concerning an
approximately 80 year old female with type II diabetes mellitus and asthma who
on approximately 11/07/2005 was vaccinated SQ with a 0.5 ml dose of Pneumococcal
23v polysaccharide vaccine (lot # 649914/0578P). Concomitant therapy included an
unspecified oral therapy. the physician reported that the patient had been
previously vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine
(date unknown). Subsequently the patient developed redness.Paient has the
following illness history - Type II diabetes mellitus;Asthma.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 07. Information has been received from a physician concerning a 45
year old female with type II diabetes mellitus who on approximately 11/07/2005
was vaccinated SQ with a dose of Pneumococcal 23v polysaccharide vaccine (lot
#649914/0578P) and a dose of influenza virus vaccine (unspecified) into the
opposite arm (unspecified). Concomitant therapy included an unspecified oral
therapy. Subsequently the patient developed redness, pain and swelling to the
arm that was used for the Pneumococcal 23v polysaccharide vac.Paient has the
following illness history - Type II Diabetes Mellitus.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient, 54 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 14. Swollen from shoulder to elbow- red and
warm to touch. Encourage to apply cold compress and follow up with PMD.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MO, USA. Female patient, 80 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 31. Profound myalgia upper extremities.
Myositis. Several days after injection reaction at 6 wks post..Paient has the
following illness history - CAD;Hyperlipidemia;Tremors.Patient was receiving
Inderal 120mg la and qd;Trental 400mg tid. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 47 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 18. Pt come to VNA office 1/12 or 1/13 and
said he still had soreness in right arm from pneumonia shot. He had been to see
his doctor. His DR told him to get an x-ray first. Rx was dated 11/22/05. He
still had not done so..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from NY, USA. Female patient, 76 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 10. On 1/10/06 pt received influenza
and pneumococcal vaccine in the left deltoid area. Pt returned on 1/13/06
reporting increased swelling and redness in this area. DR. assessed pt placed on
Augmentin 875 mg bid x8 days..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, child 11 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 16. Left arm 16 x 20 cm induration with edge
of erythema central pallor, warmth administered 9:30 swelling by 5 pm follow day
current description. Right arm 4 x 4.5 cm total erythema, swelling, warmth at
sit of Menactra 24 hours later..Paient has the following illness history -
Asthma;Allergy to ibuprofen, aspirin;Suspected allergy to shellfish..Patient was
receiving Singular 5mg qns;Advair 100/20 one BID; Zyrtec D one BID. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient, child 8 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 07. Nurse gave Pneumovax vaccine that had
expired on June 2005 to this patient. In talking to the mother on 11/17/05 she
reported that child had a red swollen L arm on 11/8/05. Patient had fever(did
not take). Mom took child to Dr. who gave oral Benadryl and Tylenol. Arm
remained red and swollen on 11/9/05. Child okay within two days and Benadryl and
Tylenol. MD to check with another MD about whether to repeat in light of local
reaction and child condition. (Sickle cell disease).Paient has the following
illness history - Sickle Cell Disease.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from DE, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 27. Patient called to report that he had
swelling of his upper arm - the same arm the pneumonia shot was given. Swelling
subsided by PM 10/28. No redness.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient, 82 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 09. PATIENT DEVELOPED A RED, SWOLLEN, ITCHY
UPPER ARM AT THE ADMINISTRATION SITE WITHIN 12 HOURS OF ADMINISTRATION. PATIENT
TREATED WITH STAT ORAL DIPHENYDRAMINE PRESCRIBED BY PHYSICIAN. ALSO PRESCRIBED
FOR THE ADVERSE REACTION WAS ATARAX 25MG PO Q 6 HRS PRN X 3 DAYS..Paient had
1/5/06 RESIDENT WAS PRESCRIBED LEVAQUIN 500MG X 10 DAYS AS WELL AS MUCO-FEN DM
FOR UPPER RESPIRATORY SYMPTOMS..Paient has the following illness history -
ALLERGIC TO PENICILLIN CONGESTIVE HEART FAILURE HYPERTENSION ATRIAL FIBRILLATION
GERD.Patient was receiving MUCOFEN-DM, LEVAQUIN, HEPARIN SUB-Q (D/C'D ON 1/6/06)
NITROGLYCERIN OINTMENT, CARAFATE, DIGOXIN, COLACE, ASPIRIN, COUMADIN, LASIX, PPD
(TUBERSOL) WAS ADMINISTERED UPON ADMISSION TO THE NURSING FACILITY 1/3/06..
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient, 91 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 12. PATIENT DEVELOPED WARM, SWOLLEN, TENDER,
REDDENED AREA AT INJECTION SITE..Paient has the following illness history -
ALLERGY TO PENICILLINS, SULFA, BACTRIM, PROCARDIA, ISOSORBIDE. CONGESTIVE HEART
FAILURE, HYPERTHYROIDISM, HYPERTENSION, CORONARY ARTERY DISEASE.Patient was
receiving PPD (TUBERSOL/APLISOL) DONE UPON ADMISSION TO FACILITY AT 1/10/06.
AMBIEN 5MG PRN INSOMNIA, PLAVIX, ASPIRIN, ZOCOR, ALTACE, KLOR-CON, PROTONIX,
TOPROL XL, LASIX, PRN ZOFRAN. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CO, USA. Female patient, 46 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 03. Pt developed erythema, induration at site
of immunization. She presented to the ER as erythema spread down her arm and up
shoulder. High fever. Admitted to hospital. Seen by infections disease
specialist who felt reaction was cellulitis in hospital x5 days on IV a
lot..Paient had Pneumonia.Paient has the following illness history - Patient
with Multiple Sclerosis on REBIF.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 36 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 02. Contracted cellulitis within hours of
receiving flu shot. Extremely sick almost hospitalized. I was on antibiotics for
14 days..Paient has the following illness history - Penicillin allergy.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 17. 24 hrs status post injection, pt has
erythema, edema and pain at site. Pt also with fever of 101 &102, no CP, no
SOB..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient, 47 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 08. I receved flu and pneumococcal vaccine on
11-08-05 were I work at 1:15 pm. The flu shot went in my right arm and
pneumococcal in the left arm. I felt some stinging after the pneunococcal shot
was given in the left arm but didn't make anything of the situation. By 5:00 PM
I went to the office and told the first aid person to look at my left arm
because it felt like it was on fire and I couldn't raise my arm. She took one
look at it and called the head person of first aid on my shift and decided to
take me.Paient had Site reaction and blood poisoning..Paient has the following
illness history - Multiple Sclerosis, under active thyroid..Patient was
receiving Avonex for treatment M.S., paxil 20mg, clonazepam 1mg levothyroxine
137mg.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 71 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 21. On 1/20/06 patient telephoned to
Department of Health. Pt. states aprox. 5 days post vaccination(10/21/05) had
rash on back, arm leg and feet, which later blistered. Pt. was evaluated by pvt.
MD. Pt. states doctor informed her that rash was due to "the flu and/or
pneumonia shot". Doctor is on vacation until 1/31/06 and is not available for
confirmation. Pt. also states that has blisters on feet and has home health
nurses to come weekly to do foot and dressing care. Pt. states had received flu
shot before.Paient has the following illness history - HTN.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 54 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 28. PATIENT DEVELOPED CELLULITIS AT THE SITE
REQUIRING ANTIBIOTICS APPROXIMATELY TWO DAYS AFTER INJECTION..Paient had HEP C.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, child 10 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 07. Flu and Pneumovax given on Dec 7 2005.
Since vaccine running increased fever, malaise, myalgias. And testing CRP,
bloodwork etc negative, fever on and off about 6 weeks. Had redness, swelling,
tenderness to R arm site 2 days after inject given. Still running on and off
fever, malaise, myalgias..Paient had Sinus infection.Paient has the following
illness history - Diabetic. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, child 4 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 24. Came into office 1-25-06 complaining of
leg pain. Examined by Dr; found to have severe quadricep muscle spasm, fever and
swelling to the site of vaccine..Paient had runny nose/cough/congestion (cold).Patient
was receiving On Nasonex at time of vaccine. Gave Tylenol and Motrin for pain
after vaccine..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 10. Pt received Pneumovax while at her reg
office visit pt called back 01/12/2006 to report increased redness, warmth,
edema left arm and painful symptoms resolving now after cold packs and Benadryl
PRN.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). Pt
c/o 12-24 hours after receiving Pneumovax. Pt c/o swelling, redness, warmth from
deltoid to elbow. Aches also, resolved 72 hours after shots..Paient has the
following illness history - Allergic Sulfa, Naprosyn.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 48 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 13. Tongue swelled that evening, he was
treated in ER with Cortisone and Benadryl and problem resolved by the next
day..Paient has the following illness history - Diabetes, Hypercholesterolemia,
Hypertension, allergic rhinitis..Patient was receiving Lisinopril, Metformin,
Lipitor, ASP..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, child 00.5 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 05. 14 hours after immunizations were
administered, developed a low grade fever. Two hours later, she began seizing.
She had 3 seizures in 20 minutes. Was taken to the ER, had a temp of 101.4, was
given Motrin, seizures seemed to stop, was discharged with "fever related
tremors." Later that day, she had 2 more seizures, went back to ER, was admitted
after having 3-5 more seizures. Episodes continued for 9 days, approx 5 minutes
to 4 hours apart, lasting anywhere from 10-15 seconds to 3 minutes. Testing
included.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient, 42 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 12. Allergic dermatitis, erythematous
maculopapular rash on post and trunk, extremity..Paient has the following
illness history - Ibuprofen, Iodine.Patient was receiving HCTZ. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NM, USA. Female patient, 48 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 03. Pain, weakness and decreased range of
motion of L arm since 11/3/05 when Pneumovax injection was given in L arm
(deltoid). Affects entire arm from L shoulder to forearm (on of sensation. Seen
in clinic 1/3/05 and 1/19/05 with same symptoms.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from SC, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 17. Swelling, rash, pain, erythema at
injection site, extends to shoulder and down L arm.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 26. L arm swelling at site of Td. Induration
and tender erythema, 7x12 cm, chills, c/w cellulitis..Paient had No.Paient has
the following illness history - Egg, erythromycin allergies..Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IA, USA. Female patient, 33 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 25. Information has been received from a
physician concerning a "normally very healthy" 33 year old white female
non-smoker with a history of acute otitis media, caesarean section requiring
hospitalization, and an allergy to clarithromycin (Biaxin) who on 25-Nov-2005 at
09:30 am was vaccinated in the right deltoid with an eighth dose of pneumococcal
23v polysaccharide vaccine (lot #A651319/1007P). Illness at the time of
vaccination included bilateral maxillary sinusitis. The patient was hospitalized
for celluli.Paient had Maxillary Sinusitis;Upper Respiratory Tract
Infection.Patient was receiving Augmentin, Nubain, Phenergan, Zithromax,
Levaquin.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Dec 2005, 20. Information has been received from a pharmacist concerning a 35
year old female with congenital heart disease who on 12/20/2005 was vaccinated
with a dose of Pneumococcal 23v polysaccharide vaccine (lot # 651859/0877R),
right deltoid intramuscularly. On 12/23/2005 the patient experienced redness,
pain, itching, swelling at the injection site. She then developed syncope. She
went to the ER. She was admitted to the hospital for high fever (103F), headache
and severe myalgia. She was tested for a multiple of t.Paient has the following
illness history - Heart disease congenital..Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from LA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Jan 2006, 10. Information has been received from a health professional
concerning a 55 year old female with penicillin allergy and unspecified
allergies who on 10-Jan-2006 was vaccinated with a dose of pneumococcal 23v
polysaccharide vaccine (0.5 ml) (lot #651330/1048P), intramuscularly.
Concomitant therapy included allergy shots and cholesterol medicine. On
10-Jan-2006 the patient's arm had a red swollen (size of an orange) reaction
with a dark center in it. The area was located around the injection site. Also,
the pati.Paient has the following illness history - Penicillin allergy,
Hypersensitivity.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 07. Information has been received from a physician concerning an
approximately 60 year old female with type II diabetes mellitus who on
approximately 11/07/2005 was vaccinated SQ with a dose of Pneumococcal 23v
polysaccharide vaccine (lot #649914/0578P) and a dose of influenza virus vaccine
(unspecified) into the opposite arm (unspecified). Concomitant therapy included
an unspecified oral therapy. Subsequently the patient developed redness, pain
and swelling to the arm that was used for the Pneumococcal 23v pol.Paient has
the following illness history - Type II diabetes mellitus..Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Jan 2006, 11. Information has been received from a pharmacist concerning an 81
year old female inpatient, with drug hypersensitivity to aspirin and meperidine
hydrochloride, and allergy to penicillin, and a history of dyspnea and
hypertension as an emergency, who on 1/11/2006 was vaccinated with a second dose
of Pneumococcal 23v polysaccharide vaccine. The patient was an inpatient at the
hospital at the time of vaccination. It was reported that the patient had been
vaccinated two weeks earlier with a dose of Pneumococca. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, child 6 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 14. Fever 103, sore arm, hives/welts down
both arms..Patient was receiving Nasonex, Poly Vi Flor. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 17. Cellulitis-like warm erythematous skin
1x9 cm in length below injection site..Patient was receiving Capoten,
Hydrochlorothiazide Mantox cream, Lovastatin. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AZ, USA. Female patient, 21 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 17. Large painful local reaction with > 10 cm
swollen, erythematous, indurated area with fever 102 degrees F..Paient has the
following illness history - Asthma.Patient was receiving Yasmin. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from MD, USA. Female patient, 25 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Jan 2006, 27. Reaction to Pneumococcal Vaccine:
Redness, Heat, Pain & Swelling at injection site along with Headache, chills,
slight fever. Patient seen in office, verbalized instructions to use Motrin,
cold packs, Benadryl, and to watch for increased symptoms. Will follow up with
patient tomorrow.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MT, USA. Female patient, 84 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 29. On Mon 01/3/06 10:00 found injection site
red ring and pale flesh colored center..Paient had Unstable angina, Afib, UTI
resolved..Paient has the following illness history - Sulfa, Amoxil. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 20. Fever, chills, temp, headache, dry cough,
anorexia, weight loss..Paient had Viral upper respiratory.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Jan 2006, 18. Left thigh red, swollen and hard.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 53 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 01. Injection site red, tender, swollen
arthralgia left arm. F/U visit 01/11/2006 pt C/O tenderness, slight
redness..Paient had Follow up visit.Paient has the following illness history -
DM II, Depression, Obesity.Patient was receiving Prozac, Amitriptyline, Xanax,
Glucotrol XL. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 07. Information has been received from a physician concerning a 71
year old female with hypertension 7/28/1999, hyperlipidaemia06/26/2001 and
pneumoconiosis 1989 who on 1/7/2005 at approximately 11:00am, was vaccinated
with a dose of Pneumococcal 23v polysaccharide vaccine. Concomitant therapy
included benidipine hydrochloride (Coniel), pravastatin NA (mevalotin), vitamin
E nicotinate (juvela N) and Clotiazepam (Rize). 11/7/2005, in the evening, the
patient developed injection site swelling, warmth and redness.Paient has the
following illness history - Hypertension, Hyperlipidemia,
Pneumoconiosis..Patient was receiving Coniel;Rize 5mg;Mevalotin;Juvela N 200mg.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 53 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 05. Information has been received from a
physician concerning a patient who was vaccinated with a dose of pneumococcal
23v polysaccharide vaccine. Subsequently, the patient developed an injection
site reaction and extreme swelling. The patient's outcome was unknown. Follow up
information has been received from a physician and from medical records
concerning a 53 year old white female smoker (1/2) pack a day) with
hypothyroidism, hyperlipidemia, hypertension, and on therapy for menopause, and
a history of kidney.Paient has the following illness history - Kidney stone,
colonoscopy, tubal ligation, nausea, ovary removal, hypothyroidism, menopause,
hyperlipidemia, smoker, hypertension..Patient was receiving
Activella;Vytorin;Levothroid;Diovan. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX). It
was reported in a published article, title as stated above and presented at the
2005 annual meeting of the American college of allergy, asthma and immunology,
Nov 3-9 2005 concerning a 23 year old female with chronic mucocutaneous
candidiasis who began to suffer from persistent thrush, failure to thrive,
recurrent otitis media (staph aureus) and pneumonia (staph aureus and
pseudomonas aeruginosa) since 6 weeks of age, who was vaccinated with
Pneumococcal 23v polysaccharide vaccine (manufacturer unknown),.Paient has the
following illness history - Failure to thrive, Pneumonia, Transplant, Serositis,
candidiasis, Otitis media chronic, chronic mucocutaneous candidiasis..Patient
was taken to emergency room. Patient died.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient, 49 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 09. Information has been received from a
nurse practitioner concerning a 49 year old female with a history of
hypertension, polycythaemia Vera and allergies to soy products who on 12/09/2005
at approximately 2:00 pm was vaccinated with a first dose of Pneumococcal 23v
polysaccharide vaccine 0.5ml (lot 650453/079P), in the right deltoid.
Concomitant therapy that day included a dose of hepatitis A virus vaccine
(unspecified) (+) hepatitis B virus vaccine (unspecified) (lot AHABB28AB), in
the left deltoid. Concomi.Paient has the following illness history -
Polycythemia vera;Hypersensitivity;Hypertension.Patient was receiving Atacand,
Toprol XL tablets.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 49 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 01. R arm pain and swelling post flu and
pnemovax injections warm to touch. Sx noted after 24 hrs of injections- local
reaction..Paient had non.Paient has the following illness history - Depression,
acne, allergy to septra, allergy to lexapro..Patient was receiving tetracycline
250mg caps bid for acne, temazepam 15mg caps 1 cap q hs,prn, tretinoin 0.05% cr
for acne, avelox 400 mg tab 1 tab qd, minocycline 50 mg caps 1 cap qd for acne.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient, 47 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 03. Pain at injection site that spread to
shoulder joint, under arm and down toward elbow, around to back, and up toward
neck. Difficulty sleeping. Soreness was severe upon movement of arm in the night
(worse between 1:30a.m. and 1:00p.m.). General feeling of sickness and fatigue
for approximately 30 hours after vaccination. Arm itching and sore to the touch
and difficulty raising it 39 hours after vaccination. Received first Pneumovax
in 2000..Paient has the following illness history - Diabetes type 1. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AZ, USA. Female patient, 51 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 01. Streaks on R arm one day post vaccine.
General lethargy and seen by Dr. on 2/2/06 at 7pm. Received hydrocortisone shot
and Augmentin.Paient had cold.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient, 38 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 03. Initial report received on 1/30/2006 from
the patients parent. A 38 year old female patient with a history of pericarditis
and insulin dependent diabetes had received an administration (route not
reported) of Fluzone SV 2005-2006 USP lot number not reported, in the left arm,
and an administration route not reported, of another manufacturers Pneumovax 23
vaccine, lot number not reported in the left arm on 11/03/2005. that same day
the patient developed chest and shoulder pain. the patient was uncomfortable
f.Paient has the following illness history - Per the reporter, the patient had
no illnesses at the time of the vaccination. The patient had a history of
pericarditis and insulin dependent diabetes. She was taking Cozaar, Levoxyl and
Lantus at the time of the vaccination..Patient was receiving
Cozaar;Levoxyl;Lantus.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 74 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 03. Left upper arm inferiously with 11.0 X
9.0 C erythema with mild increased warmth, only slight induration at superior
aspect..Paient had swollen ankle.Patient was receiving MVI, HCTZ 25 mg qd,
Atenolol 100 mg qd, prednisone 5 mg, cozaar 100 mg qd, actonel 25 mg wkly, asda
81 mg qd, omega 3 & 6 qd, pravachol 40mg qd, k-dur 10 meq qd. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Jan 2006, 17. Information has been received from a registered pharmacist
concerning a 51 year old male with history of psychiatric issues, history of
seizures "that occurred a long time ago" who "one week ago" was vaccinated with
a dose of pneumococcal 23v polysaccharide vaccine (0.5 ml), intramuscularly.
Subsequently, the patient experienced seizures. The patient was treated with
levetiracetam (KEPRA), and "is much better now." The reporter considered
seizures to be other important medical event (OMIC). Additional infor.Paient has
the following illness history - Convulsion;Psychiatric disorder NOS.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a published literature article concerning a
7/12 year old male who was vaccinated with Pneumococcal 23v polysaccharide
vaccine and varicella virus vaccine live (date unknown). On an unspecified date,
the patient developed neutropenia, x linked agammaglobulinemia, streptococcus
pneumonia (serotype 18F) meningitis, pneumonia, varicella titer was negative and
he did not developed antibody responses to diphtheria, tetanus and pneumococcal
antigens. At the time of this report,. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 79 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 07. Patient had pneumonia shot 2/7/06 - Right
arm is red, swollen and firm from shoulder to elbow. Also area is itching. No
pain, patient started feeling itchiness in right upper arm last evening. Zyrtec
10mg to take one daily for 7 days given 2/8/06. B/P 108/64-60-20-98.Paient has
the following illness history -
Diabetes;HTN;Anxiety;Depression;Hypercholesterolemia.Patient was receiving
ASA;Atenolol;Fluoxetine;Fosamax;HCTL;
Ibuprofen;Lantus;Lisinopril;Nasacort;Zoloft.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, 87 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 17. Redness, warm, tenderness at injection
site. Patient also complained of feeling "woozy" next day. Pt. given Zyrtec.
Redness decreased and better within 2 days after injection..Paient had
fatigue.Paient has the following illness history - hypertension, hyperlipidemia,
aortic stenosis.Patient was receiving Fosrnopril, furosemide. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, 73 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 06. Pt reported soreness night of vaccine,
next morning came into clinic, arm red, warm, tender approximately 5x6 area. Pt
will take Benadryl..Patient was receiving Lipitor, Premarin, Omeprazole. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Jan 2006, 11. Cellulitis around injection site.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 25 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 06. Initial report received on 09/Jan/2006
from a health care provider. A 25 year old male patient had received and
administration (route not reported) of Menactra, lot number U1877AA, in the left
deltoids; a subcutaneous injection of YF-VAX, lot number UE664AB, in the right
arm; an administration (route not reported) of another manufacturer's
Pneumococcal vaccine, lot number 1047P, in the left deltoid and an
administration (route not reported) of another manufacturer's Hepatitis B
vaccine, lot number 0031P, in.Paient has the following illness history - The
patient had no illness or pre-existing medical conditions at the time of this
report..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 25 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 28. Information has been received from a
nurse practitioner concerning a 25 year old female inpatient with obesity, other
unspecified conditions, latex allergy, morphine allergy, and multiple other
medication allergies, who on 12/28/2005 was vaccinated subcutaneously in the
left arm with a dose of Pneumococcal 23v polysaccharide vaccine (lot unknown)
and influenza virus vaccine (unspecified), prior to discharge from the hospital.
Patient was in the hospital for an unspecified reason. Nurse reported that the
pat.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a female patient who
was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. The day
after vaccination, the patient experienced seizure-like symptoms. Subsequently,
the patient also experienced soreness. Unspecified medical attention was sought.
At the time of this report. the patient's outcome was unknown. No product
quality complaint was involved. Upon internal review, seizure-like symptoms were
considered to be an other important me.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from ME, USA. Female patient, 83 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 06. Reddened area app 3" around injection
site. Started with shoulder pain in evening worsening during night. No better no
worse this am..Paient has the following illness history - Hyperlipidemia, Toe
injure, Right knee replacement.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Feb 2006, 08. Pt c/o having fever, chills and not feeling well. Pt has red
edema on right arm deltoid area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IA, USA. Female patient, 78 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 08. One day post vaccination patient
complained of increasing mild redness and soreness. Whole arm started to swell
by the time the patient returned home from our office on the day of
immunization. Patient went to emergency room; Benadryl recommended..Paient has
the following illness history - Hyperlipidemia, depression.Patient was receiving
Lexapro 20 mg.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 21 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 01. The patient developed a painful, swollen,
mildly red area on her left posterior upper arm. The patient also experienced an
increased heart rate (up to 150 bpm), fevers (up to 40.8 C), and increased white
blood cell count (up to 26,000). She was started on naproxen 250mg by mouth
three times daily..Paient had Pneumonia.Paient has the following illness history
- Acute disseminated encephalomyelitis..Patient was receiving APAP, azithromycin,
ceftriaxone, famotidine, ferrous sulfate, heparin sodium, albuterol nebulizer.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 49 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 09. Pt. c/o low grade fever and injection
site was red, swollen, and painful to touch for 4 days after injection..Paient
had Elevated blood sugar, newly diagnosed diabetic.Patient was receiving Not on
any other meds.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from VA, USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 09. 4:30 went out to dinner drank 4 beers,
ate a few french fries and bites of burger then said he wasn't feeling well.
5:30 pm that day nauseated and pale, dicphoratic, stumbling. 1am 2/10/06 till in
the middle of the night, disoriented fell and broke rib, nausea, vomiting. Went
to ER. These events reported by daughter..Patient was receiving Lipitor,
Hydrochlorothiazide, Atenolol, ASA 81mg.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OR, USA. Female patient, 63 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 10. Patient died in her sleep the night after
receiving the vaccine..Paient has the following illness history - NKDA or birth
defects. Diabetes, HTN, hyperlipidemia, obesity hypothyroidism, GERD,
cataracts.Patient was receiving metformin, avandia, lipitor, hctz, cozaar,
synthroid, omeprazole, asa. Patient died on -0/00/2006.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from NC, USA. Female patient, 74 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 08. Discomfort L arm 2-10-06;
Induration and erythema; tenderness; temp 100. Treatment-Medrol Dose pack and
Keflex 500 mg 3 times a day for 7days. 2-13-06 (Patient reports resolving).
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AZ, USA. Female patient, child 9 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 14. 4.5 cm x 6cm on R upper arm pain rated at
7-8 on 1-10 scale. Applied warm compress for about 15min..Paient had
Asthma.Patient was receiving Albutero Sulfate 0.083%, Brompheniramine DM/pseudopine,
ibuprofen (60mg/5ml) inhaler-Albuterol. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 01. Information has been received from a physician concerning a 60
year old male, with unknown pertinent medical history and unknown drug
reactions, allergies, who in 10/25/2006 or Nov 2005, was vaccinated route
unknown with a dose of Pneumococcal 23v polysaccharide vaccine (lot unknown). In
January 2006, the patient experienced Streptococcus Pneuomiae and was
hospitalized for 0-3 days. It was reported that the patient was treated with
antibiotics while in the hospital. The patients present status was
reported.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KS, USA. Female patient, 67 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 11. L upper arm with redness, edema, warm to
touch "sore". No shortness of breath..Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient, 83 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 18. Patient administered Pneumococcal vaccine
in upper right arm. Area of warmth and redness observed..Paient had
Bronchitis.Paient has the following illness history - Community -acquired
pneumonia, Thrombocytopenia.Patient was receiving Tylenol, Tessalon, Lovenox,
guaifenisin la, Moxifloxacin, potassium chloride. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 14. Left upper extremity swelling and
pruritus. Chills 1st night after injection 2-14-06. Treatment-warm compress.
Increase Left upper extremity- followup with physician. 2/20/06 -"much better
swelling down"..Paient had Rash, itchy legs and arms-Maxide reaction.Paient has
the following illness history - Maxide; History-hypertension.Patient was
receiving Lopressor, cardizimer, Aspirin. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AK, USA. Female patient, 76 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 31. Soreness at site of pneumonia vaccine 1st
night, some itching noted-redness and swelling noted from shoulder to elbow.
Lasted 2 weeks. 1st called 11/4/05-noted some improvement after five days
11/4/05. Follow up 12/1/05.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from ID, USA. Female patient, child 6 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 06. Pneumococcal vaccine given in deltoid IM.
Next day arm swollen, hot, red from shoulder to elbow. Pain with
movement..Paient has the following illness history - Thrombocytopenia (ITP)l.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AK, USA. Female patient, 83 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 03. States arm hurt - stinging at site within
3 hours of vaccinations. Continued to worsen in pain, noticed pinkish color at
site. Progressively got worse over next 5 days at which time client went to
local ER - given pill to swallow and script for Benadryl. Called us on 12/1 and
interviewed on 12/2. Arm improved as of today..Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 27. Arm swelling, red, warm, painful when touched.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 31. Approx. 4 hours after inj pt called c/o
red, warm, 'tight' left deltoid (inj site). Encourage antihistamine and icing
area. RC in 4 hours found pts arm red, warm and indurated with diff raising arm
due to "tightness @ arm" otherwise felt fine..Paient has the following illness
history - Sulfa-Hypersensitivity pneumonitis;2 hours Bird fancious
disease..Patient was receiving Fosamax. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 38 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 23. Patient given Pneumococcal vaccine,
Developed fever, malaise, headache, pain and induration at inj site. Increased
WBCs noted. Admitted, treated and released. No sequelae noted.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 63 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 26. Initial report received from another
manufacturer, report number WAES0511USA03790, on 2/15/2006. Information was
received from a health care professional concerning a 63 year old male patient,
with a history of asbestosis, who received an intramuscular, left arm injection
of Fluzone SV 2005-2006, lot number 01854AA (not a valid manufacturer lot
number), and an intramuscular, first dose, right deltoid injection of Pneumovax
23, lot number 649693/0456P, on 10/26/2005. Three hours post vaccination, the
patient.Patient was receiving Lipitor, Celexa, Lisinopril, Hydrochlorothiazide,
Vitamins.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AZ, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 24. Patient given Pneumococcal vaccine
developed fever, malaise, pain and swelling at inj site. Treated and resolved
with no lasting effect.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 38 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 17. Inflammation, severe pain, and redness
started in PM on 2/17/06. By the evening of 2/18/06, patient reports severe
pain, inability to move right arm, increasing redness of arm passing down past
elbow with streaking. Went to ER at this point where she was given Keflex,
Percocet and Benadryl. To return to primary MD on 2/21/06..Paient has the
following illness history - Thyroid cancer 4/12/05.Patient was receiving
Botox-1/28/06, Jasmine, Levoxyl.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 24 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 16. Pt presents to ER with fever of 103.1n
nausea, vomiting, headache, overall body pain. All occurring within 12 hours of
getting Pneumovax vaccine. Area of injection 8x7 cm area of erythema, warmth and
induration in his left deltoid region. Margins of erythema are sharp. Some
axillary tenderness without definite adenopathy. Pt also has had intermittent
shaking, chills and weakness.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient, 42 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 10. Severe pain at injection site. Right arm
- arm was incapacitated. Pt stated he got weak and fainted. ER ov - Oxycodone,
Percocet;IV..Paient has the following illness history - Asthma;Rhinitis.Patient
was receiving Advair;Rhinocort;Advil;Singular;Proventil.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IA, USA. Female patient, 46 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 02. Left deltoid, red itchy, warm to touch
and swollen. Distance line of where redness and edema stop. Used ice to site.
Also stated had nausea/aching that lasted approx 12 hours..Paient has the
following illness history - History of pneumonia. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AZ, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 17. Fever-headache localized swelling and
redness at injection site..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 51 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 11. Patient had right shoulder swelling and
pain increasing in severity with onset 1.5hrs post pneumoccoal vaccine. Swelling
in upper deltoid and hand and fingers, Ecchymosis at inferior border of deltoid
muscle. Fluid collection. MRI did reveal rotator cuff tear was present..Paient
has the following illness history - Diabetes Mellitus, Status post- pancreas and
kidney transplant, recurrent UTI's, osteomyletis, pathology foot
fracture.Patient was receiving Fosamax, Lamisil, Pepcid, Sandiamune, Prednisone,
Lash, Imuran, Toprol XL, Ferrous Sulfa, orthro tricycline. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Jan 2002, 24. Localized reaction to Pneumovax placed 1/24/06. Pt seen
1/27/06. Erythema upper L arm. No weeping, tenderness. Swelling. Rx'd Medrol
dosepack Benadryl. 1 week followup..Paient has the following illness history -
Celebrex, Hypertension.Patient was receiving Cozaar, Hydrochloride, Aspirin.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 13. Tetanus site: induration, color, erythema
immediately surrounding injection site 5cm height by 7cm width; Pneumovax site:
no reaction at injection site but pt had 2 areas of color and erythema on lower
portion of arm-see diagram on back. No lymphadenopathy noted. Low grade fever
100..Patient was receiving Synthroid, triamterene/hydrocholorothiazide, Fosamax,
Vagifem. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 25. Day after vaccine in left arm, large red
long streaks appeared not at injection site but around arm running toward under
arm. Also next 3 days sneezing all day and nose ran clear water all day also arm
was sore and painful. Under arm tissue still sensitive, tender..Paient has the
following illness history - Heart disease, GERD. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IA, USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 20. Day after receiving injection developed
swelling, pain and redness of upper arm (circumferentially) with chills, no
fever documented. Seen in ER 2 days after receiving injection given morphine,
Ancel IV and Rx'd po cephalexin..Patient was receiving Fosamax 70 mg
one/wk;Levoxyl 50 mcg daily.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 60 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 16. Myalgia and fatigue for 4 days after
vaccine.Paient has the following illness history - Diabetes Mellitus;Congestive
Heart Failure;Sulfa Allergy.Patient was receiving Spironolactone 25mg;Metoprolol
50mg; Vytorin;Temazepam 30mg;Vicodin ES; Bumetanide 1mg;Glipizide ER 5mg;
Klor-Con 10mg;Fluconazole 150mg. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WV, USA. Female patient, child 10.3 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Feb 2006, 01. Mom states developed fever
evening 2-1-06 and not wanting to apply weight to legs this afternoon 2-2-05.
Tylenol/Motrin. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 53 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 27. Upper left arm cellulitis with
erythematous area about 20cm x 15cm, increased temp at site with palpation.
Pneumovax administered on 1/27/2006. Pt started pegasys and ribavirin treatment
same day for hepatitis C virus Pegasys injection site was right below
abdomen..Paient has the following illness history - Hepatitis, asthma, HTN,
GERD..Patient was receiving Motrin, Celexa, Singulair, Prilosec, Atrovent,
Allegra, Ambien, Advair, Ribavirin, Pegasys, MVI. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MT, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 28. 5 days post vaccine developed very sore
reddened upper arm continuing on across her chest. Dx lymphangitis mild
cellulitis..Paient has the following illness history - PCN;Demerol;Mobic.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 55 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 26. Initial report received from another
manufacturer, report number WAES0511USA03757, on 15/Feb/2006. A 55 year old
female patient, with a history of chronic bronchitis and high cholesterol,
received on intramuscular, left arm injection of Fluzone SV 2005-2006,
manufacturer lot number U1854AA; and an intramuscular, right deltoid second dose
injection of Pneumovax 23, manufacturer, lot number 649693/0456P; on
26/Oct/2005. The patient reportedly received influenza vaccinations yearly.
There was no illness at the.Patient was receiving Lipitor.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KY, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 13. Received vaccine at 11:15, by 6 pm arm
red, hot swollen from shoulder down to elbow..Paient has the following illness
history - hydrocodone. Patient recovered.
…………………………………………………………………………………….
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from KY, USA. Female patient, 41 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 17. Not able to lift arm, large rough
knot at shot site, red solid ring that grew daily.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 79 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 17. 02/18/2006 - to ER for redness, swelling,
right deltoid - warm to touch, developed 6 hours after pneumovax injection.
Treated with Ancef IV, then Keflex for 3 days..Paient had Pre-op physical.Paient
has the following illness history - ASA, Bactrim, Floxin.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 47 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 06. Red arm, swollen, itchy for 1 1/2 hrs
then went away.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from VA, USA. Female patient, 40 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 21. Patient complains of soreness of left
arm. Arm is warm to touch. VHC notified at 10:30. VHC provider evaluated patient
and gave instructions: Alternate warm-cold compress for 48 hrs. Take Motrin for
pain..Paient has the following illness history - Diabetes.Patient was receiving
BP medicine. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from ID, USA. Female patient, 54 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 27. Developed severe nausea, vomiting and
muscle aches 3-4 days after vaccine. ~1 week after developed severe dizziness,
inability to focus, memory loss. Over the next months symptoms have improved
slowly. Still complained of severe weakness and fatigue. Can only work 4 hrs day
then has to rest..Paient had COPD, bronchitis, Ethohism. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Feb 2006, 12. Patient was given Pneumococcal vaccine- developed reaction,
swelling at site, pain and induration. (Patient had been admitted to hospital on
2/11/06 for colic, abdominal pain, syncope and collapse, vertigo..Patient was
receiving 2/11/06-2/14/2006: Aztreonam; IV hepatin, Lansuprazole, meclizine,
morphine sulfate, naprosen, sodium chloride, vancomycin IV. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CO, USA. Female patient, 83 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 01. Localized reaction, redness, burning,
itching & edema..Paient has the following illness history - Penicillin,
morphine, asortic acid. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, child 8 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 24. Left arm -local swelling 2cm x 2.5 cm
area of induration.Paient had J Diabetes Mellitus.Paient has the following
illness history - J Diabetes Mellitus. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Swelling and pain onset a few hours after the vaccine was administered on
2/22/06. 2/23/06 significant edema down to elbow. Looks like cellulitis. Started
Keflex-well F/U..Paient has the following illness history - NKDA.Patient was
receiving Naproxen, Thyroid Armour. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, child 11 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 09. Injection given 02/09/2006 in left arm
outer aspect. 02/10/2006 patient developed weakness, shivering and eventually
inability to walk. Patient has cerebral palsy. Had right hemisphrectomy
03/21/2001. Mom refused pneumoccal vaccine in the past. History of status
epilepticus. Had fever to 101, treated with Motrin. Recovered 02/11/2006..Paient
has the following illness history - Cerebral Palsy. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KY, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 22. Local reaction, redness, swelling,
pain..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AR, USA. Female patient, 17 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 27. Extremely swollen left arm from elbow to
shoulder. Swelling into left scapula and left side of neck. Entire upper arm
painful & Red. Unable to move arm up or away from body or straighten at elbow.
Feeling faint when standing and Nausea from pain. Saw primary physician
2-28-2006; prescribed Medrol Dose Pack. Elbow still swollen on 3-3-06..Paient
had Spondoloarthropy.Paient has the following illness history - Allergic
-Penicillin, melons, grass, weeds, trees, mold, cats, horses, shrimp, cucumbers,
carrotts, peaches, nectarines..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Jan 2006, 20. Information has been received from a registered nurse
concerning a 68 year old male with asthma and a Naproxen allergy who on
1/20/2006 was vaccinated SC with a 0.5ml dose of Pneumococcal 23v polysaccharide
vaccine (lot 650453/0791P). there was no concomitant medication. On 1/21/2006
within 24 hours, the patient experienced swelling, redness and pain in the site
and went down the patients arm to the wrist. Unspecified medical attention was
sought. It was noted that the patient was unable to work for 3 days,.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NE, USA. Female patient, 84 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 23. Initial report received from another
company (reference number QAES0511USA00613) on 2/28/2006. This information was
reported to the other company by a pharmacist. An 84 year old female patient
with no reported medical history, had received an intramuscular injection of
Fluzone SV 2005-2006 USP, lot number U1806AA, in the right deltoid and an intra
muscular injection of Pneumovax 23, lot number 650453/0791P, in the left deltoid
on 10/23/2005. The patients daughter called the pharmacist to report that on
10/2. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from VA, USA. Female patient, 75 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 18. On 10/18 her arm was painful, red and
swollen. She also had fever, body aches throughout 10/18, 10/19, 10/20 & 10/21.
She was also nauseous. When she presented to me on 10/21 her arm was red and
splotchy. I referred immediately to MD and called MD and he prescribed Keflex.
She also went to MD that night and he confirmed Cellulitis and said Keflex
ok..Paient has the following illness history - Allergy -
Fluoroquinolones.Patient was receiving Betimol;Premarin;
Chlordiazepoxide/amitriptyline.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 25 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 27. L arm at injection site tender eve of
injection and progressively became worse. On 3/1/06, an area of induration,
redness and warmth at site measured 3" circ with axillary lymph node involvement
and much pain. Was sent to MD and was dx with cellulitis. Tx - 500mg keflex q12h
for 12 days and off work for 2 days using ice packs to area prn. On 3/3/06,
redness has abated as well as induration and most of the pain, but a residual
lump is felt. On 3/6/06, the arm is fine - no additional complications..Patient
was receiving birth conrol pills.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 79 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 02. Local reaction (3 patients in 1 month
with local reaction).. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 53 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 28. Vaccine: Pneumovax, given intramuscularly
in right deltoid, on 02/28/2006 at 14:40. Patient reports feeling bad starting
16:00-17:00, by 20:00 fever 101.7 degrees, chills, achy all over, then injection
site very sore. Next day arm red, swollen, warm..Paient has the following
illness history - Hepatitis C, COPD, Obesity, Penicillin and Lidocaine allergy..
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 71 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 03. Approximately 9 hours after receiving
vaccine, patient complained of pain in left shoulder. A large, red, hard raised
bump was noted..Paient had Admitted for pneumonia 2 days prior.Patient was
receiving Ceftriaxone, carvedilol, Sinemet, azithromycin, escitalopram,
fluticasone nasal spray, furosemide, guaifenesin, levothyroxine, losartan,
pantoprazole, risperidone, tamsulosin, warfarin. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 39 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 18. Fever 101-102, myalgias, swelling,
redness moderate 8 cm diameter both deltoid for 5 days following
immunization..Paient has the following illness history - History Non Hodgkins
Lymphoma s/p bone marrow transplant.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 62 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 06. Local reaction to pneumovax given on
03/06/2006..Patient was receiving Vicodin, Erythromycin, Gantanol. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from GA, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 19. Sore arm since vaccine was administered.
Woke up on 3/2/06 with pain in the shoulder and arm muscle. In arm vaccinated
with the pneumococcal vaccine.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, child 5 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 25. Given pneumovax, had redness and
swelling.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 63 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 28. 1 days after injection, redness,
cellulitis around the injection..Paient has the following illness history -
Discharge summary states scleroderma, hypertension, gi bleed, allergy.
msv.Patient was receiving Levaquin;Estrace;Zestril. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from UT, USA. Female patient, 52 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 01. Local reaction to pneumovax.
Erythema/induration of skin left deltoid region, moving down to just above
elbow. Started 6 hours after injection. Prescribed medrol pack, keflex, and
lortab..Paient had N/A.Patient was receiving Synthroid, maxide. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 01. Severe pain, swelling, redness - same
evening. Went to ER - given pain meds and antibiotic..Paient has the following
illness history - coronary artery disease, hypertension, diabetes mellitus type
II.Patient was receiving ASA, Toprol, Lipitor, Avandia.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a pharmacist concerning an elderly male who
was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine (lot
#651320/1008P). Concomitant therapy included an unspecified thyroid medication
and naproxen. Subsequently the patient developed cellulitis, burning and redness
at the injection site. The patient sought medical attention and was treated with
cephalexin (KEFLEX). Subsequently, the patient recovered. the reporting
pharmacist considered cellulitis, burni.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Common variable immunodeficiency presenting as lymphonodular hyperplasia
pernicious anemia and breast cancer. Journal of Allergy and Clinical Immunology
2006:S110-S110. Information has been received from a published literature
abstract concerning a 56 year old female with a history of treated right breast
cancer 7 years prior, now in remission, presented with weight loss, anorexia,
and loose stools. She was previously well, without fevers. She was a nonsmoker,
had no history of recurrent infections and had.Paient has the following illness
history - Breast cancer, non smoker..Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NH, USA. Female patient, 58 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 28. Pt reports redness, swelling, pain at
site. Also reports nausea and vomiting since she received medication (vaccine).
Pt has been using Tylenol for pain..Patient was receiving Lisinopril,
Pravastatin, Lantus Insulin, Zetia. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from VA, USA. Female patient, 43 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 28. Pt developed soreness of arm. Pneumovax
given in (extending from shoulder to elbow and toward breast). She also had
multiple red swollen nodules. No fever..Paient has the following illness history
- Cutaneous lupus/allergies: ASA/TCN/Keflex/PCN/Sulfa/Cipro. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from IA, USA. Female patient, 66 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 31. VACCINE ADMINISTERED 10/31/2005.
PT RETURNED TO CLINIC 11/1/2005 COMPLAINING OF REDNESS AND SWELLING IN ARM WHERE
VACCINE WAS ADMINISTERED. SOLUMEDROL 125 MG GIVEN IM. ON 11/8/2005 PT RETURNED
TO CLINIC FOR FOLLOW-UP AT WHICH TIME SHE FELT BETTER. PT STATED FEELING
"CREEPY, CRAWLY" HAD DIMINISHED. PT WAS TAKING BENADRYL AND AYRTEC AT THAT TIME,
BUT HAD STOPPED TAKING PREDNISONE DUE TO HYPERACTIVITY..Paient had NO.Paient has
the following illness history - ALLERGIES TO PENICILLIN, SULFA, CEPHALEXIN,
ASPIRIN, CODEINE, TYLENOL, ZOCOR, TRICOR, POSSIBLE PREDNISONE ALLERGY.Patient
was receiving CAPTOPRIL 25MG BID, BENADRYL, SOLUMEDROL, ZYRTEC, PRILOSEC 20MG
PRN. Patient died on -0/00/2006.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 54 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 11. Patient admitted 2/6-2/13 for coronary
bypass surgery. On 2/10 patient received pneumovax vaccine. On 2/11 the patient
developed fevers of unknown origin. Fevers treaded downward and patient
discharged 2/13. Patient re-hospitalzied 2/15 for fevers of unknown origin up to
102. Infectious disease consult obtained and it was felt that most probable
cause of fevers was pneumovax - no other suspected source. All cultures
negative. Fever resolved and patient discharge home on 2/17/06..Paient had
Recovering from CABG on 2/6/06.Paient has the following illness history -
Hypertension, hyperlipidemia, borderline diabetes, SP CABG (CAD), Smoker.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 22 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 13. Rx axillary lymph node swelling and rt
arm discomfort. Cellulitis requiring hospitalization and IV-ABX sent home with
picc line and IV-ABX developed clots hospitalized again. Dc'd with PO ABX and
Coumadin. DVT's L arm.Paient has the following illness history - Rheumatoid
Arthritis, Autism.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Hypergammaglobulinemia IgG-2 Subclass Deficiency and Recurrent Infections in
Adults. Journal of Allergy Clinical Immunology 2006. Information has been
reported in a published abstract article, title as stated above, concerning four
patients in a study (three female, one male (WAES#0603USA00735) between the ages
of 51-71 years who were vaccinated with pneumococcal 23v polysaccharide vaccine.
All four patients had abnormal responses to pneumococcal 23v polysaccharide
vaccine; one failed to respond to pneumoco.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Feb 2006, 28. Information has been received from a physician concerning a 67
year old male with osteoarthritis, rheumatoid arthritis, hypertension and
hyperlipidemia and no known drug reactions/allergies, who on 28-Feb-2006 was
vaccinated intramuscularly in the right deltoid with a 0.5 mL dose of
pneumococcal 23v polysaccharide vaccine (Lot #651320/1008P). Concomitant therapy
included amlodipine besylate (+) benazepril hydrochloride (LOTREL), atorvastatin
calcium (LIPITOR), aspirin, psyllium husk (METAMUCIL), cod liver.Paient has the
following illness history - Osteoarthritis, rheumatoid arthritis, hypertension;
hyperlipidaemia.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Hypergammaglobulinemia IgG-2 Subclass Deficiency and Recurrent Infections in
Adults. Journal of Allergy Clinical Immunology 2006.Information has been
reported in a published abstract, title as stated above concerning four patients
in a study (three female (WAES#0602USA05966), one male) between the ages of
51-71 years who were vaccinated with pneumococcal 23v polysaccharide vaccine.
All four patients had abnormal responses to pneumococcal 23v polysaccharide
vaccine vaccine; one failed to respond to pneumococ.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AZ, USA. Female patient, 77 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 27. Tachycardia, weakness, Pain in arm
vaccine administered radiating into head and neck, nausea..Paient had Noe.Paient
has the following illness history - Darvon, migraine headaches, osteopenia,
supravenous tachycardia.Patient was receiving Toprol, Mialcalcin, Tylenol #3.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, 40 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 07. 7cm x 8cm red, warm area at injection
site..Paient had Upper respiratory infection..Patient was receiving Levoxyl,
Wellbutrin, Claritin, Nasonex..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, child 5 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 17. Lt arm redness/warmth/swelling form
deltoid to elbow, with elbow effusion. Was admitted and treated for
cellulitis..Paient had Sickle Cell Disease - not sick.Paient has the following
illness history - Sickle cell disease.Patient was receiving Amoxicillin.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Received injection 3-8-06 called 3/10/06 with c/o redness, warmth at
site..Patient was receiving Cholesld Chlor-Trimeton MV1. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IA, USA. Female patient, 59 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 04. WITHIN 2 HOURS OF PNEUMONIA VACCINATION
PATIENTS ARM BECAME PAINFUL. IT CONTINUED TO WORSEN BECOMING MORE PAINFUL AND
SWOLLEN. PT RETURNED TO CLINIC FOR SYMPTOMS 3 DAYS POST INJECTION. PREDNISONE 40
MG DAILY FOR 2 DAYS GIVEN. IBUPROFEN 200 MG 2 PILLS FOUR TIMES DAILY FOR 2 DAYS.
PT SEEN AGAIN 6 DAYS POST INJECTION AND STATED HIS ARM WAS "FEELING
FINE"..Paient has the following illness history - HTN, HLP, CARDIOMYOPATHY,
COPD, PCN ALLERGY, SULFA ALLERGY.Patient was receiving LIPITOR 5MG, LISINOPRIL
10MG, SPIRONOLACTONE 25MG, ASPIRIN 325MG, COREG6.25MG BID, COMBIVENT INHALER 2
PUFFS QID. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Sept 2005, 27. A 72 year old female patient received a pneumococcal vaccine
on her left deltoid on 09/27/05. She came to the hospital on 09/28/05 and
presented with a red, tender, and swollen left upper extremity. She was admitted
to the hospital and she received IV Ancef and oral Augmentin for treatment of
suspected cellulitis or an allergic reaction from the vaccine.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OR, USA. Female patient, 13 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 16. PAIN IN RIGHT ARM UNABLE TO MOVE WIITHOUT
PAIN. LOSS OF APPETITE, NAUSEA, ELEVATED TEMPERATURE..Paient had MINOR FLU LIKE
SYMPTOMS RUNNY NOSE. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 52 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 31. Developed malaise and fever of 101.2
approx 20 hours after vaccination. Entire upper surface of left arm swollen,
blotchy red, and sore. Gradual improvement over the next three days. Missed 2
days work. Took ibuprofen, aspirin..Paient has the following illness history -
Sulfa allergy Penicillin allergy Allergic rhinitis Depression.Patient was
receiving Feverfew herb Paxil. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 48 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 15. Fever 103; painfull swelling at the
injection site..Paient had Breast Ca Asthma Hypertension.Paient has the
following illness history - NKDA.Patient was receiving Prilosec 20mg QD Zoloft
100 mg QD Lisinopril 10mg QD Advair 100/50 mcg Calcium + Vit D Multivitamin.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 80 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2005, 08. Patient received booster for pneumovax
from the pcp office on 11/17/2005 and then was admitted to the hospital for
surgery, and as part of their protocol, got pneumovax again. He was discharged
post op and returned the next day with fever 103 and painful swollen arm at site
of injection extending from deltoid all the way to the forearm.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 74 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 23. 2/24/06 Sudden onset chills and fever 5
pm. 2/25/06 Generalized weakness, inability to walk 2 am. Hospital admission
T=38.3, mild tenderness, no inflammation at injection site of pneumovax. 2/27/06
Erythematous rash left upper arm extending from below injection site to the
elbow..Paient has the following illness history - No allergies, ASCVD, CA
prostate;Aortic Aneurysm, Pacemaker insertion 02/14/06..Patient was receiving
Lipitor, Coreg, Mavik, Ditropan, Zetia, Doxasorin, Spironolactone, aspirin,
multiple vitamin.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a 50 year old female nurse, with asthma and
penicillin allergy and a history of splenectomy, who on 2/6/06 was vaccinated in
her left arm with a dose of pneumococcal 23v polysaccharide vaccine (lot #
650453/0791P). On 2/6/06, within 1 minute of receiving the vaccination in her
left arm she began to experience an adverse reaction. She reported that her
throat started to close, and she developed a cough. She stated her "chest closed
up" and she had a pain in her left shoulde.Paient has the following illness
history - Splenectomy; Asthma; Penicillin allergy.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, 46 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 13. Pt was given influenza vaccine and
pneumococcal vaccine 3/13/2006 prior to discharge from hospital. He came to the
ED 3/15/06 @ 5:39 with a swollen face he was given Benadryl and
Prednisone..Paient had Asthma, recovering pneumonia, bronchitis,
hypertension.Paient has the following illness history - Information received
from ER summary states cerebral palsy as Health HX. msv.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 28. Beginning 3/1/06 swelling and redness of
L arm at location of pneumococcal polysach vaccine. Fever and headache started
3/1/06. Fever cont'd thru 3/4. Headache persist, L arm pain persists as of
3/8/06..Paient has the following illness history - HTN.Patient was receiving
KCL;Estratest HS;ACIP;Maxite;CA;Metamucil.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CO, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 17. SHOT GIVEN ON FRIDAY 8:30 AM 3/17/06.
PAIN IN ARM AT SHOT LOCATION STARTED IN THE AFTERNOON AND THE PAIN SPREAD
THROUGH MY MUSCLES. MY SKIN WAS SO SENSITIVE I COULD NOT BE TOUCHED AND ALL MY
MUSCLES ACHED. AT FIRST THE SHOT AREA WAS NOT RED BUT LATER BECAME INFLAMED AND
SPRED OVER MY ARM. I COULD NOT GET OUT OF BED AND EVERY MOVMENT HURT. NO
APPETITE. ON SATURDAY I WAS CHILLED & ON SUNDAY I WAS HOT. MONDAY, I AM UP AND
ABLE TO FUNCTION BUT MY ARM IS STILL INFLAMED AND SORE. I DIDN'T THINK TO TAKE A
TEMPE. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from DC, USA. Female patient, 33 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 15. Sore arm around injection site shortly
after shot. Soreness continued but diminished through 3/22/2006. Limited
movement of arm from 3/16/2006 to 3/20/2006. Redness of the bicep area. 103
degree fever 3/17 - 3/19/2006, 101 degree 3/19 - 3/20/2006..Paient has the
following illness history - HIV+.Patient was receiving Wellbutrin XL, Cymbalta,
Seroquel. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 43 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 20. Arm swollen at injection site X 4 days.
Resolved without medical treatment..Paient has the following illness history -
Allergies - PCN HIV, morbid obesity.Patient was receiving Xaletra, combavir,
tenodovir. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 33 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 15. Injection site irritated day following
injection. On exam (3/17/06). Erythema from elbow to mid-bicep. Treated with
cephalexin 500 mg qid 7-10d..Paient has the following illness history -
Asymptomatic HIV. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MT, USA. Female patient, 49 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 05. See attached page.Paient has the
following illness history - Penicillin. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 06. Initial and follow up information has
been received from a registered nurse, via a company representative (initial
information), concerning a 69 year old male patient, with no known medical
allergies, who on 10/06/2005 was vaccinated intramuscularly with a dose of
Pneumococcal 23v polysaccharide vaccine (lot 649989/0579P)> it was reported that
at the time of vaccination, the patient had acute bronchitis. It was previously
reported that on 10/06/2005 the patient developed severe inflammation at his
injection.Paient has the following illness history - Bronchitis acute.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 18. Injection given right deltoid. Pt
tolerated procedure well. Pt came back to clinic the next day, Oct 19, 2005 with
reaction to site where pneumovax given. She had a swollen indurated area on her
deltoid which measured 4 x 6.5cm. Mildly tender to palpitation mildly
erythematous. Advised to not have further pneumonia vaccines. Benadryl oral and
hydrocortisone cream to area, as well as ice..Paient has the following illness
history - Hypertension, reflux (GERD), chronic lichen sclerosis of vulva, Post
menopausal, Hiatal hernia, Gastritis, osteopenia..Patient was receiving
Omeprazole, Norvasc, Calcium with vit D, Fosamax, baby aspirin, Estrace cream..
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IA, USA. Female patient, 93 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 15. Family reported temp 101, lethargy,
agitation for 2-3 days, starting 2-3 days after immunization. Was seen in office
11/21/2005 - afebrile; family reported "downhill" from there, no cause of
fever/infection identified; continued WBC decreased..Paient had Lymphoma,
HTN.Patient was receiving Avalide 150/12.5 1 po qd; Allopurinol 300 mg 1 po qd.
Patient died on -1/00/2005.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 46 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 03. Information has been received from a
medical assistant concerning a 45 year old female with migraines (approximately
18-Mar-2005), multiple sclerosis relapse with optic neuritis and dizziness
(approximately September 2005), burning with injections of interferon beta-la
(REBIF) therapy, pneumonia (December 2005) and a history of pneumonia (2000) who
on 03-Jan-2006 was vaccinated with a dose of pneumococcal 23v polysaccharide
vaccine (lot #651319/1007P). Concomitant suspect therapy included interferon
beta-la.Paient had Migraine; Multiple sclerosis relapse; Pneumonia; Injection
site irritation.Paient has the following illness history - Pneumonia.Patient was
receiving Relpax; Rebif; Levaquin.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IA, USA. Female patient, 67 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 22. Cellulitis like reaction, left deltoid
area with lymphangitis streaks. Treated with augmention BID X 1 week..Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from MO, USA. Female patient, 68 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Mar 2006, 21. Cellulitis of R upper
extremity..Paient had URI.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 81 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 14. Pt c/o severe right arm (deltoid) pain at
6AM (3/15/06. At 1PM right deltoid was noted to be red, warm and swollen, temp
102.4F. Pt did not eat lunch and c/o nausea. He was given Tylenol for pain and
temp. At 2:40PM noted to be wheezing. O2 Sat 96-97%. Right arm red,induration
12cm x 27.5cm. He was given Prednisone 40 mg/day x 5 days. Claritin 10mg qid,
Zantac 150mg bid..Paient has the following illness history - Penicillin allergy;
Alzheimer's, dementia, HTN, depression, anemia, allergic rhinitis..Patient was
receiving Lasix, KC1, Celexa, Aricept, Docusate, Flomax, Nasalide,
Claritin.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, 50 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 23. 1st 24 hrs painful injection site (fever,
chills, shaking); onset of fever, lasted 4 days (b/w 100 degrees and 102.8;
increased arm soreness, swollen injection site 3" diameter, Fiery band developed
inj site 3/4 the way around arm above elbow, still and painful, cleared in 2
wks..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 16. Pneumovax injection yesterday 30 min
after receiving started itching. C/O soreness and warmth. No change since onset.
Tx with cool compresses, triamcinolone cream 0.1% tid and Zyrtec 10 mg q day.
Initially area red, warm L deltoid 5 1/2" x 6 1/2" not subsided by
3-20-06..Paient has the following illness history - Increase
lipids;HTN;Osteopenia;Carotid Stenosis.Patient was receiving
Zocor;ASA;Norvasc;Zetia. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 09. Pt reported that at pneumococcal site she had pain, swelling,
heat, redness which extended down to wrist. Contact ER - nurse advise to take
Tylenol. She went to Dr on her traveling. On Monday at 6 pm given 10 days of
cephalexin 500 mg to take qid. Direct back or used at 08:30 that decreased
swelling. No redness, states she can now bend her elbow and it seem to be
getting better. Client asked to call back when she returns from her visit out of
town and give additional information of when symptoms subsided c. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Sept 2005, 26. L deltoid - pneumococcal vaccine, experienced severe pain
scale 1-10 #10. Spoke to Dr 9/27/05. Dr thought it could be reaction from flu
shot. There after she reported she were paralyzed from neck to toes could not
move. Experienced difficulty breathing, symptoms. Subsided on the third day at
08:30 am..Paient had Cerebral Palsy/Heart Condition. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 04. 10/5/05 In arm right deltoid pneumoccal vaccine site, soreness,
warm. Swelling, aching /// /// /// swelling down arm to armpit. Says she took
ibuprofen /// also took benadryl last night. Edema progressed /// 4 fingers
above her elbow in her right arm /// /// //// //// .. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 03. Pt's daughter reported that on 10/3/05 her mom received
pneumococcal vac. around 12:00 noon. R deltoid. Tuesday noted swelling, redness
around upper arm, warm to touch mild itching. Swelling extended to above her
elbow.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Mar 2006, 23. Information has been received from a pharmacist concerning an over
65 year old patient who on approximately 23-Mar-2006 was vaccinated with a 0.5
ml dose of pneumococcal 23v polysaccharide vaccine. On 23-Mar-2006 "almost
instantly" the patient experienced a seizure. Unspecified medical attention was
sought. At the time of this report, the patient's outcome was unknown. No
product quality complaint was involved. Upon internal review, seizure was
considered to be other important medical event (OMIC). Addition.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AL, USA. Female patient, child 6 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 21. Swelling, - cellulitis at site with
edema, erythema and violaceous hive, positive warm to palpation. Pt placed on
Augmentin ES..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AL, USA. Female patient, child 8 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 21. cellulitis at site with edema, erythema
and violaccous hue which resolved in 7 days.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 14. Patient cannot move arm around especially in the morning. This
started right after reaction on the injection site. Patient uses left arm where
he got the pneumovax, to play golf. It has affected his golfing..Paient had
pain, redness, site of injection..Paient has the following illness history -
N/A. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, 81 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 01. 24 hrs after getting flu/pneumo shot.
Chest had cough and cold s/s, paralysis of left side, loss of balance and stiff
neck lasting 1 1/2 wks. Prostate and windy probs..Paient had Prostate, urinary
retention.Paient has the following illness history - Neck injury in
1942..Patient was receiving BP meds.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 29. Local reaction, left deltoid surrounding
area, red, warm, tender, swollen to touch. Cold compress applied. Given appt to
see MD for further eval..Paient has the following illness history - Diabetes,
Hypertension. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NM, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 27. Urticaria at injection site - Pruritus of
conjunctiva. Gave 25mg of Benadryl intramuscularly and Benadryl cream..Paient
had Hypertension.Paient has the following illness history - Allergies to
penicillin and potassium.Patient was receiving Nexium, Doxaosin, Lopid, Norvasc,
ASA, Toprol XL. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 28. Red warm rash upper arm medial to
vaccination site. size about 7cm x 10cm..Paient had no.Paient has the following
illness history - amoxicillin.Patient was receiving Zovirax, altace,
hydrochlorthiazide, levothyroxine, asa, lipitor, ambien, nasonex, glucosamine
sulfate. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NV, USA. Female patient, 46 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 27. Pt given the vaccine on 3-37-06. Within
24 hrs, pt had compliants of swelling in her rt arm with redness below the
injection site, numbness of her left face, tingling and numbness in her arms,
headache, nausea and temperature of 101-102 degrees. Temperature on 3-30-06 was
101.3 with a red cellulitis type patch right below the injection site of the rt
arm..Paient had possible ear infection.Paient has the following illness history
- allergies to Percocet.Patient was receiving Was given Amoxil, but only took
one pill.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from ME, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Mar 2006, 31. Patient complained of pain in left upper arm. Left arm elbow to
shoulder reddened, with slight swelling, warm to touch..Paient had Hypertension,
GERD.Paient has the following illness history - Hypertension, GERD. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 60 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 22. (OMIC) Patient received Pneumovax at
routine physical on 3/22/2006 about 11:30am. Complained of burning during
injection. That afternoon worsening pain, redness and swelling. Seen in our walk
in clinic that evening with 5+cm swollen, red, tender, indurated right deltoid.
Treated with 80mg IM depo Medrol. Had swallowing difficulty 20-30 min after
taking Cipro 3/23/2006. Went to ER treated for anaphylaxis with EPI, IV
Benadryl, Solumedrol and Pepcid. Discharged on a Prednisone taper. Seen at 5:00
pm 3/24/06 a.Paient has the following illness history - Allergic codeine,
nonsmoker, HTN, GERD, asthma, allergy, depression, osteoporosis, s/p breast
cancer, hyperlipidemia..Patient was receiving Norvasc, Lipitor, Zyrtec, Advair,
Seroquel, Prevacid, Lotensin HCT. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AZ, USA. Female patient, child 00.4 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 09. Persistent fever and irritability
for 48 hrs after vaccines.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 24. Serum sickness, arthralgia/fever.Paient
has the following illness history - CAD, HTN, DM, Allergy Atacand,
Lipitor..Patient was receiving Norvasc, Zoloft, ASA. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from VA, USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 03. Moderate upper arm swelling, redness, and
pain, nausea, myalgias..Paient has the following illness history - Allergies:
codeine, mycin, Talwin, Demerol, Claritin D, Vioxx, Peanuts, Mold, dust, trees,
all narcotics except Darvocet, Flexeril..Patient was receiving Zyrtec, Celebrex,
Nasonex, Estadise, Nexum, Skelaxin, Tramadol, Acular, Albuterol, Azmacort,
Elidel cream, Multi Vit, Fiberon, calcium, Ferrous sulfate, Sudafed.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from GA, USA. Female patient, 18 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 13. Extreme pain by late afternoon - could
not sleep because of pain- took Tylenol. Saw doctor on 12/15/2005, was given
anti-inflammatory medicine- doctor stated immunization possibly given too high
and in joint - arm fine as of today..Paient had NO.Paient has the following
illness history - NO.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 42 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 03. Right upper arm swelling, pain warmth.
Rx: cool compresses/ibuprofen..Paient has the following illness history -
Codeine/2 pack/urticaria allergies. On teraydine for acute.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 62 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 24. No reaction to medication. Possible
injection to wrong site. Subacromial space. Causing lt shoulder and neck pain,
moderate pain..Paient has the following illness history - DM II, HTN,
Hyperlipidemia. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 79 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Aug 2005, 02. Upon admission, patient reported erythema
and warm to touch at the pneumococcal vaccine injection site. She received the
vaccine as an outpatient.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AZ, USA. Female patient, 67 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 04. Left upper arm is red, and hot to touch
with a welt at the injection site, temperature has been between 100 and 100.6
(oral). Client is taking Tylenol for fever and discomfort, cool compress to
injection site.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 1996, 01. Information has been received from a male consumer regarding a
case in litigation who in 11/1996, was vaccinated with a dose of pneumococcal
23v polysaccharide vaccine. Concomitant therapy included a dos of influenza
virus vaccine (unspecified). Within 24 hours, the patient was in the ER with
saucer size blotches on his torso, thighs, arms, and sides. Prednisone was
prescribed (in descending amounts) along with clobetasol propionate (Temovate)
and was ineffective. Two months later, it erupted again with the.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, child 6 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 29. 8-10cm erythema, swollen area. Prescribed
steroids and Augmentin..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, 41 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 20. Rapid onset in 12 hrs of left arm
swelling/redness. MRI confirmed cellulitis, superficial fascitis. 4/21/06
Discharge Summary of 16 pages reviewed. Final diagnosis confirmed cellulitis. He
appeared slightly confused at times, but seemed alert and appropriate when
questioned. He described the pain as 10/10..Paient has the following illness
history - S/P Splenectomy, Migraine HT;s, Seasonal allergies. 4/22/06 Per review
of d/c summary, pt was told in the past that he had borderline diabetes..Patient
was receiving Nortriptyline, Zomig, Lipitor, ibuprofen, Claritin and
Depakote.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, child 10 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 15. Pneumococcal 23 given SQ to patient,
returned next day with swollen painful arm. Admitted 3/17 - 3/19 for cellulitis
at injection site..Patient was receiving Singulair, Zyrtec, Concerta,
Ditropan.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient, 73 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 04. Cellulitis at injection site in left
deltoid 4" x 4" red swollen area..Paient had Annual Physical.Paient has the
following illness history - Hypertension, Increased cholesterol, GERD.Patient
was receiving Premarin, Zocor, Baby ASA, Prilosec, Hyzaar, Advair Discus.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 25 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 21. On 3/22/06, day after injection, pt
reported left upper arm swollen, red, and painful. Seen by Dr on 3/23 had low
grade fever, instructed to take Benadryl, Motrin and call if S/SX worsen. 3/24
pt advised to go to ER for evaluation. Hospital reports induration increased, pt
left arm mobility impaired due to pain. Admitted placed on Vnosyn, not
effective, changed to Vancomycin..Paient has the following illness history -
Chronic Neutropenia, Glycogen storage disease, Crohn's disease..Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from RI, USA. Female patient, 75 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 04. Extreme tenderness at injection site
beginning about 8-10 hours following administration into left deltoid 1 1/2 - 2"
area of pale erythema at site.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 74 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 03. Redness, swelling below injection site
with fever..Paient has the following illness history - PCN, Darvocet, Sulfa,
ASA, HTN, Gout, CAD, osteoporosis.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 73 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 03. Erythema To RT Deltoid post Pneumovax
very itchy spreading. Malaise no fever. Placed on Keflex and Benadryl.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 22 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 11. Edema, pain, induration - improving.
Treated with Indocin, Benadryl, APAP, Cold packs..Paient had ETOH
detoxification/ in withdrawal.Paient has the following illness history - GERD,
Asthma, Hepatitis C. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 58 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 29. On 03/29/06, patient presented to the
immunization clinic in the am for Tdap and pneumococcal as per ordered by Her
Dr. On 3/30/2006 pt had appt with her doctor for other reasons. Pt was sent to
immunization appt to all out VAERS form. Per pt. Doctor prescription. PCN and
was told to apply ice to shot site to decrease swelling. Per pt about 6:00pm she
c/o stiffness and soreness (scale of 1-10 per pt pain rates 7) where
pneumococcal was given. SQ site was warm to the touch and measured 64 x 69cm, no
other co. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 53 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 13. Extreme pain in arm of injection site, 5
hours later pain caused nausea and dizziness. Next day, heavy nasal and sinus
congestion. On the third, I reported to the local walk-in clinic because it was
a Sat and my doctor's office was closed. I could not breath through my nose, had
post nasal drip that choked me. I was very wheezy, doctor gave me a breathing
treatment with a nebulizer for 10 minutes that lasted for 3 hr. He also
prescribed albuteral air chamber. This treatment lasted only 30 minutes. I
we.Patient was receiving HCT, Lipitor..Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 40 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 11. Swelling, redness, heat at injection site
a few hours after immunization. Hives pt took Benadryl to reduce symptoms.
Reported adverse effect to Pharmacy the next day.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AR, USA. Female patient, child 4 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 13. Large local reaction with papulo-macular
erythematous area with 8cm X 8cm on R upper thigh with STS and R thigh diameter
(31 cm) L thigh diameter (30cm), increased STS noted after 12 hrs s/p shot.
Fever to 104 after 12 hrs s/p shot.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 56 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 18. Body aches, high fever, chills.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 60 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 29. Pain, redness, induration at injection
site. Pain mediates entire arm.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AL, USA. Female patient, 22 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 10. Reports He ETOH abuse and low immune
system. On 3/10 he requested following TD, Flu, Pneumonia vaccine, even though
he is only 22 YR old. On Sat 3/11, client reports awakening with red, swollen,
tender left arm with limited ROM. Around 2pm, noted fever 102.4, and feeling
achy all over. Saw DR who prescribed Z Pac 5day and Ibuprofen. 3/14 Still C/O
some tenderness, and swelling able to move arm better, but still not full
ROM..Paient had Non specific SX: cough, weakness.Patient was receiving Steterra,
IBP, Tylenol PRN.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NE, USA. Female patient, 77 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 19. Red swollen warm painful redness 8 inches
in length and 3.5 inches in width pt. does state site is looking better than it
did last noc. informed pt. to take otc benadryl and ice to site. if worsen to
report back asap..Paient had YES, PRESSURE IN BILAT. EARS LIGHTHEADED UNSTEADY
WHEN AMB..Patient was receiving FOSAMAX 70 MG, CA 1200-1500MG/D, MVI. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from GA, USA. Female patient, child 12 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 19. Received phone call at 4:30pm. Stated
child was seen in office today for reaction to vaccine received in Right Deltoid
(Pneumovax). Stated red, swollen area around injection site, no fever, warm
erythema with mild edema on right upper arm, no infection noted. Stated was a
local reaction and mom was advised to watch area for cellulitis and to return to
office in 2-3 days if no better..Paient has the following illness history -
Hearing deficit.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from SC, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 12. Pt recieved pneumovax on 4/12/06 and was
feeling fine at the time. Also had lab testing routinely done that
day-CMP,Lipid, TSH, T4,CBC. Labs and vaccine ordered. Pt. returned on 4/13
complaining of shortness of breath, chest pain, fatigue and fever
overnight-evaluated by me. Vital signs were normal and exam unremarkable that
day and was reassured- EKG normal. Given durabac samples for pain and told to
rest and drink fluids. also had labs from day before checked and had lft
elevation but otherwise OK and tol.Paient has the following illness history -
Trigeminal Neuralgia, Hypothyroidism.Patient was receiving lipitor 20 mg qd,
Tegretol 200 mg qid, Neurontin 800 mg qid, Synthroid 50 mcg qd, MVI,
Calcium.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 17. On 4/17/2006 at 4:15pm, following day
mildly painful, 2 day later painful and red, today 4/20/06, still red and
swollen 16x22cm..Paient has the following illness history - Seasonal Allergies.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NM, USA. Female patient, child 20.7 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 12. Immediately after giving the
second injection, PPV23 patient became flaccid, started crying and put head
back. She turned cyanotic around mouth eyes and nose. Was brought directly to
EMS where O2 was started (around 4:45pm) and epinephrine 01 MES of 1:1000
SQ..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, child 7 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 18. 04/19/2006 pt presented to center with
temp 102.3 and left upper arm swollen, warm, erythematous. 4/20/2006 area if
erythema increased. Pt admitted to hosp..Paient had Hx of cough x 2 days.Paient
has the following illness history - HgB SS disease.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient, 76 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 19. Pt received injection 4/19. Had pain in
arm at site. Woke up 4/20 with erythema from elbow to shoulder. Mild swelling
right elbow above injection site..Paient had Sinusitis. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a female who was
vaccinated with pneumococcal 23v polysaccharide vaccine. Subsequently, the
patient experienced loss of sensation and use of her arm, numb paralysis which
lasted for several days and weeks. The physician did not know if this was caused
by the vaccine or the administration of the vaccine. At the time of the report,
the patient was recovering. Loss of sensation and use of her arm, numb,
paralysis were considered to be disabling. Additio.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 20. Temp 101, right area pain, radiating from
shoulder to fingers day after injection, chilling, slightly swollen, hot to
touch at injection site. MD advised Benadryl OTC 25mg BID, warm compresses to
site. After Tylenol ore Ibuprofen PRN pain, Pt was not able to take
Benadryl..Paient had Colitis.Paient has the following illness history -
Dysrhythmia, cardiac.Patient was receiving Actonel, Adacel, Folic Acid, Imuran.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, child 10 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 21. Child was recommended to receive
Pneumococcal vaccine per immunologist child received PCV instead of PPV..Paient
has the following illness history - Bipolar disorder..Patient was receiving
Benadryl, Lithium, Adderall. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from GA, USA. Female patient, 22 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 08. Information has been received from the
mother of a 22 year old hospitalized female with sickle cell anemia and no
allergies who on 4/8/2006 was vaccinated with a dose of pneumococcal 23v
polysaccharide vaccine, for sickle cell anemia. Concomitant therapy included
dexamethasone (manufacturer unknown) and acetaminophen oxycodone hydrochloride
(Percocet). It was noted that the patient was hospitalized for her sickle cell
anemia. On 4/8/2006 she was released after receiving the pneumococcal 23v
polysaccharide v.Paient has the following illness history - Sickle cell anemia,
Hospitalization..Patient was receiving Percocet, Decadron tablets..Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Apr 2006, 03. Resident received Pneumovax 0.5cc IM injection on 4/3/2006 in
right upper arm. Area of 20cm x 27cm reported to be red, swollen, warm to touch.
Resident complained of pain in area. Reaction noted by nurse 4/5/06..Paient has
the following illness history - Allergies PCN, Cephalosporins. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Apr 2006, 03. Resident received Pneumovax on 4/3/06 0.5cc IM in right deltoid.
7cm x 7cm area of injection became red, warm, swollen and resident complained of
pain in area. Reaction reported on 4/5/06 by nurse.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Apr 2006, 03. Resident received Pneumovax on 4/3/06 0.5cc IM injection. Area of
injection became red, swollen and hard 16cm x 15cm. Resident complained of pain.
Right arm/elbow. Reaction reported by nurse on 4/5/06.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Apr 2006, 03. Resident received Pneumovax 04/03/06 0.5cc IM injection in left
upper arm on 4/5/06, area observed 13cm x 14cm was red, swollen. Resident
complained of soreness in area. Reaction reported by nurse on 4/5/06.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 12. 12-24 hours after vaccination, pt was
sent to Extended care for pain, swelling in armpit and arm down to elbow, light
headedness and a sore somewhat hoarse throat. TX Depo Medrol 80mg IM, Benadryl
50mg PO, Tylenol 1000mg PO Triamcinolone 0.1% cream topically..Paient has the
following illness history - Allergic to PCN.Patient was receiving Premarin,
Provera.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from CA, USA. Female patient, 68 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 18. Local reaction, not feeling
well.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 73 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 10. 4/10 received inj right deltoid about
11:00am 4/10 pm right arm swollen around site, skin hard, painful. 4/11 am
increased swelling radiating to elbow at inside of arm, very painful. 4/11 pm
entire arm bright red, blisters noted around inj site, pain radiating to wrist.
4/12 appt at appt RX Keflex 500mg QID x 10d. 4/14 pain gone, redness diminished
no new blisters denied other s/s. 4/19 all above s/s gone..Paient had UTI.Paient
has the following illness history - Allergy, Laminectomy, Seizure disorder, HTN,
Osteoporosis, Hyperlipidemia.Patient was receiving Aleve, ASA, Calcium, Atenolol,
Lipitor, Avapro, Fosamax, MTV.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 20. Had DPT and Pneumovax on 4/20/06 within
24 hours developed pain, swelling, redness at site of Pneumovax and temp 103.7,
fever lasted until 4/24..Paient has the following illness history -
Hypertension.Patient was receiving Cozaar, Thamterse, Ambien. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 18. Left upper arm pain, swelling, redness.
Pain radiating to distal arm, head, fingers. Ice and ibuprofen helped relieve
discomfort. Swelling and redness resolved at office visit 4/19 9AM. Still left
upper arm soreness but improving..Paient has the following illness history -
Augmentin-Jaundice. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 35 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 20. C/o arm being swollen, red, achy, warm to
touch. Tx: ice, Tylenol prn. Zyrtec 10mg 1 daily x 5 days..Paient has the
following illness history - CAD, Neuropathy.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 18. Redness, swelling of left arm..Paient has
the following illness history - IBS, Osteoporosis.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, child 10 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 21. Child was recommended to receive
"pneumococcal vaccine" per Immunologist. Child received PCV instead of
PPV..Paient had cerumenosis.Paient has the following illness history - Bipolar
disorder.Patient was receiving Benadryl, vitamins, Adderall. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient, 45 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 20. Pt reported symptoms of pain,tenderness
and swelling in left upper arm at injection site. Pt rated pain at 8/10. She
complained of feeling ill-after resting felt better. During follow up visit with
doctor, her temperature was 97.1 F. Doctor's impression was that she was having
a severe local reaction. Doctor wrote a prescription for Lortab for pain if
needed..Paient has the following illness history - Diabetes, Synalgos allergy,
hypothroidism, allergic rhinitis.Patient was receiving Aspirin, Claritin,
Glipizide, Lantus, Levoxyl, Lisinopril, Multivitamin, Vitamin C. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient, 93 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 21. Pt stated she was unable to raise left
arm when taking her shirt off and had instant pain over the left anterior
portion of her shoulder. She had immediate nausea and did vomit. Small movements
produced pain at time of follow up visit. She stated the pain seem to be
traveling up her neck and down through her back at times. She was advised by NP
to take Aleve one tab twice daily. She was also given Darvocet N 100. Also
advised to use Tylenol 2 tabs for breakthrough pain as she needs to..Patient was
receiving Aspirin, Atenolol, Enalapril, Lovastatin, Norvasc, Plavix.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OR, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 26. Pt complained of red and swollen left
deltoid. Site of Pneumovax injection on 4/26/06..Paient had Recheck HTN
visit.Patient was receiving Lipitor, Lexapro, Lisinopril. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 24. Back pain, muscle aches, headache, abd.
discomfort, upset stomach, chills, edema at site with redness, warmth, anorexia
and insomnia. Had surgery scheduled for 4/25/2006 and was cancelled. Was started
on Cephalexen 500 mg. twice daily for 10 days..Paient had Sore throat.Paient has
the following illness history - Diabetes, hypothyroidism, HTN, Ostium Secundum
Atrial Septal Defect.Patient was receiving Furosemide 20 mg daily Diovan 320 mg
daily, Norvasc 10 mg daily Toprol XL 200 mg daily Prevacid 30 mg daily Metformin
500 mg daily Levothyroxine 50 mcg daily ASA 81 mg daily. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NM, USA. Female patient, child 20.1 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 24. Fever to 104.5 late same day of
vaccine. Emesis and persistent fever to 101.0 since (2 days) 8cm area red,
indurated skin left thigh IM site..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, 53 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 28. Pneumovax 0.5CC IM LD was administered
12/28/05 at 1515. 12/29/05 she presented at ER saying a few hours after shot she
noticed redness in injection area. It was accompanied by severe pain radiating
to the left shoulder and upper back. 5/16/06 -22 page DC summary and medical
notes from hospital stay 12/29-12/31-2005 at Lourdes Medical Center-Pneumovax on
12/28/05-presented to ED on 12/28/05, approximately 2 hours after injection with
c/o swelling and pain in left arm and shoulder, the site of the vaccine,
w.Paient has the following illness history - CAD, hyperlipidemia, hypothyroid..
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, 53 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 25. Pt received vaccination 4/25/06. Pt
called office next morning c/o arm swollen and cannot bend. Pt came in for
exam..Paient has the following illness history - DM, HTN.Patient was receiving
nystatin powder, Milarais 24mg. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 01. @ days after injection of pneumococcal
vaccine, she developed a reddened area about 3" in diameter, some soreness, and
slight swelling of area. She is to use ice to area and Tylenol..Paient has the
following illness history - Acute Renal Failure; Hearing loss; Allergic
Rhinitis; Breast Cancer; Hyperlipidema; Menopause; DVT; Celft palate; Basal cell
carcinoma; Supraventricular tachycardia; Pulmonary embolus; ARDS..Patient was
receiving Vitamin C; Sudafed; Nasonex; and Alavert.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 32 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 28. Pneumovax 0.5cc 4/28/2006-4/29/2006
mid-day (+) fevers, diarrhea L deltoid red, painful. Unable to lift arm.
ER-temperature 103-LP done-Keflex 500 po qid x 10 days, Motrin prn. Seen in
clinic 5/1/06..Paient had HIV; Acute pharyngitis.Patient was receiving PPD
0.1cc-Parke Davis-23081-LFA.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 24 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 01. Pneumovax vaccine 0.5 to right deltoid on
5/1/06 12pm pt noted pain at infection site that evening and warmth no fever and
erythema deltoid, right axilla. returned to clinic 5/2. Cephalexin 500 QID 10d,
Codeine PRN..Paient had HIV, Bipolar.Paient has the following illness history -
HIV, Cleft palate, Cleft Lip..Patient was receiving PPD.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 48 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 01. See vaccine schedule below. 48 hours
after receiving YF and other vaccines on 5/1/06, and 4 hours after receiving
Pneumovax and Menomune on 5/3/06, she developed shaking chills, and shoulder
pain. Today I received a phone message that she is hospitalized with fever 103
and stiff neck..Patient was receiving Lipitor.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 74 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 18. Red rash on shoulder/arm/chest/back about
20 x 30cm, starting from injection site (TD)..Paient had CPE.Patient was
receiving Levoxyl; Fosamax.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 40 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 16. ERYTHEMA, PRURITIS RIGHT ARM SITE OF
INJECTION, FEVER, COUGH. gIVEN 10 DAY COURSE AUGMENTIN.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 01. Swelling, redness, warmth right deltoid
area. Discomfort, tenderness at site low-grade fever. Advised cold pack, Tylenol
prn. Given 1000mg Tylenol po in office..Paient has the following illness history
- HTN; AF; Hyperlipidemia; Osteoarthritis; Colon Polyps; Bilateral knee
replacement.Patient was receiving lisinopril; Crestor; Warfarin; Digitek.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 26. Within 3 hours of vaccine administration
she felt inflammation at site of injection. By the next morning, inflammation
with heat and firmness in area covered an 18 X 15cm oval area of L upper outer
arm with some tenderness at site of edema, slight tenderness..Paient had
UTI.Paient has the following illness history - HTN; Onychomycosis;
hyperglycemia; abnormal lft's; arthritis..Patient was receiving Bactrim DS bid x
7d (4/26/06)' DynaCira CR 10gm; HCTZ QD. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 05. SX began 05/03/06 pm after injection site
a small bump, arm red from shoulder to elbow, warm to touch, not itching. At
that point pts wife stated he had Pneumovax 1/05, Pt did not remember..Paient
had Cough.Patient was receiving Diazepam. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 17 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 05. Spiking fevers to 103.9, 6 inches of
erythema at inoculation site photo available..Paient has the following illness
history - Acne, HX Adenoid resection..Patient was receiving PPD.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OR, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 10. Dizziness and swelling for 2
weeks..Paient has the following illness history - Diabetes type 2,
Hypertriglyceridemia, eye lesion..Patient was receiving Advicor, Glucotrol, Move
free with Glucosamine and chondroitin, Flaxseed, Alcarnatine, Omega vitamin MSM,
Folic acid, Allerest, Coricidin, Aspirin..Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 76 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 25. Right arm violous edema, sharply
demarcated involving lateral arm, no ulcers, no deficits nerve sense or motor
deficit..Paient had burning, chills, redness right arm.Patient was receiving
Lipitor 10mg, ASA 81mg, Imdur 60mg. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 03. 3-4 hrs after injection, pt developed a
lot of pain followed by redness and swelling that evening along with chills. c/o
deep ache down her left arm to left hand the next morning. Will use ice,
Tylenol, Benadryl.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AZ, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 02. Following day patient reported red, hot
arm with red streaks under arm. Notified local MD placed on antibiotics given
cortisone shot..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from SC, USA. Female patient, 58 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 31. On 3/31/06, at Outpatient Clinic, I
recieved a Pneumovax Injection. I had moderate pain in left knee and had not
slept adequately in two months.(normal knee deterioration-no accident relation)
That day; I told my assigned physician that I needed help with my knee pain. His
primary concern was general health care and re-assignment of Rx to hospital
protocal. As a typical 'new' patient; I was told (by Staff nurse) after Dr.
consultation, that the Pneumonia vaccination was 'a good idea' and I was
supposed to h.Paient had Knee Pain; Chest congestion..Paient has the following
illness history - Lung damage due to prior surgery from surgery in 1994 for head
injury. Lumbar surgery 3/06..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 43 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 27. Pt administered pneumococcal vaccine in
the morning on 4/27/06. Several hours later, in the afternoon, pt noted redness,
swelling and pain at injection site that was also spreading to axilla. By
evening pain had become so bad patient found it difficult to move affected arm.
On 4/28/06 pain, redness and swelling continued to worsen and patient had low
grade fever. Patient took aspirin 325mg in the morning and evening with no
symptom relief. On 4/29/09 again took aspirin 325mg twice daily and began to
hav. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from , USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 25. Information has been received concerning
a 68 year old female with rheumatoid arthritis, osteoporosis and pain who on
11/25/2005 was vaccinated (route unknown) with a dose of pneumococcal 23v
polysaccharide vaccine (lot # unknown) and a jab of influenza virus vaccine
unspecified. Concomitant therapy included diclofenac, leflunomide, tramadol HC1
(Tramadolor), cholecaloiferol, risedronate sodium (Actonel) and etanercept
Enbrel. It was reported that a patient was a participant in a study. In the
evening of 11.Paient has the following illness history - Rheumatoid arthritis,
Osteoporosis, Pain.Patient was receiving Cholecaloiferol, Diclofenac, Enbrel,
Leflunomide, Actonel, Tramadolor. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AZ, USA. Female patient, 57 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 20. 04/20/2006 received injection 4/21/06
site had soft tissue swelling, warm and hard to touch. Site was erythematous as
well..Patient was receiving Allergy injection.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from UT, USA. Female patient, 35 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 08. Patient presented to this Immunization
Clinic on 8 May 2006 at 1300 hours stating PA-C had advised her to receive a
Pneumonia Vaccine. Therefore, patient was vaccinated with Pneumovax(adult
formulation)0.5ml given SQ over the right deltoid without any reaction noted at
time of vaccination. Patient contacted this Immunization Clinic on 10 May 2006
stating she had localized redness, swelling, and heat at the injection site on
her right arm and was advised to see a provider for further evaluation. Patient
p.Paient had Patient was prescribed a Zithromaz Z-Pak on 8 May 06 by PA-C..Paient
has the following illness history - Danazol.Patient was receiving Patient had
PPD (TB skin test) 5 Test Units administered to left foreaarm on 1 May 2006 with
results read on 3 May 2006 from left forearm as zero milimeters = negative. No
other reactions noted at that time. Proventil 90 mcg Inhaler Sig:2.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, child 11 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 08. FEVER 101.6, VOMITING, REDNESS AND PAIN
INJECTION SITE.Patient was receiving ALBUTEROL. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 09. Several hours after vaccine was
administered, pt developed a red indurated rectangular area that was tender to
touch at the site of the injection. Patient called office and MD instructed her
to watch for worsening factors (i.e. fever), use Benadryl prn, Hydrocortisone
cream prn, and ice. Instructed pt that symptoms should subside in a few days and
that it is most likely an allergic reaction and not to get the pneumovax in the
future..Paient has the following illness history - Novocaine.Patient was
receiving Synthroid 125mcg. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 25. Pain from shoulder to elbow, fever,
chills, loose bowels, SOB, restless, decreased sleep, increase BP, fatigue. TX
Aleve PRN pain, Avelox 400mg #5 x 5 days. Clarinex 5mg QD..Paient has the
following illness history - Hypercholesterol, BPH, decreased WBC, decreased
Platelets, seasonal allergies..Patient was receiving Lipitor, Lunesta, Nasonex,
Udaminsp, Allegra..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from HI, USA. Female patient, 53 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 05. Swelling and pain in arm just distal to
injection unable to move arm for 2 days due to pain. Swelling and pain slowly
resolving without treatment. pt has rheumatoid arthritis..Paient had Allergies
Sinuses.Paient has the following illness history - Rheumatoid arthritis,
allergic rhinitis..Patient was receiving PPD, Lexapro, Tums, Vit D,. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 15 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 09. Painful, red, hot to touch. When woke up
Weds am 5/10/06 Pt states is not as sore today appears to be getting better..
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 03. 05-03-06 Pneumococcal vaccine adm.
05-05-06 Pt. presents to clinic with s/s and diagnosis cellulitis at INJ site
and surrounding area extending down to wrist. Pt had Levaquin treatment x10days
with three office follow up visits before s/s resolved 05/15/06..Paient has the
following illness history - Betadine.Patient was receiving Calcium, multi vit,
Lipitor, Ecotrin ASA, Levoxyl, Fosamax, Nasacort.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, 80 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 11. Right arm swelling, erythema, pain upper
arm. Came in next day-dx allergic reaction. Given script for Prednisone 20mg
bidx3days. When called to check on patient the next week-patient never filled
script-thought it would upset her stomach. States arm is fine now..Paient had
s/p strep pneumonia 3/06.Paient has the following illness history - Coumadin.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IA, USA. Female patient, 67 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 16. 05-16-06 Pneumococcal vaccine adm.
05-17-06 Pt. presents to clinic with approx 9x14cm erythema and feverish area
surrrounding INJ site and distal left arm. Pt was treated with Keflex and
Prednisone and instructed to return to physician if s/s didn't subside..Paient
has the following illness history - zetia, pcn, sulfa, aciphex, ditropan,
ultram, neurontin.Patient was receiving omnicor, zantac, singulair, lasix,
nasocort, buspar, citracal, micalcin, premarin.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Apr 2004, 26. Info has been received from a physician, via a company
representative, concerning a 98 year old male who "two years ago", on 4/26/04,
was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. "Two
weeks ago" on 4/26/06, the pt died due to non-pneumococcal cause. It was
reported that the pt was hospitalized or had prolonged hospitalization and that
the experience was life threatening. The non-pneumococcal cause of death was
considered to be immediately life-threatening. Additional info has been. Patient
died on -0/00/2006.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received via another company from a rheumatologist
concerning an approx 84 yr old female with osteoarthritis concerning an approx
84 yr old female with osteoarthritis who in 2006 was vaccinated with
pneumococcal 23v polysaccharide vaccine by a general physician. Subsequently, in
2006, the pt presented at emergency dept and was admitted with severe swelling
and pain in arm. The pt had high temp of 38C degree. The fluid from the arm was
drained and tested. The results showed severe inflam.Paient has the following
illness history - Osteoarthritis. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 16. Redness/pain at injection site began 8
hrs after injection, vomiting after 42 hrs..Paient has the following illness
history - Titanium, Neosporin.Patient was receiving Keflex 500mg.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, child 10.4 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on July 2003, 30. Information has been received
from a RN concerning a 16 month old female who on 30Jul03 was vaccinated SC with
a first dose of 0.5ml varicella virus vaccine live. Concomitant vaccinations
given on that same day included a fourth dose of pneumococcal 23v polysaccharide
vaccine (manf unspecified) and a fourth dose of diphtheria (+) pertussis vaccine
(unspecified) (+) tetanus toxoid (manf unk). Almost immediately after the
injection the pt experienced hives and redness around the injection site.
Unspecified me.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 15. Pneumovax given on 5/15/06 right deltoid.
5/16 pt came to MD with right arm erythema and edema at inj site, despite use of
acetominophine and ice packs x5. MD and Allergy MD saw patient and prescribed
prednisone 60mg qd. 5/17 the patient returned with increased swelling and
erythema to upper arm extending to elbow, erythema to shoulder and side of neck.
Pt face is flushed and states she "does not feel well". No temp, chills or
sweats. Pt stated she did take prednisone as prescribed. pt admitted to
hospi.Paient has the following illness history - HTN, Allergic Rhinitis, Hx
Colon CA with colon resection, Congenital Nystagmus, questionable TIAs.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 82 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 15. Patient reported redness, swelling and
warmth at injection site. Warm moist heat to area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 04. Pt received Pneumovax 23 during hospital
admission. Leucocytoclastic vasculitis developed after injection. Generalized
erythematous nodules and papules were seen..Paient has the following illness
history - Patient has a history of COPD and hyperlipidemia patient has
NKDA..Patient was receiving Ciprofloxacin 200 mg IV q12b, Oxycodone/ APAP 5/325
PO q4prn. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 80 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 15. Severe Swelling of l upper
extremity..Patient was receiving Fosamax.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 84 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 27. Both arms and shoulder froze after shots.
Pt doesn't have full function of arms/shoulders. Experience pain and
discomfort..Patient was receiving Aspirin/APAP/Codeine. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 22. Patient given Pneumovax IM in left
deltoid on 5/22/06. Returned to clinic on 5/24/06 and observed a 5" area of warm
erythematous skin around upper arm, approx. 1 inch below the injection site to
the distal humerus. Tender to touch. Doctor instructed patient to use warm
compresses and Advil 200 mg q 12hrs..Paient had Hepatocellular Carcinoma.Paient
has the following illness history - Diabetes mellitus.Patient was receiving
Atenolol, Lisinopril, Metaformin, Glyburide, Lantus, Asprin, Gabapentin. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 19. Admitted to hospital on 5/21/06. States
received "Pneumonia Shot" on 5/19/06. Right upper arm swollen and reddened,
entire upper on upon admission. Diagnosis, cellulitis. Treated pt with Levaquin.
Called Pharmacy for vaccine used there..Paient had Acute MI, Angiogram
done..Paient has the following illness history - Allergies: Penicillin,
Tetracycline, Sulfa; Hx MI..Patient was receiving Plavix, Nitroglycerin,
Lipitor, Lopressor, Aspirin, Lisinopril, Evista, Synthroid.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 76 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 23. (OMIC). Pt received Pneumovax 0.5cc IM
during general visit on 2/23/06. Pt was counseled on benefits and potential side
effects associated w this immunization. At this time the pt also instructed to
report any s/s ET acute distress, SOB, or rash, vaccine given in left deltoid on
2/23/06. On the 24th, the pt presented to the clinic as a walk in stating that
his left arm was swollen, hot and sore. When examined upper arm was noted to be
1.5 times the pts normal size, with tenderness upon movement. The pt was.Paient
has the following illness history - GERD, Hyperlipidemia, OA, COPD.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
May 2006, 07. Pt administered Pneumovax PPV 23 vaccine 0.5mL SC x 1. Pt
experienced local reactions outside of normal. Pt experienced severe redness and
pain at inj site. Malaise and increased temp reported. Temp was not
recorded..Paient has the following illness history - Admitted for acute MI..
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from DC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on May 2006, 06. Pt administered Pneumovax 0.5mL SC x 1. Pt experienced local
reactions outside of normal. Pt experienced malaise in addition to severe
redness and pain at injection site. Temp was not recorded..Paient has the
following illness history - Pt admitted to hospital for chest pain and CHF..
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MT, USA. Female patient, 30 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 12. Information has been received from a
health professional concerning a 30 year old female with asthma who on 5/12/2006
was vaccinated IM with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine
(lot 651320/1008P). On about 5/15/2006, the patient was seen in the office with
an infected arm. She was admitted to the hospital that day for a possible staph
infection. Laboratory diagnostic studies included blood and other test done in
the hospital. At the time of this report, she was still in the hospital
rec.Paient has the following illness history - Asthma.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from GA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 22. Pt received Pneumovax 23 left deltoid,
5/22/06 at 4pm, within 1 hour swelling in left shoulder radiating to neck and
down to antic cubital Fossa of left elbow, advised NSAID with Rocephin.Paient
has the following illness history - All sulfa.Patient was receiving B12,
Ogen.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 53 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 16. Cellulitis to left upper arm.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 38 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 12. Pt received pneumococcal vaccine,
developed reaction, swelling at the site, pain and induration..Paient had
Admitted for colic, abdominal pain, syncope and collapse, pain, vertigo.Patient
was receiving 2/11-2/14/06 Aztreonam IV, Hepatin, Lansoprazole, Meclizine, Vanco
IV, Morphine, Naproxen. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 63 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 12. Admitted 5/10/06 discharged 5/17/06.
Received pneumococcal vaccine (routine). Developed L arm rash, swollen arm.
Treated with Tylenol, Keflex PO, warm compresses..Paient had abdominal pain, h/o
rectal bleeding.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from KS, USA. Female patient, 77 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Apr 2006, 24. FOUR HOURS AFTER THE SHOT HAD
SOB, FEVER OF 103 DEGREES. DID NOT GO TO THE ER DUE TO THE COST. BETTER THE NEXT
DAY. fEVER WENT DOWN. ALL SYMPTOMS GONE BY THE FOLLOWING DAY..Paient had
NO.Paient has the following illness history - NO. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 67 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 22. Pt states the day after receiving the
Influenza & Pneumococcal vaciines his Rt shoulder started to hurt with stiffness
& the pain/stiffness started to progress down into his hips & knees. He has
difficulty opening his Lt hand when he wakes up in the morning. He states he has
a little arthritis in the Lt shoulder & "spurs" here & there" but his physician
is not able to find the cause of the joint problems..Paient has the following
illness history - Pt reported joint problems today 5/30/2006..Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from ME, USA. Female patient, 16 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 24. Patient developed fever and chills after
receiving vaccinations. Area of injection developed a red erythema area. Patient
admitted to hospital for suspicion of cellulitis and started on intravenous
antibiotics..Paient has the following illness history - Pt two years post-liver
transplant.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient, 79 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 22. Swelling pain right arm.Paient has the
following illness history - Sulfa. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 58 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 18. Intense pain in arm, could not move arm,
difficulty breathing. Morphine for Pain, Medrol..Paient has the following
illness history - Emphysema (COPD).Patient was receiving Percocet,
Keflex.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 16. One week after vaccination patient had
severe polyarticular arthritis, and generalized weakness, was unable to get out
of bed for several days. Had hand swelling, pain and stiffness lasting several
weeks. All symptoms resolved after a short course of systemic steroids.
Rheumotlogic workup yielded only mild DJD..Paient has the following illness
history - Hypertension Fatty liver disease. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 18 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 31. Patient received Pneumovax at the clinic
on 5/31/06. Developed redness and swelling at the injection site. Emergency room
visits x 4 (given Rocephin x 2, Rx for Keflex and later Augmentin). Admitted to
hospital on 6/4/06 for IV antibiotics, started on Clindamycin and Zosyn. Later
Zosyn discontinued and Vancomycin initiated..Paient has the following illness
history - Sulfa.Patient was receiving Birth Control Pills.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Apr 2006, 28. Information has been received from a physician concerning a 74
year old female with reportedly no adverse drug reaction or allergy, who on
4/28/2006 the patient experienced deep vein thrombosis DVT and was admitted to
the hospital. It was reported that the patient had blood work performed. The
patient was given intravenous IV heparin. It was reported, that the patient was
on enoxaparin sodium Lovenox therapy until the patients warfarin sodium Coumadin
became therapeutic. Additional information has been requ.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 27 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 02. Per patient- Temp got as high as 102 F
on 6/3/06. He called in to after hours nurse line on 6/3/06 and spoke with MD,
who recommended taking Tylenol prn. He called in to clinic 6/5 for a work excuse
letter and we had him come in to clinic to check his injection sites. Right arm
was benign. Left upper arm was red, hot and swollen. Patient was sweaty and
warm, but afebrile. He had taken Tylenol approximately 2 hours prior. MD
examined him. Recommended using ibuprofen and acetaminophen to control continued
fev.Paient has the following illness history - HIV. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 16. Arthus-Hypersensitivity reaction-severe
swelling at arm and shoulder. Required surgical I & D. Onset about 2-6 hours.
06/22/2006-12 page medical records received from North Memorial Health Care, to
include H&P and DC summary for hospitalization 2/19-2/22/06. Chief complaint:
left shoulder pain. Receiving immunization and indicated that at the time of the
injection she felt the shot hit something and had tingling immediately
afterwards and pain. RX at office with Z-Pak for sinusitis. Pain increased,
sought r.Paient has the following illness history - hypertension sinusitis
glaucoma arthritis eczema.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 71 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 17. Pt developed redness and swelling in L
arm, 4 hrs after receiving a Pneumovax. She has not had any fever. Pt was given
an injection of Benadryl and of Kenalog. She was sent home with a RX for
Benadryl and Keflex..Patient was receiving HTN meds. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CO, USA. Female patient, 42 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 13. Arm pain, rash, redness, chills,
streaking to axilla, infection, treated with ibuprofen and Augmentin.Paient has
the following illness history - Asthma Allergies: Codeine, Iodine.Patient was
receiving Advair, Albuterol, Singulair.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, child 11 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 04. Patient received three IM immunizations
at once. Patient immediately reached for his throat due to apparent laryngeal
spasm at approximately 12:00. Oxygen administered immediately, 25mg IV
diphenhydramine given. Epinephrine not required. Discharged to home after
abservation period. Later that night 05/05/06 @ 02:48 patient presented to the
ED with fever to 102, vomiting for 90 minutes. Diphenhydramine and prednisone
given in ED at approximately 04:43. Patient discharged from ED with Epipen,
prednisone pres.Paient had ITP Aspleenic since 1997.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from SD, USA. Female patient, 31 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 23. 05/25/06 at 1310 pt went to the Emergency
Room for eval of Right Arm (deloid) where tetanus and pneumovax given on
05/23/06. Patient complained of onset fever on 05/24/06 evening. Site appeared
to be erythema, warm to the touch, but muscle tissue soft otherwise with limited
ROM secondary to pain per ER report. Sensation intact, motor intact, no vascular
compromise and tendon function normal per ER report. Patient clinical impression
was 1)Soft tissue localized reaction 2nd to immunization. 2)fever 2nd t.Paient
has the following illness history - Ancef, Morphine, Diamox, PCN, Sulfa.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AZ, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 03. After injection noted red, swollen L
arm/shoulder. Severe induration/erythema involves most of upper arm..Patient was
receiving Atenolol, Pravachol.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 17 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 02. Swelling, redness, hives localized to
immunization site, pain radiating to back reaction progressed later on 6/4/ to
fever, vomiting and chest pain prompting hospital admission.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OR, USA. Female patient, 24 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 06. Within 24 hours, 1cm red induration
lesion at injection site with 2 other lesions on same arm. One 4cm; the other
1cm. All in deltoid region..Paient has the following illness history - Asthma;
NKDA.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, 67 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 24. Left arm red, muscle pain and swelling at
injection site. Treatment: observe site..Paient has the following illness
history - Hyperlipidemia; hearing loss; BPH; Hypertension; colon polyps; lumbar
HNP; chronic fatigues; HCM; Cellulitis; CPE; Hand injury; Knee pain; pharyngitis
acute.Patient was receiving Toprol XL 25mg 1 tab qd; Prinivil 40mg 1 tab qd;
Diclofenac sodium 50mg 1 tab bid use prn for arthritis pain, avoid chronic daily
use; Epi-pen; aspirin 81mg 1qd.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CO, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 31. Cellulitis developed with red, hot and
firm areas at and adjacent to injection site. Started on antibiotic,
antihistamine, anti-inflammatory and ice packs. Upper left arm 3" X 6" into
axilla..Paient has the following illness history - HTN; Depression; GERD; MI;
Shingles; Kidney Stone.Patient was receiving Lunesta; Toprol; Cytotec; Naprosyn;
HCTZ; Nexium; Paxil; Fiorinal; ///; calcium. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 73 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 29. Approximately 36 hours after receiving
pneumococcal vaccine patient developed edema, redness, and pain to left upper
arm in deltoid region. Arm x-rayed; no fracture found..Paient has the following
illness history - NKDA; PMH: History of Pancytopenia; Cirrhosis; Coronary artery
disease; Chronic obstructive pulmonary disease; history of heart failure and
resides in a nursing home.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 60 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 15. This pt had pneumonia vaccine 11/22/1989
with no reactions. She had /// again 5/15/06 and within 24 hours developed
swelling of upper arm in area where she received it. The arm still swelling, 1
week later and there is some residual redness of upper arm as of 6/7/06..Paient
has the following illness history - Sarcoidosis. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 76 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 09. Diarrhea, vomiting, unable to breathe. I
was sick for almost 2 weeks. As of today 6/8/06 I'm still coughing.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 07. Five days after injection of Adacel, c/o
itching at site, red and hard area about the size of 50 cent piece. Advised to
use Benadryl, cold compresses and Tylenol prn..Paient had Annual physical.Paient
has the following illness history - Hyperlipidemia; right carpel tunnel
syndrome..Patient was receiving Lipitor; ibuprofen; chondroitin. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 13 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 14. Presented to Emergency Center later in
the day of immunization complaining of right arm pain & swelling. Patient
admitted to hospital for sickle cell anemia with hypoxia (O2 sat to 80%).
Acetaminophen, morphine,empirically started on antibiotics, ketorolac. "Edema
was possibly secondary to a reaction to Pneumovax.".Paient had Sickle Cell
Anemia.Paient has the following illness history - NKDA.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 88 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2006, 30. Left upper arm with moderate redness and
edema..Paient had acute abdomen.Paient has the following illness history -
CODEINE, OXYCODONE ALLERGY.Patient was receiving famotidine, pantoprazole,
hydrochlorothiazide, diltiazem, sertraline, valsartan, alprazolam, potassium
chloride, fleet enema, psyllium laxative. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient, 59 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 31. Pt's L arm became swollen, red and
tender. She states symptoms appeared about 24 hrs after vaccine. Tx: Benadryl
and symptoms resolved..Paient had Ankle edema bilateral.Paient has the following
illness history - Iodine, Sulfa, PCN, michdentin.Patient was receiving
Lisinopril 10mg; Synthroid 25mg; Lipitor 20mg; aspirin 81mg. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 09. Patient received 1/2 dose Td due to
local reaction in 1996. She experienced elevated temperature (100) numbness all
over, worse in legs, rash evening of vaccine; presented to ER 6-10-06. No
treatment; symptoms resolved..Paient had no.Paient has the following illness
history - allergic to codeine; hypertension; osteopenia;osteoarthritis,
esophagitis.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient, 80 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 13. MD reported that patient received
vaccination within 2 years of previous shot and had diffuse immunological
reaction to left arm with red swollen tender hot area, "immunological memory".
6/16 arm better; less red, less swollen; positive antineutrophil cytoplasmic
antibody.Paient had non q-wave MI; coronary artery disease, atrial fib.Paient
has the following illness history - history allergy to codeine, penicillin,
sulfa. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a 66 year old female consumer with history of
reaction to [loratadine] (CLARITIN) and IgA who 8 years ago was vaccinated with
a first dose of pneumococcal 23v polysaccharide vaccine. There was no
concomitant medication. Subsequently, three and a half years ago, the patient
reportedly was not immune and experienced pneumonia. She reportedly received two
other doses of pneumococcal 23v polysaccharide vaccine after she was
hospitalized. At the time of the report, the patient.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient, child 7 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 09. The day after she received vaccination,
she started developing erythema and swelling on the site of injection, which
became tender, and started spreading slowly over deltoid area. When seen 3 days
after vaccination, had cellulitis developed on right deltoid area, 3
fluctuation/abscess. I do not believe this was a reaction of vaccine per se, as
any injection can break skin and become a site of entry to S. aureus
infection..Paient had Allergic rhinitis.Paient has the following illness history
- Allergic rhinitis; overweight.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from MN, USA. Female patient, 53 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Dec 2005, 21. Cellulitis - large area of local
reaction - arm. Seen in ER 3 times. She saw me on 12/27 when it was
resolving..Paient has the following illness history - Celebrex; Vioxx.Patient
was receiving Enalapril; Piroxicam.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 56 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 05. Swelling under right axilla. No temp. Tx:
Antihistamines.Paient has the following illness history - Allergic
rhinitis.Patient was receiving Synthroid; Allegra. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from RI, USA. Female patient, 59 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 12. Left arm cellulitis. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from DC, USA. Female patient, 17 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 14. Within 30 minutes of administration, pt
developed localized swelling, erythema, ecchymosis and pain at administration
site. (Vaccine was given SQ/IM due to her diagnisis of ITP.).Paient had
ITP.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CT, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 12. Tender L Deltoid eschar with 1cm central
skin necrosis. That slowly healed over 6 weeks without need for medications or
surgical debridement or grafting..Paient has the following illness history -
Penicillin.Patient was receiving Not relavent. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 84 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 24. Angioneurotic edema cellulitis
approximately 6 cm in diameter..Paient has the following illness history -
Discharge summary states vertigo, hypertension, renal insufficiency, cataracts.
msv. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 14. Redness, swelling, fever, knobs under
skin. Swelling goes down after aspirin and ice applied. Swelling returns after
aspirin wears off. Started 15 days after shot. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 79 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 26. Patient developed swelling, redness, and
pain on the same arm the vaccine was administered in. This developed ~ 24 hours
after administration. Site of swelling and site of vaccination different..Paient
had DVT, UTI.Paient has the following illness history - HTN, h/o CVA, CAD,
seizure disorder.Patient was receiving IV Heparin, Vytorin, Levaquin. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 23. Red and sore with infection Pneumovax
2.5 days achy, temp, sweating.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 49 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 26. Redness at injection site (by patient
description), swelling, temp to 103 F, no itching, no wheeze..Paient has the
following illness history - Asthma.Patient was receiving Advair; Albuterol;
Singulair; Flonase; Spirina. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WV, USA. Female patient, 59 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 19. Red, swollen arm day after Pneumovax
administered. Prednisone and Keflex prescribed..Paient has the following illness
history - Lung cancer, HTN, Hyperlipidemia, Asthma.Patient was receiving
Ibuprofen, ranitidine, formoterol, flunisolide, simvastatin.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WV, USA. Female patient, 57 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 19. Red, swollen arm day after Pneumovax.
Presented to ER two days after Pneumovax. Treatment unknown..Paient has the
following illness history - CAD, smoker, osteoarthritis, elevated PSA,
Hyperlipidemia, HTN, Angina.Patient was receiving oxycodone, ranitidine,
lactulose, diazepam, aspirin, atorvastatin, nitroglycerin, pentoxifylline,
terazosin, finasteride, nitrofurantoin, colestipol.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 27. Patient's husband called for his wife
two days after having received the vaccine with c/o redness, swelling, and pain
at the injection. She also had chills with no fever, and a splotchy rash on the
affected arm to her elbow.It was described as being much worse than any vaccine
she had recieved. Arm felt heavy and had a lot of pain when moving it. Symptoms
had gotten a little better today so they opted not to have evaluation by
provider. She will continue to monitor the area, apply compresses, and take
oral.Paient had No illness but had a swollen ankle she was evaluated for..Paient
has the following illness history - No known allergies. Pt has aortic valve
disease and hyperlipidemia..Patient was receiving Pt is currently taking,
verapamil, lipitor, premarin.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KS, USA. Female patient, child 20.8 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 13. Leg swelled up 6 cm hot area,
refusal to walk, extreme local pain requiring narcotics.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KS, USA. Female patient, child 20.8 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 22. Pt's leg swelled up and he
refused to walk.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 04. Information has been received from an LPN
concerning a 65 year old female patient with a urinary tract infection (UTI),
rheumatoid arthritis, hyperlipidemia, GERD, COPD, and no known allergies and a
recent history of hospitalization for right flank pain (diagnosed with UTI) who
on 05/04/2006 or 05/05/2006 before being discharged from hospital was vaccinated
IM in the deltoid with a dos of pneumococcal 23v polysaccharide vaccine
Concomitant therapy included atorvastatin calcium (Lipitor) and ciprofloxacin
hy.Paient had UTI; COPD; GERD; Rheumatoid arthritis; Hyperlipidemia.Paient has
the following illness history - Medical History: Hospitalization. Concurrent
conditions: UTI; COPD; GERD; Rheumatoid arthritis; Hyperlipidemia.Patient was
receiving Lipitor; Cipro.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 10. Information has been received from a health authority concerning a
36 year old male who on 11/10/2005 was vaccinated intramuscularly in the arm
with a dose of pneumococcal 23v polysaccharide vaccine (lot #648713/1336N, batch
#hv24420). Concomitant suspect therapy given intramuscularly in the same arm
included a dose of influenza virus split virion 3v vaccine inactivated (Enzira)
(batch #02701). That same day the patient experienced a severe systemic
reaction. The patient felt unwell (fatigue) and feverish w. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 16 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 05. Paleness, weakness, rapid heart rate,
dizziness, general malaise. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient, 79 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 27. Red, swollen area left deltoid.Paient had
Cough.Paient has the following illness history - Hypothyroidism, hyperlipidemia,
hypertension, osteopenia..Patient was receiving Synthroid, Diovan, ASA, HTZ,
MVI, Calcium, Lipitor. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 27. Pt in for complete physical on 06/27/06
and a pnemovax was administered. Pt called on 6/29/06 & c/o redness, swelling,
and discomfort at injection site as well as a fever. Pt instructed to use
tylenol or ibuprofen as needed and to call if symptoms worsened or did not
improve..Paient had Pt described redness, swelling, and discomfort at injection
site accompanied by a fever..Paient has the following illness history - asthma/
copd hypothyroidism carotid stenosis pud/ crohn's disease hyperlipidemia
osteopenia.Patient was receiving actonel 35mg q wk asacol 400mg 3 tabs bid
synthroid 50mcg q day lipitor 20mg q day nexium 40mg q day singulair 10mg q day
advair 250/50 2 puffs bid asa 81mg q day multi-vitamin q day zyrtec d prn
albuterol prn glucosamine chondro. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 11. The day after vaccination (6/12), there
was redness and warmth at the site of injection. The nurse marked it to assess
swelling. The patient was afebrile and able to move the arm with no limits. On
6/13, swelling and warmth was increased, so IV cefazolin was started due to
suspected cellulitis. The patient received 2 days of cefazolin and was
discharged from the hospital 6/15. The reaction was improved..Paient had C diff
diarrhea.Paient has the following illness history - C. difficile diarrhea, s/p
bilateral knee arthroplasty, hypertension, hypercholesterolemia, anxiety.Patient
was receiving vancomycin 125mg po qid, metoprolol 50mg bid, enoxaparin 40mg sq
daily, atorvastatin 20mg daily. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
June 2006, 07. Information has been received from a physician concerning a 62
year old male patient with left hemiplegia and a history of stroke several years
ago who on 06/07/2006 was vaccinated IM in the the left upper arm with his
second dose of pneumococcal 23v polysaccharide vaccine (lot #650835/0966P, batch
#nb29850). A few hours post vaccination the patient developed an injection site
reaction with redness and warmth. In the evening the symptoms worsened and he
developed swelling of the whole arm down to the finger.Paient had
Hemiplegia.Paient has the following illness history - Stroke; hemiplegia.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient, 48 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 28. Swelling of arm, pain, rash as well as
swelling of her throat. ER 6/28.Tx with ?? and Benadryl. Treated with Keflex 500
mg QID for 1 week begining 6/30..Paient had No.Paient has the following illness
history - Diabetes Type 2 Hypertension.Patient was receiving avandia 8 mg ASA 81
mg HCTZ 12.5 mg Zestril 20 mg.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient, 26 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2006, 05. Ten minutes after injection patient
complained of severe itching. Dime sized redness noted at injection site.
Patient was provided with an ice pack and instructed to use some
Benadryl..Paient has the following illness history - Allergies: Morpine,
Dilantin, Depakote, Nickel, Latex, Paper tape.Patient was receiving Humalog,
HCTZ, Lantus, Levothroid, Lipitor, Lisinopril, Lortab, Naproxen, Trazadone.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, child 7 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 21. Rash developed around injection site.
Hot to touch, raised. Rapidly developed (with in one hour of injection)..Paient
has the following illness history - ADD.Patient was receiving Adderall XR.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 21. Discomfort, redness and swelling in
upper arm. Treated with ice and elevation. Seen by physician..Patient was
receiving Multivitamin, Metformin and ASA.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 21. Redness, swelling, RU extremity down to
medical elbow area. No axillary adenopathy. Trt: ice packs, elevation,
antihistamines. Seen by Dr..Paient had Chapped lips (cheilitis).Paient has the
following illness history - PCN, Sulfa.Patient was receiving Claritin, HCTZ,
Levoxyl, Estradiol, Ambien.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OR, USA. Female patient, 40 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 26. Patient complained of nausea, vomiting,
fever (100.1), swelling and redness at sit of injection (left deltoid) IM.
Adacel..Paient had No.Paient has the following illness history - II Diabetic,
ED, Hyperlipidemia, fatigue.Patient was receiving ASA, lantus Insulin, Cialis,
Lipitor, Androgel. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, swelling, pain in right
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 50 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from MA, USA. Female patient, 22 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling
in right upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Redness, swelling, warmth, pain in right upper arm axillary area.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Redness, warmth, swelling, pain in right upper arm axillary area.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 44 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 22. Redness, warmth, pain, swelling in right
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 49 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 33 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 35 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 31 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 22. Redness, warmth, pain, swelling in left
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 39 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in left
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 57 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 49 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 22. Redness, warmth, pain, swelling in right
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 35 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right
upper arm.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 63 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 22. Redness, warmth, pain, swelling in right
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 40 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 22. Redness, warmth, pain, swelling in right
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 35 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 45 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, swelling, pain in right
upper axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 42 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness, warmth, pain, swelling in right
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 45 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 22. Redness, warmth, pain, swelling in right
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 38 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 26. Left blank on form.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 50 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 26. Left blank on form.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 32 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Left blank on form.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 30 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Left blank on form.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 42 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Left blank on form.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 41 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Left blank on form.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 37 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 22. Left blank on form.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 48 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 22. Redness/warmth/pain/swelling in axillary
area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 34 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness/warmth/pain/swelling in R upper
A axillary area. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 36 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness/warmth/pain/swelling in right
upper arm axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 41 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness/warmth/pain/swelling in R upper
A axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 30 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 20. Redness/warmth/pain/swelling in R upper
A axillary area.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from PA, USA. Female patient, 62 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on July 2006, 03. Pneumovax and DT Mon July 2,
2006 had DT several times past that July 3-4-5-6,2006. Fever 102, myalgias,
arthralgias, unwell, pain lt arm site of Pneumovax..Paient has the following
illness history - Breast cancer, asthma, acid reflux. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 22. Pt called several hours after the
administration on 2/22/06 c/o pain and difficulty moving of left arm. Symptoms
were at the highest level the first 3 days after immunization and she states
today 7/11/06 that she has steadily improved since. Has recovered for the most
part, presenting 7/11/06 with vague discomfort in the lower aspect of left arm,
3 to 4 inches above elbow.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 52 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2006, 11. The patient experienced a full body
arthritic reaction with joint aches in the knees and shoulders most
prominent..Paient had Type 2 DM, hyperlipidemia, hypertension.Paient has the
following illness history - see number 18.Patient was receiving MVI, metformin,
asa, lipitor. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 60 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 07. Patient received Pneumovax on 6/7/06 to
right deltoid. Patient returned 6/8/06 complaining swollen right deltoid . She
was given Benadryl and Tylenol..Paient has the following illness history -
Allergy to Iodine History of HSV type 2, GERD, DJD.Patient was receiving
Verapamil, Prevacid, Amitriptyline, Nasacort, Albuterol, Azmacort, Vicodin,
Cyclobenzapril, Methocarbamol, Acyclovir.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NM, USA. Female patient, 67 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2006, 10. Rash right arm, muscle pain (arms,
legs), neck pain, fever and loss of appetite..Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OR, USA. Female patient, 28 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 21. Patient received Td shot and PPV23 on
06/21/2006. Today she states that her arm is sill swollen from the PPV23. On
examination, the patient has developed cellulitis to the left deltoid (site of
PPV23 vaccination).. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
June 2006, 16. Information has been received from a general practitioner
concerning a 66 year old female with a history of pituitary adenoma, diabetes
insipidus, pituitary hormone deficiency, pancreatitis, chronic obstructive
pulmonary disease, allergic rhinoconjunctivitis and nephrolithiasis who on 16
June 2006, was vaccinated (route unknown) in the left upper arm with a dose of
pneumococcal 23v polysaccharide vaccine (Lot # 650833/0882P, Batch # NC72130).
About twelve hours later, she developed severe swelling of the wh.Paient has the
following illness history - Pituitary adenoma; Diabetes insipidus; Pituitary
hormone deficiency; Pancreatitis; Chronic obstructive pulmonary disease;
Allergic rhinoconjuctivitis; Nephrolithiasis.Patient was receiving
Ciprofloxacin. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OR, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 09. Patient present to clinic on 2/10/06 with
"20 x 16 cm red elevated sore" Swelling started 2-3 hours after injection. Given
prescription of Keflex 500 mg qid x 7 days and ibuprofin 800 mg tid. On 2/13/06
patient returned for follow up. Per chart note, "inner elbow continues with
swelling, upper arm with decreased swelling, discolored yellow around injection
site, pain decreased..Paient has the following illness history - Psoriasis;
Hypothyroidism;Depression; Hypertension; Sarcoidosis..Patient was receiving
Celexa 10 mg;Levothyroxine 75 mcg; Estradiol 1 mg;Calcium, Vitamin C, Zinc, and
Vitamin E..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, 47 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 27. Significant pain, erythema and
induration in area (anterior and medial) around left deltoid. Significant
streaking of tissue with well demarcated erythema, but no axillary node
involvement. Fevers with temperature of 101 F. Symptoms began at 12 hours post
administration and were still present on days. Treated with Ibuprofen (600 mg,
QID) and antibiotics for possible cellulitis (Cefpodudine 400, BID x 7
OMS).Paient had A1 HIV, HTN.Paient has the following illness history - A1
HIV.Patient was receiving Lisinopril, Alprazolam, HCTZ.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Pneumococcal vaccine polyvalent Pneumovax 23, 0.5ml single dose vials. The
expiration date is ambiguous. Lot number 0751P. It is depicted on the vial as
07Jun06. Interpreted as expiring June 6 2007 and June 7 2006.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on June 2006, 27. A 35-year-old female patient received an injection of
pneumococcal vaccine on 06/27/06. On 06/28/06, at 0300 in the morning, 13 hours
after the pneumococcal vaccine was administered, the patient complained of
severe muscular pain in the right shoulder at the site of injection. The patient
had not previously complained of any pain. Tylenol was administered to the
patient as a rescue medication for the pain. No laboratory or diagnostic testing
was done.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2006, 22. Hives left eye very swollen, rash on
face, neck lasted a week. Went to DR for diagnosis and got Prednisone for 5 days
and used over counter Benadryl..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 67 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2006, 06. Pt developed erythema macular around the
injection site one after the shot. Pt did not developed fever no hives. Area was
slightly swollen. Pt was treated with Zyrtec improving. Pt was in the clinic
today 7/17/06. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient, 20 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2006, 17. Very pronounced local reaction. 4-5 inch
diameter red, swollen, painful, hot area at location of injection. Red area
expanded to about 5-6 inch diameter today. No improvement..Paient has the
following illness history - Splenectomy years ago, allergic to PCN, sulfa,
Doxycycline..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from LA, USA. Female patient, child 10 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2006, 19. Received TC from pts mother on
07/19/2006 at 3:30 pm. States pts right arm swollen. Instructed to apply cold
compresses and take to ER and to call 911 it has problems breathing..Paient has
the following illness history - Sickle Cell Disease.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 28 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2006, 18. Pneumovax vaccination occurred 7/18/06
at 4pm. There was immediate pain with injection of Pneumovax. Pain worsened as
the day progressed and peaked for next 48 hours. Injection was administered in
left shoulder. All of left upper extremity was painful/tender to palpation.
Erythema and edema of left deltoid occurred appx 12 hours later. Fever started
appx 30 hours after injection with a max temp of 101deg F. I was evaluated by
another physician at another clinic and was started on Avelox 400mg one
tab.Paient had Was visiting facility for dermatology referral..Paient has the
following illness history - Hx of Asthma, seasonal allergies, back pain, R
shoulder SLAP lesion, bilateral lower extremity- exercise induced compartment
syndrome, depression..Patient was receiving Advil, Tylenol.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 07. Initial report received on 13Jul06 from
another manf who had originally received the report from a healthcare
professional. A 69 yr old female pt with a past medical history of allergy to
Penicillin (hives), and who had a current work related injury of left leg
contusion with probable hematoma, had received an intra muscular dose of Fluzone
2005-2006, lot number U1912AA and a first IM dose of Pneumovax 23, lot number
650649/0790P, on 07Nov05 at 16:30PM. The sites of administration were not
reported for eith.Paient had At the time of vaccination the patient had a work
related injury of left leg contusion with probable hematoma..Paient has the
following illness history - The patient has a past medical history of allergy to
Penicillin that causes hives..Patient was receiving Tylenol; Antibiotics
("Keter"); Prednisone.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OK, USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 12. Malaise, swelling, throbbing to 3 inches
below the right elbow, radiating to inner right arm, painful to touch. 10-13-05
started Benadryl and Aleve every 4-6 hours. 10-17-05 swelling and inflammation
gone but aching remains. Will continue Aleve. 10-19-05 tenderness only at
injection site..Paient had No.Paient has the following illness history -
Shellfish, MSG, alcohol Auto immune liver problem Arthritis.Patient was
receiving Urso, Premarin. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OK, USA. Female patient, 50 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 27. Client stated she woke up Sat morning
with red welts on arm, nausea, shortness of breath.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OK, USA. Female patient, 79 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 01. Redness and swelling below immunization
site.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OK, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2004, 26. Client complain of severe pain under
right arm-axilla unable to move arm above 45 degree angle. Pain sometimes
radiate down arm to hand. Upper inner arm is warm to touch. Referred to Doctor,
he diagnose lymph node infection patient put on Bextra 20mg daily.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 71 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2005, 28. Information has been received from a
pharmacist concerning a 71 year old white female with no relevant medical
history reported who at 06:10 on 28-APR-2005 was vaccinated subcutaneously in
the left arm with a first dose of pneumococcal 23v polysaccharide vaccine. It
was reported that the patient had pneumonia at the time of vaccination. At 12:00
on 28-APR-2005, the patient developed redness, warmth and swelling at the
injection site. Subsequently, the patient recovered. The reporter felt that the
patient's.Paient had Pneumonia. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, 57 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2005, 29. Initial and follow-up information has
been received from a registered nurse and a physician concerning a 57 year old
white female patient with chronic obstructive pulmonary disease, reactive airway
disease, hypertension, hyperlipidemia, pneumoconiosis and allergies to
penicillin, erythromycin, prochlorperazine, and oxycodone (+) aspirin who at
03:50 on 29-JUN-2005 was vaccinated IM in the right deltoid with a first 0.5 mL
dose of pneumococcal 23v polysaccharide vaccine (Lot# 649692/0371P). Concomitant
thera.Paient has the following illness history - chronic obstructive pulmonary
disease, reactive airway disease, hypertension, hyperlipidemia, pneumoconiosis
and allergies to penicillin, erythromycin, prochlorperazine, and oxycodone (+)
aspirin.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2000, 03. Information has been received from a
certified medical assistant concerning a 69 year old patient with high blood
pressure, GERD, IBS, and lots of allergies, who on 5/3/00 and on 8/22/05 was
vaccinated with a first and second dose (lot # 647661/0055R) of pneumococcal 23v
polysaccharide vaccine, respectively. After the first dose, on 5/3/00, the
patient developed a 4x6cm red area on left arm and was diagnosed with
cellulitis. After the second dose the patient developed a swollen red area at
site of injection.Paient has the following illness history - Blood pressure
high; Gastroesophageal reflux disease; Irritable bowel syndrome;
Hypersensitivity.Patient was receiving Prevacid.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Sept 2005, 13. Information has been received from a health care worker
concerning a patient who on 13-SEP-2005 was vaccinated with a dose of
pneumococcal 23v polysaccharide vaccine (lot # 649981/0704P or 650451/0750P). On
15-SEP-2005 the patient was seen by a physician, after developing a local
reaction described as a large swollen painful area in left arm at site of
injection down to forearm. The patient was placed on Keflex and Domboro soaks.
At the time of the report the patient was in the process of treatment. No
prod.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Sept 2005, 30. Information has been received from a registered nurse
concerning a 32 year old male who on 30-SEP-2005 was vaccinated IM with 0.5 mL
dose of pneumococcal 23v polysaccharide vaccine (lot # 650649/0790P). On
approximately 30-SEP-2005, the patient reported that he went to an urgent care
facility due to a severe localized reaction. He was diagnosed with cellulitis
and placed on cephalexin (Keflex). A product quality complaint was not involved.
Cellulitis was determined to be an other important medical event (OM.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Sept 2005, 20. Information has been received from a registered nurse
concerning a 51 year old female who on 20-SEP-2005 was vaccinated SC with a 0.5
mL dose of pneumococcal 23v polysaccharide vaccine (lot # 650649/0790P). On an
unspecified date in approximately September 2005, the patient went back to her
physician and was diagnosed with localized allergic urticaria and was placed on
methylprednisolone (Medrol) dose pack. A product quality complaint was not
involved. Localized allergic urticaria was determined to be an ot.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 28. Information has been received from a
licensed practical nurse concerning a 68 yr old female pt with an allergy to PCN
and codeine and a past medical history of carcinoma of the uterus, GERD, and
lumbar spinal stenosis, who on 28Sep05 was vaccinated in the left arm with a
dose of pneumococcal 23v polysaccharide vaccine (lot 650084/0605P). There were
no other concomitant vaccination administered at the same time. On the day of
vaccination with pneumococcal 23v polysaccharide vaccine, 28Sep05, the pt
reported.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 63 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 04. Information has been received from a RN
pharmacist concerning a 53 yr old female with a sulfa allergy who on 04Oct05 was
vaccinated IM in the deltoid with her second 0.5ml dose of pneumococcal 23v
polysaccharide vaccine (lot 650649/0790P, also reported as lot 650648/0967P). It
was reported in follow up information that the pt developed soreness, redness
and tenderness at the injection site and into her chest area on 04Oct05 at 8PM.
She required medical intervention and was diagnosed with cellulitis and
was.Paient has the following illness history - Sulfonamide allergy.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 11. Information has been received from a physician concerning a 47yr
old female with sulfa allergy and diabetes who on 11Oct05 was vaccinated (left
deltoid) with 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot
649695/0512P). Within 24 hrs, on 12Oct05, the pt called the office and
complained of pain at the injection site. On 13Oct05 the pt developed headache,
hot, induration and swelling at injection site. The pt was treated with
acetaminophen (Tylenol) and ibuprofen (unspecified). As of 14Oct05, the.Paient
has the following illness history - Sulfonamide allergy; diabetes. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from WA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT
(PNEUMOVAX). Information has been received from a RN concerning a pt with a
history of pulmonary disease who was vaccinated with pneumococcal 23v
polysaccharide vaccine (lot 0650643/0790P). The registered nurse reported that
the pt developed redness, swelling and heat in the injection site arm after
vaccination, during the past 3 months. The pt received oral antibiotics. At the
time of the report, it was unk if the pt recovered. The RN felt that redness,
swelling and heat in the pt's injection site arm was considered to.Paient has
the following illness history - Lung disorder.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 76 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 12. Initial and follow-up information has
been received from a pharmacist concerning a 76 year old male who on 12-OCT-2005
was vaccinated intramuscularly, with 0.5 ml dose of pneumococcal 23v
polysaccharide vaccine (Lot # 651539/0607R). It was reported that this was the
first dose of pneumococcal 23v polysaccharide vaccine that the patient had
received. On 12-OCT-2005, the patient was also vaccinated intramuscularly in the
left arm with 0.5 ml dose of influenza virus vaccine (unspecified). On
13-OCT-2005, the p.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 01. Information has been received from a health professional
concerning an adult patient who, in the last month, in approximately October
2005, was vaccinated IM with a 0.5 ml dose of pneumococcal 23v polysaccharide
vaccine (lot # 649914/0578P). In approximately October 2005, in the last 30
days, the patient experienced cellulitis at the injection site and was treated
in the hospital with IV antibiotics, recovered and was released. It was noted
that the patient recovered within 3-7 days post vaccination. It was.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 16. Information has been received from a health professional
concerning an adult pt who less than 2 days ago on approx 16Oct05 was vaccinated
IM with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine. (lot
649914/0578P). In Oct 2005 the pt experienced an injection site reaction
including redness, swelling and local pain at the site. The pt was treated with
diphenhydramine hcl (Benadryl). At the time of this report, the pt was still
recovering. It was also noted that this was a revaccination and the pt
had.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a health professional concerning an adult pt
who in the last 30 days, approx Oct 2005, was vaccinated IM with a 0.5ml dose of
pneumococcal 23v polysaccharide vaccine (lot649914/0578P). In approx Oct 2005,
over the last 30 days, the pt experienced an injection site reaction including
redness, swelling and pain and was treated with diphenhydramine hc1 (Benadryl).
The pt recovered in 3-7 days. It was also noted that this was a revaccination
and the pt had at least one and pos.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 60 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 1997, 05. Initial information and follow up
information has been received from a licensed practical nurse and medical
records concerning a overweight 68 year old female who wears corrective lenses
and has allergies itching to amoxicillin (-) clavulanate potassium Augmentin,
grass and trees, hypertension (controlled), bilateral lower extremity edema
(controlled. Physiologic flow murmur, coronary artery disease, hypothyroidism
(recently decreased levothyroxine sodium dose because of TSH suppression), GERD,
degenerative.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse concerning one of four
patients with a history of pulmonary disease who was vaccinated with
Pneumococcal 23v polysaccharide vaccine (lot 0550549/0790P). The registered
nurse reported that the patient developed redness, swelling and heat in the
injection site arm after vaccination, during the past 3 months. The patient
received intravenous antibiotics in an outpatient setting. At the time of the
report, it was unknown if the patient recovered. The registe.Paient has the
following illness history - Lung disorder..Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 01. Information has been received from a pharmacist concerning an
adult patient (age and gender not reported) with unknown medical history and
unknown allergies, who in early Oct 2005, was vaccianted intramuscularly with a
0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 644220/1119M) which
had expired on 4/9/04. It was reported that the patient developed redness,
swelling at the injection site and general malaise 24 hours post vaccination,
was treated with cephalexin Keflex, and recovered fully in ab.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient, 54 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a
registered nurse concerning a 54 year old female who on 10/24/05 at 4:30 pm was
vaccinated with a first dose of Pneumococcal 23v polysaccharide vaccine (lot
647661/0055R), in the right deltoid. Subsequently, she called the physician
complaining of pain at injection site. The patient was seen in the office on
10/26/05 for cellulitis to right shoulder, induration, erythema in linear area
below injection site and running medially around anterior aspect of shoulder and
into.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NV, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 01. Information has been received from a certified medical
assistant concerning an adult (age and gender not reported) patient who in
approximately Oct 2005 (over the last month), was vaccinated intramuscularly
with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine (lot
649695/0512P). Subsequently, on an unspecified date, the patient developed an
injection site reaction to include soreness, warmth, erythema and swelling. The
patient was treated with antibiotics and on an unspecified date recovered
fully..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 77 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 04. Information has been received from a
registered nurse concerning a 77 year old male with unspecified medical history
who on 11/4/2005 was vaccinated with Pneumococcal 23v polysaccharide vaccine
(0.5 ml) (lot 650329/0747P), intramuscularly in the right arm. Concomitant
therapy included unspecified medication. Subsequently the patient had a swollen,
red, right arm, no fever. The patient was seen in the doctors office. The
patient was diagnosed with cellulitis and was treated with oral antibiotics, The
patient.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from SC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 09. Information has been received from a respiratory therapist
concerning a female age not provided, who on 11/9/05 was vaccinated IM into the
left arm with 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot
649988/0692P). The patient also received influenza virus vaccine unspecified on
the opposite arm. On approximately 11/9/05, the patient developed hot, painful
and swelling about size of half dollar at injection site. The physician ordered
50mg of diphenhydramine hydrochloride Benadryl PO and 30 mg p. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 20. Information has been received from a licensed practical nurse
concerning an elderly female patient who is a diabetic and has a history of
mastectomy who on approximately 20-OCT-2005 "three weeks ago" was vaccinated
with a dose of pneumococcal 23v polysaccharide vaccine (lot #649914/0578P).
"Within 24 hours of dosing" the patient experienced cellulitis. It was noted
that if she would have waited a few more days before contacting the physician's
office, would have required hospitalization. It was noted that s.Paient has the
following illness history - Mastectomy, Diabetes..Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 54 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a
registered nurse concerning a 54 year old female with unspecified medical
history who on 11/7/05 was vaccinated with Pneumococcal 23v polysaccharide
vaccine 0.5 ml (lot 650329/0747P) Concomitant therapy included unspecified
medication. Subsequently, the patient developed a swollen, red arm. The patient
was seen in the doctors office. The patient was diagnosed with cellulitis and
was treated with oral antibiotics. The patient was reportedly doing well. The
reporting nurse.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse concerning a 77 year old
female with unspecified medical history who was vaccinated with pneumococcal 23v
polysaccharide vaccine (lot #650329/0747P) (0.5ml), intramuscularly. Concomitant
therapy included unspecified medication. Subsequently, the patient experienced
cellulitis. The patient was seen in the emergency room and was treated with
antibiotics. The patient was reportedly "doing well". The reporting nurse
considered cellulitis to be disabling. It.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from SC, USA. Female patient, 49 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a
respiratory therapist concerning 49 year old black female educator (164 lb, 66")
with no known drug allergies and sarcoidosis who on 07NOV-2005 was vaccinated
intramuscularly with 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot
649988/0692P). The patient also received influenza virus vaccine (unspecified)
on the opposite arm. On 07-NOV-2005, the patient developed erythema, hot,
itching and swelling about size of "half dollar" at injection site. The
physici.Paient has the following illness history - Concurrent conditions:
Sarcoidosis. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 37 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 08. Information has been received from a
licensed practical nurse concerning a 37 year old white non drinking (also
reported to use alcohol regularly, 2-3/day), male, chef, with no known
allergies, who lives with his wife, performs his own activities of daily living
and is independent, with a past surgical history of an open reduction with an
internal fixation of the right lower leg, who has reflux disease, multiple
sclerosis for the past two years, inflammatory acne, migraines, joint pain in
the pelvic and thi.Paient has the following illness history - Multiple
sclerosis; open reduction of fracture with internal fixation. Gastrooesophageal
reflux disease; smoker; acne; migraine; arthralgia..Patient was receiving
Avonex; Prevacid; tetracycline hydrochloride 500mg.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 01. Information has been received from a registered nurse concerning a
32 year old female with asthma and type I diabetes mellitus who in 11/05 was
vaccianted subcutaneously with 0.5ml dose of Pneumococcal 23v polysaccharide
vaccine (lot 649697/1038P). It was reported that the patient had been vaccinated
with the first dose of Pneumococcal 23v polysaccharide vaccine. The registered
nurse reported that the next day the patient developed a local reaction
involving pain and difficulty moving her arm, which was dia.Paient had Asthma;
Type I diabetes mellitus.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a
registered nurse concerning a 69 year old female with a penicillin allergy hives
who on 11/7/2005 at 1630 was vaccinated intramuscularly with her first dose of
Pneumococcal 23v polysaccharide vaccine (lot 650649/0790P). Concomitant vaccine
therapy included a dose of influenza virus split virion 3v vaccine inactivated
Fluzone given intramuscularly in the other arm lot U1912AA. At the time of
vaccination the patient had a left leg contusion with a probable hematoma (work
r.Paient had Contusion of lower leg.Paient has the following illness history -
Hives, penicillin allergy.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CT, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 17. Information has been received from a registered nurse
concerning a 75 year old female patient, with a history of vaccination (route
unknown) by another facility with her first dose of Pneumococcal 23v
polysaccharide vaccine (manufacturer unknown) >5 years ago and unknown drug
reactions allergies, who on 11/17/05 was vaccinated intramuscularly in the left
deltoid with a 0.5ml booster dose of Pneumococcal 23v polysaccharide vaccine
(lot 651329/1047P). Concomitant therapy included metoprolol succinate
(Toprol.Patient was receiving Aspirin; Avapro; Prevacid; Synthroid; Toprol XL
tablets; Zocor; Vitamins; Ambien.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 29. Information has been received from a physicians assistant
concerning a 72 year old male with polycythaemia (stable in past 5 years), no
allergies, and folliculitis of the face and neck. On 11/29/2005 the patient was
hospitalized for a change in mental status and a seizure. It is part of the
hospitals protocol to offer a patient the vaccine if they have not had one. The
patient had never had one so that same day he was vaccinated intramuscularly
with a first 0.5 ml dose of Pneumococcal 23v polysaccharide vac.Paient had
Convulsion, mental status changes.Paient has the following illness history -
Polycythaemia, hospitalisation, folliculitis..Patient was receiving Aspirin;
Plavix; Doxycycline; Dilantin.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient, 56 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 05. Information has been received from a
health professional concerning a 56 yr old female pt with allergies to codeine
derivatives, penicillins and tetracyclines who on 04Nov05 (also reported as
05Dec05) was vaccinated IM in the left deltoid with a dose of pneumococcal 23v
polysaccharide vaccine (lot 650541/1004P) (also reported as 650542/1005P).
Concomitant therapy included influenza virus vaccine (unspecified). There was no
illness at the time of vaccination. The pt had a local reaction at the injection
site.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse concerning two patients
who were vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot
650454/0751P). Subsequently, the patients developed injection site swelling and
fever. The patients are being treated with acetaminophen Tylenol and application
of ice pack. No other information was available regarding the adverse event or
the patients outcomes. There was no product quality complaint reported. The
reporter considered the patients adver.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered pharmacist concerning a patient
who was vaccinated with pneumococcal 23v polysaccharide vaccine. Concomitant
therapy that day included influenza virus vaccine (unspecified). Subsequently
the patient experienced cellulitis in the arm that the pneumococcal 23v
polysaccharide vaccine was given. Unspecified medical attention sought..Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OR, USA. Female patient, 52 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 16. Information has been received from a
registered nurse concerning a 52 year old female with exercise induced asthma
and allergies to penicillin and sulfonamide who on 11/16/05 at 2:30pm was
vaccinated IM, into the left deltoid, with a 0.5 ml dose of Pneumococcal 23v
polysaccharide vaccine (lot 651328/1046P). Concomitant therapy included
influenza vaccine (lot U1827AA) given IM into the right deltoid. On 11/16/05,
shortly after the vaccination, the patient developed redness, warmth, swelling
and pain at left.Paient has the following illness history - Asthma exercise
induced, Penicillin allergy, Sulfonamide allergy..Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Initial and follow up information has been received from a office manager of a
physician's office concerning a male pt, who was vaccinated with a second dose
of pneumococcal 23v polysaccharide vaccine and subsequently experienced
cellulitis in his arm after receiving the vaccination. The office manager
reported the pt had been in the ER for another reason; however, he received the
dose of pneumococcal 23v polysaccharide vaccine, due to the state law that
requires hospitals to offer it before a pt leaves the.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, child 12 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 31. Information has been received from a
registered nurse concerning a 12 year old African American female with allergy
to penicillin and sulfa who on 10/31/05 was vaccinated a first dose of
pneumococcal 23v polysaccharide vaccine (0.5ml) (lot # 651318/1006P), IM in the
left arm. There was no illness at the time of vaccination. On 11/2/05, the
patient presented to the office with injection site pain, swelling, and
tenderness of the left arm. It was also reported that two days post immunization
the patient devel.Paient had Sulfonamide allergy; Penicillin allergy.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MS, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a licensed practical nurse concerning a
female pt who was vaccinated with a 0.5ml dose of pneumococcal 23v
polysaccharide vaccine (lot649695/0512P) and within 72 hrs she developed
cellulitis at the injection site. The pt sought medical attention and was
treated with antibiotics. The pt recovered. There was no product quality
complaint reported. The reporter considered cellulitis at injection site to be
an other important medical event (OMIC) and disabling. Additional infor.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MO, USA. Female patient, 52 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 08. Information has been received from a
health professional concerning a 52 year old immunocompromised female with
rheumatoid arthritis who on 12/08/05 was vaccinated SC in the right arm with a
0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P).
Concomitant therapy the same day included influenza virus vaccine (unspecified)
and tuberculin given in the left arm. On 12/10/05 the patient presented with
cellulitis of her right arm. She was treated with antibiotics and has recovered.
There was.Paient has the following illness history - Rheumatoid arthritis,
Immunosuppression.Patient was receiving Tuberculin.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MS, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a licensed practical nurse concerning a
female patient who was vaccianted with a 0.5ml dose of Pneumococcal 23v
polysaccharide vaccine (lot 649695/0512P) and within 72 hours she developed
cellulitis at the injection site. The patient sought medical attention and was
treated with antibiotics. The patient recovered. There was no product quality
complaint reported. The reporter considered cellulitis at injection site to be
an other important medical event (OMIC) and disabling.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 77 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 04. Information has been received from a
registered nurse concerning a 77 year old female with hypertension,
diverticulitis, osteoporosis, arthritis, and a sulfa allergy who at 1:15pm on
1/4/06 was vaccianted intramuscularly in the left arm with a 0.5 ml dose of
Pneumococcal 23v polysaccharide vaccine (lot 649914/0578P). Concomitant therapy
included alprazolam Xanax, amlodipine besylate Norvasc, Telmisartan Micardis,
ranitidine HCL Zantac, risedronate sodium Actonel, vitamins and acetaminophen
Tylenol. Approxim.Paient had Hypertension; Diverticulitis; Osteoporosis;
Sulfonamide allergy; Arthritis.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Jan 2006, 13. Information has been received from a pharmacist concerning a 62
year old male, with ampicillin allergy, sulfamethoxazole allergy, and
simvastatin (manufacturer unknown) allergy, who on 1/13/06 was vaccinated
intramuscularly in the left deltoid with a 0.5 ml dose of Pneumococcal 23v
polysaccharide vaccine (lot 649732/0513P). ON 1/15/06 the patient was presented
to the ER and diagnosed with cellulitis. The patient was treated with
clindamycin manufacturer unknown and released. The patients present status
was.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Jan 2006, 13. Information has been received from a pharmacist concerning a 62
year old male who on 1/13/06 was vaccinated intramuscularly in the left deltoid
with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649732/0513P).
On 1/15/06 the patient was presented to the ER and diagnosed with cellulitis.
The patient was treated with Ibuprofen Motrin and released. The patients present
status was reported as unknown. The pharmacist is requesting a lot check. The
patient's experience was considered to be an impor.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 74 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 24. Information has been received from a
healthcare worker/office manager concerning a 74 year old female, with unknown
medical history and unknown drug reaction/allergies, who on 1/24/06 was
vaccinated intramuscularly with a 0.5ml dose of Pneumococcal 23v polysaccharide
vaccine (lot 651330/1048P). About 4 hours post vaccination, on 1/24/06, the
patient developed swelling and redness near the injection site. She was treated
at a local ER with some form of steroids and released. The patients present
status was.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse concerning a patient with
a history of pulmonary disease who was vaccinated with Pneumococcal 23v
polysaccharide vaccine (lot 0650649/0790P). The registered nurse reported that
the patient developed redness, swelling and heat in the injection site arm after
vaccination, during the past 3 months. The patient received oral antibiotics. At
the time of the report, it was unknown if the patient recovered. The registered
nurse felt that redness, swelling and h.Paient has the following illness history
- Lung disorder..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse concerning a patient with
a history of pulmonary disease who was vaccinated with pneumococcal 23v
polysaccharide vaccine (lot # 0650649/0790P). The registered nurse reported that
the patient developed redness, swelling and heat in the injection site arm after
vaccination, during the past 3 months. The patient received oral antibiotics. At
the time of the report, it was unknown of the patient recovered. The registered
nurse felt that redness, swelling and.Paient has the following illness history -
Lung disorder.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 01. Information has been received from a pharmacist concerning an
adult patient (age and gender not reported) with unknown medical history and
unknown allergies, who in early October 2005, was vaccinated IM with a 0.5mL
dose of pneumococcal 23v polysaccharide vaccine (lot # 644220/1119M) which had
expired on 4/9/04. It was reported that the patient developed redness, swelling
at the injection site and general malaise 24 hours post vaccination, was treated
with cephalexin, and recovered fully in about one week..Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NV, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 01. Information has been received from a certified medical
assistant concerning an adult (age and gender not reported) pt who in
approximately Oct 2005 (over the last month), was vaccinated IM with a 0.5ml
dose of Pneumococcal 23v polysaccharide vaccine (lot 649695/0512P).
Subsequently, on an unspecified date, the pt developed an injection site
reaction to include soreness, warmth, erythema and swelling. The patient was
treated with antibiotics and an on unspecified date recovered fully. The patient
experienced.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NV, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 01. Information has been received from a certified medical
assistant concerning an adult (age and gender not reported) patient who in
approximately in October 2005 ("over the last month"), was vaccinated
intramuscularly with a 0.5 mL dose pneumococcal 23 v polysaccharide vaccine (Lot
# 649695/0512P). Subsequently, on an unspecified date, the patient developed an
injection site reaction to include soreness, warmth, erythema and swelling. the
patient was treated with antibiotics and on an unspecified date recover.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on May 2006, 24. Information has been received from a licensed practical nurse
concerning a female with an allergy to the flu vaccine who on 24May06 was
vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot
653284/0002P). That same day, post immunization, the pt experienced an
anaphylactic reaction and was hospitalized. She was treated with epinephrine and
diphenhydramine (Benadryl). Subsequently, the pt recovered. Anaphylactic
reaction was considered to be an other important medical event (OMIC) a.Paient
has the following illness history - Allergy to vaccine.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 45 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on May 2006, 05. Initial information (via a company rep)
and follow up information has been received from a physician, concerning a 45 yr
old white female, with no known medical history and no known drug
reactions/allergies reported, who on 05May06 was vaccinated SC in the right arm
with a first dose of pneumococcal 23v polysaccharide vaccine (650644/0004F).
Concomitant therapy included vancomycin. It was previously reported that on
05May06 after receiving the immunization the pt developed cellulitis. It was
reported that t.Paient had Fever.Patient was receiving Vancomycin.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from ID, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Apr 2006, 17. Information has been received from a RN concerning a 69 yr old
white female who on 17Apr06, was vaccinated IM with a 0.5mL first dose of
pneumococcal 23v polysaccharide vaccine (lot 650330/0748P). Several hours post
vaccination, the pt developed pain at the injection site. The pt's arm was very
sore to the point of having trouble lifting the arm. The pt might have also
developed redness and swelling at the injection site. The pt was treated with a
triamcinolone acetonide (Kenalog) injection to get relief. S.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from ID, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Dec 2005, 14. Injected limb mobility decreased; injection site erythema;
injection site pain; injection site swelling. Information has been received from
a registered nurse concerning a 66 year old white female who on 12-DEC-2005 was
vaccinated intramuscularly with a 0.5ml dose of pneumococcal 23v polysaccharide
vaccine (lot 650660/0748P). Several hours post vaccination the patient developed
pain at the injection site. The patient's arm was very sore to the point of
having trouble lifting the arm. The patient might have.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from ID, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Apr 2006, 08. Information has been received from a RN concerning a 71 yr old
white male who on 08Apr06 was vaccinated IM with a 0.5mL second dose of
pneumococcal 23v polysaccharide vaccine (lot 650330/0748P). Several hours post
vaccination, the pt developed pain at the injection site. The pt's arm was very
sore to the point of having trouble lifting the arm. The pt might have also
developed redness and swelling at the injection site. On 09Apr06, the pt was
treated with a triamcinolone acetonide (Kenalog) injection to get.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Apr 2006, 13. Information has been received from a physician concerning a 63
yr old male physician, with unk medical history, who on 13Apr06 was vaccinated
(route unk) with a dose of pneumococcal 23v polysaccharide vaccine (lot
651328/1046P). There was no concomitant medication. On 13Apr06 the pt developed
cellulitis. The pt was treated with antibiotics (unspecified). No product
quality complaint was involved. The reporting physician requested a lot check.
Cellulitis was considered to be disabling and other important med.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 79 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Aug 2005, 01. Initial and follow up information has
been received from a medical assistant, via a company rep, concerning an 80 yr
old white retired male, with glucose intolerance, hyperlipidemia, herpes zoster
virus, and a history of abdominal aortic aneurysm, AAA, who on 01Aug05, was
vaccinated SC with a first dose of pneumococcal 23v polysaccharide vaccine (lot
649694/0386P). Initially the nurse reported that, on an unspecified date, the pt
developed cellulitis of the arm after having been vaccinated with
pneumococcal.Paient has the following illness history - Abdominal aortic
aneurysm; glucose intolerance; hyperlipidaemia; herpes virus infection.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a pharmacist, via a company rep, concerning a
female (age unk) who in Apr 2006, was vaccinated (route unk) with a dose of
pneumococcal 23v polysaccharide vaccine (lot unk). It was reported that after
receiving a dose of pneumococcal 23v polysaccharide vaccine the pt had to be
admitted to the hospital because of a fever. The fever developed within 23 hrs
of receiving the vaccine. It was reported that the pt had a low grade fever
before vaccination and she was being observed.Paient had Medical observation;
slight fever; upper respiratory tract congestion. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KS, USA. Female patient, 59 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 03. Initial and follow up information has
been received from a RN concerning a 59 yr old female pt (198 pounds) with a
sulfa allergy, who on 03Mar06, was vaccinated IM into the right deltoid with a
0.5ml first dose of pneumococcal 23v polysaccharide vaccine (651320/1008P).
Subsequently, the pt's right deltoid was swollen, red and warm to touch at the
injection site. The pt also experienced injection site pain. The pt was treated
with cephalexin (Keflex) 500mg BID for 7 days. Subsequently, the pt recovered.
No p.Paient has the following illness history - Sulfonamide allergy.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KS, USA. Female patient, 71 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 09. Initial and follow up information has
been received from a RN concerning a 71 yr old white male pt who on 09Mar06 was
vaccinated IM into the right deltoid with a 0.5ml first dose of pneumococcal 23v
polysaccharide vaccine (651320/1008P). On 09Mar06 in the evening, the pt
experienced swelling, redness and pain in the right arm at the injection site.
The pt also developed cellulitis and injection site local heat. The pt was
treated with cephalexin (Keflex) 500mg every four hours for 10 days and
diphenhydramin.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 22. Initial and follow up information has
been received from a medical assistant concerning an 66 yr old white male
painter, with an allergy to aspirin, hypertension, back pain, and non insulin
dependent diabetes, who on 22Mar06 was vaccinated IM in the right arm with a
first 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 651320/1008P).
There was no concomitant medication. In the evening of the injection, on
22Mar06, the pt's right arm became painful and swollen. It became worse the next
day. It was. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 87 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Mar 2006, 20. Information has been received from a
health professional concerning an 87 yr old Caucasian male with diabetes
neuropathy, non insulin dependent diabetes mellitus, aspirin allergy and
hypertension who on 20Mar06 was vaccinated with a second dose of pneumococcal
23v polysaccharide vaccine (0.5ml) (lot651320/1008P), IM, in the right arm.
There was no concomitant medication. There was no illness at the time of
vaccination. One day after injection the pt developed soreness at the site of
injection. An exam revea.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KS, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 10. Initial and follow up information have
been received from a RN concerning a 72 yr old white male pt who on 10Feb06 was
vaccinated IM into the left deltoid with a 0.5ml first dose of pneumococcal 23v
polysaccharide vaccine (lot 651321/1036P). On 11Feb06, the pt developed left
upper arm redness to the elbow. Within the last 6 weeks, the pt experienced an
injection site reaction to include swelling, local heat and pain. The pt was
treated with cephalexin (Keflex) 500mg, four times daily for 10 days,
acetaminop.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Sept 2005, 01. Information has been received from a registered nurse
concerning an adult (age and gender unknown) patient who within the last six
months, on an unknown date, was vaccinated (route unknown) with a 0.5mL dose
pneumococcal 23v polysaccharide vaccine (lot # 650329/0747P). Subsequently,
within the last six months on an unspecified date, the patient developed an
injection site reaction which included pain, redness, swelling, and local heat.
The patient also developed cellulitis and was treated with antibiotics..Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 75 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 14. Information has been received from a
registered nurse concerning a 75 year old female with no known allergies who on
9/14/2005 at 3:30 pm was vaccinated with a dose of Pneumococcal 23v
polysaccharide vaccine 0.5ml IM lot 647661/0055R, in the right deltoid.
Concomitant therapy that day included influenza virus split virion 3v vaccine
inactivated lot U1772AA, in the left deltoid. Subsequently within 24 hours, the
patient developed an adverse reaction on right arm. The patient experienced
redness at injection.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 03. Information has been received from a physician concerning a 58
yr old female who on 03Oct05 was vaccinated IM with a 0.5mL first dose of
pneumococcal 23v polysaccharide vaccine (lot 650327/0792P). Concomitant
vaccination on the same day in the other arm included a dose of influenza virus
whole virion 3v vaccine inactivated (Fluzone). On 03Oct05, within 1.5 hrs of
vaccination, the pt experienced a very sore arm. Unspecified medical attention
was sought. No treatment was required. Additional information has b.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from VA, USA. Female patient, 85 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 11. Information has been received from a
health professional concerning a 86 year old female with asthma, chronic
obstructive pulmonary disease, dust allergy, pollen allergy and mold allergy who
on 10/11/2005, between 11:00 and 16:00, was vaccinated IM in the right deltoid
with a 0.5ml second dose of Pneumococcal 23v polysaccharide vaccine (lot
646501/0497N). Concomitant therapy included a dose in the left arm of influenza
vaccine unspecified. On 10/12/2005 the patient presented to the doctor office.
She had a.Paient has the following illness history - Asthma, Chronic obstructive
pulmonary disease, house dust allergy, pollen allergy, mycotic allergy..Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 13. Information has been received from a 70 year old female with
depression, acid reflux, a broken left arm and no allergies who on 10/13/2005,
was vaccinated SC in the right arm with a 0.5ml dose of Pneumococcal 23v
polysaccharide vaccine (lot 650331/0749P) last dose reportedly received 10 years
prior. Concomitant vaccinations on that same day included a dose in the right
arm of influenza virus vaccine (unspecified). Other concomitant therapy included
esomeprazole magnesium (Nexium), tolterodine tartrate (Detr.Paient has the
following illness history - Depression, Acid reflux Oesophageal, arm
fracture..Patient was receiving Nexium, Zoloft, Detrol. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 82 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 20. Information has been received from a
pharmacist concerning an 82 yr old white female hospital inpt with a penicillin
allergy who on 20Oct05 at 14:30pm was vaccinated IM in the left deltoid with a
0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 651524/0605R).
Concomitant vaccination at the same time included an IM dose in the right
deltoid of influenza virus split virion 3v vaccine inactivated (Fluarix)
(lotAFLUA123BC). Concomitant therapy included levothyroxine Na (Synthroid), Mg
oxide (Mag ox 40.Paient had Cardiac failure congestive; hematocrit low;
haemoglobin low; rectal bleeding.Paient has the following illness history -
Hospitalization; penicillin allergy.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 21. Information has been received from a health professional
concerning a female pt who on 21Oct05 was vaccinated IM in the right deltoid
with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine. Concomitant
therapy at the same site in the right deltoid included a dose of influenza virus
vaccine (unspecified). On 22Oct05 the pt complained redness and soreness at the
site. Unspecified medical attention was sought. The pt is recovering. Follow up
information indicated that the pt has recovered. No additional.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 17. Information has been received from a pharmacist concerning a 65
yr old male with an enlarged prostate and a history of benign prostatic
hyperplasia who on 17Oct05 was vaccinated with a 0.5mL IM dose of pneumococcal
23v polysaccharide vaccine (lot 649988/0692P). Suspect vaccination that day
included a dose of influenza virus vaccine (unspecified). Concomitant therapy
included morniflumate (Flomax). The pt complained the same evening that he
difficulty voiding. It was reported that the pt had enlargement of t.Paient had
Enlarged prostate.Paient has the following illness history - Benign prostatic
hyperplasia.Patient was receiving Flomax (Morniflumate). Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from CO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT
(PNEUMOVAX). Information has been received from a physician concerning a female
adult who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine.
Concomitant therapy included a dose of influenza virus vaccine (unspecified).
Subsequently, the pt experienced neck pain. Unspecified medical attention was
sought. There was no additional information regarding the pt's present status.
No product quality complaint was involved. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 36 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 10. Information has been received from a RN
concerning a 36 yr old male who on 10Oct05 was vaccinated IM with a 0.5ml dose
of pneumococcal 23v polysaccharide vaccine (lot650327/0792P). Concomitant
therapy included a dose of influenza virus vaccine (unspecified). On 10Oct05
later that day, the pt experienced a severe localized reaction with soreness,
redness, and bruising from the deltoid to the elbow, headache and a fever to 101
deg F. It was noted that the pt also experienced 5 minute episodes of nausea,
dyspn.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MT, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a
licensed practical nurse concerning a 66 yr old female pt with allergies to
meperidine hydrochloride (Demerol), codeine, and procaine hydrochloride
(Novocain), degenerative joint disease, hormone deficiency and dyspepsia who on
25Oct05 was vaccinated IM into the upper left deltoid with a second dose
pneumococcal 23v polysaccharide vaccine (lot 651523/0604R). Concomitant therapy
given IM into the left deltoid included a third dose of influenza virus whole
virion 3v vaccin.Patient was receiving Prevacid; Prilosec.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a RN concerning a 63 yr old male with a
history of pneumonia last year. On an unspecified date, the pt was vaccinated IM
with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649697/1038P).
Concomitant suspect therapy included an unspecified influenza virus vaccine
administered into the opposite arm. On an unspecified date, the pt developed
redness, swelling, and tenderness up to the shoulder for several days. The pt
sought unspecified medical attention. It was.Paient has the following illness
history - Pneumonia.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 11. Information has been received from a RN concerning a 59 yr old
male with neck squamous cell carcinoma, metastases to lung and a history of left
upper lobe lobectomy. On 11Oct05 the pt was vaccinated IM with a 0.5mL dose of
pneumococcal 23v polysaccharide vaccine (lot 649697/1038P). Concomitant suspect
therapy included an unspecified influenza virus vaccine. On an unspecified date,
the pt complained of a scratchy throat and cough after vaccination. On 14Oct05
the pt was treated for wheezing and a worsening o.Paient has the following
illness history - Surgery, squamous cell carcinoma; Metastases to lung;
dyspnea..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NJ, USA. Female patient, 44 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a
healthcare worker concerning a 44 yr old female pt with asthma and environmental
allergies who on 25Oct05 was vaccinated IM with her first dose of pneumococcal
23v polysaccharide vaccine (lot 649912/0529P). Concomitant therapy included
fluticasone propionate (+) salmeterol xinafoate (Advair), tiotropium bromide
(Spiriva), montelukast sodium, and albuterol. On 26Oct05 the pt developed
redness at injection site (not specified). On 27Oct05 she was seen in the office
with bl.Paient has the following illness history - Asthma; environmental
allergy.Patient was receiving Albuterol, Advair, Singulair, Spiriva.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 37 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 24. Cellulitis; Fatigue Information has been
received from a physician concerning a 37 year old female with sulfa allergy and
a history of migraine who on 24-OCT-2005 at 5:00 PM was vaccinated with
pneumococcal 23v polysaccharide vaccine (lot #651318/1006P), in the left arm
upper arm. On 24-OCT-2005 the patient's left arm became swollen with pain, heat
and fever (40 C). The patient took diphenhydramine HCL (Benadryl), "which helped
a little." On 27-OCT-2005 she was seen by the doctor and she was given an
antibi.Paient has the following illness history - Migraine Sulfonamide
allergy.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 63 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 19. Swelling; Pain; Erythema; Skin warm
Information has been received from a Certified Medical Assistant (CMA)
concerning a 63 year old female with allergy to tetanus vaccine, depress and
acid reflux (esophageal) and a history of hysterectomy, sinus operation and
kidney stone who on 19-OCT-1-2005 was vaccination with 0.5ml pneumococcal 23v
polysaccharide vaccine (lot #650454/0751P) subcutaneously. Concomitant therapy
included lansoprazole (Prevacid), venlafaxine HCL (Effexor) and imatinibmesylate
(Gleevec). On.Paient has the following illness history - Hysterectomy, sinus
operation, kidney stone Allergy to vaccine; depression; gastroesophageal reflux
disease; blood pressure high..Patient was receiving Gleevec Prevacid
Effexor.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 29. Injection site reaction Information has been received from a
registered nurse concerning a patient who on 29-OCT-2005 was vaccinated
intramuscularly with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine
(lot #651329/1047P). Concomitant therapy included influenza virus vaccine
(unspecified). Eight to twelve hours later the patient developed a local
injection site reaction. Unspecified medical attention was sought. It was
reported that the patient was recovering. No product quality complaint was
involv.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Incision site cellulitis; pain; vomiting Information has been received from a
registered nurse concerning a patient in their 60's who in approximately October
2005 was vaccinated intramuscularly with a 0.5ml of pneumococcal 23v
polysaccharide vaccine. Concomitant vaccination at the same time included
influenza virus vaccine (unspecified) (both vaccines were administered at
separate sites and via separate syringes). Subsequently the patient developed a
site reaction of cellulitis, vomiting and described thei.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Dizziness;Fatigue;Inappropriate Schedule of drug administration; amnesia
Information has been received from a registered nurse concerning her friend an
82 year old female patient with memory loss who on approximately 25-OCT-2005
("about a week ago") was vaccinated (route unknown) with a second dose
pneumococcal 23v polysaccharide vaccine (Lot # and Batch # unknown). It was
reported that the patient also received the influenza virus vaccine
(unspecified). The patient was complaining of exhaustion, dizziness,.Paient has
the following illness history - Memory loss; immunization.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from ID, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 02. Information has been received from a physician concerning a
male who on 02-NOV-2005 was vaccinated with a second dose of pneumococcal 23v
polysaccharide vaccine. Concomitant therapy that day in the sane arm included
influenza virus vaccine (unspecified). The first vaccination was given three
months ago and second was given by mistake. On 02-NOV-2005 the patient
experienced pain at the injection site. Follow up reported that the patient "did
not have reaction" Additional information has been requested..Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, 71 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 25. Edema peripheral; burning sensation;
discomfort; urticaria; erythema Information has been received from a registered
nurse concerning a 71 year old white male with a penicillin allergy who on
25-OCT-2005 was vaccinated in the right deltoid muscle pneumococcal 23v
polysaccharide vaccine (lot #549989/0579P). Concomitant therapy that same day
included a vaccination in the left deltoid muscle with influenza virus split
virion 3v vaccine inactivated (Fluzone) (influenza virus split virion 3v vaccine
inactivated).Paient has the following illness history - Penicillin
allergy.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning an adult patient who
within the lst week (approximately November 2005) was vaccinated SC with a 0.5ml
dose of pneumococcal 23v polysaccharide vaccine. Concomitant vaccine therapy
administered on the same day included a dose of influenza virus vaccine
(unspecified). The physician reported that within the last week (approximately
November 2005) the patient developed redness only, at the injection site. It was
mentioned that the patient may have been gi.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 23. Information has been received from a female consumer who on
23-OCT-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide
vaccine (lot reported as "1406P". Concomitant therapy that day in the same arm
included influenza virus vaccine (unspecified). She reported that she became
quite ill beginning the day after receiving the shots, on 24-OCT-2005. The
patient's physician confirmed that she experienced a severe reaction to the
vaccination. The patient ended up missing a full week of work and a. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 08. Initial and follow up information has
been received from a health professional concerning a 68 year old white female,
with hypertension, hypercholesterolemia, penicillin allergy, venous
insufficiency and peripheral vascular disorder who on 08-NOV-2005 was vaccinated
intramuscularly in the left deltoid with a second dose (0.5 ml) of pneumococcal
23v polysaccharide vaccine (lot 651329/1047P) and at the same time was
vaccinated intramuscularly in the right deltoid with a second dose of influenza
virus SAg 3v.Paient has the following illness history - Concurrent conditions:
hypertension, hypercholesterolemia, penicillin allergy, venous insufficiency,
peripheral vascular disorder.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient, 74 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 26. Information has been received from a
health professional concerning a 74 year old female with allergies to
acetaminophen (+) hydrocodone bitartrate (LORTAB) and acetaminophen (+) codeine
phosphate (TYLENOL 3) who on 26-OCT-2005 was vaccinated intramuscular in the
right deltoid with a dose of pneumococcal 23v polysaccharide vaccine.
Concomitant vaccines that day included the influenza vaccine (unspecified).
There was no illness at the time of vaccination. On 26-OCT-2005 she had a severe
local reaction on.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 74 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 08. Follow up information has been received
from a licensed practical nurse concerning a 74 year old male patient, with
hypertension, hyperlipidemia, erectile dysfunction ("ED"), and unknown drug
reactions/allergies who on 08-NOV-2005 was vaccinated intramuscularly in the
left deltoid with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine. It
was also reported that the patient received a second dose of influenza virus
vaccine (AVENTIS) intramuscularly in the right deltoid on the same day. The
patient s.Paient has the following illness history - Concurrent conditions:
Hypertension, Hyperlipidemia, Erectile dysfunction.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CT, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 08. Information has been received from a registered nurse
concerning a 3 year old male with asthma who on 08-nov-2005 was vaccinated
subcutaneous in right arm with a dose of pneumococcal 23v polysaccharide
vaccine. The patient was given a flu shot (unspecified) in the same arm as
pneumococcal 23v polysaccharide vaccine. On 08-nov-2005, 6 hours after the
vaccination, the patient developed a cellulitis reaction, 103 F fever, erythema
and pain. The pain was reported as recovered. There was no product quality
c.Paient has the following illness history - Concurrent conditions: asthma.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse concerning a patient in
approximately October 2005, was vaccinated intramuscularly with 0.5 ml of
pneumococcal 23v polysaccharide vaccine. Concomitant vaccination at the same
time included influenza virus vaccine (unspecified)(both vaccines were
administered at separate sites and via separate syringes). Subsequently the
patient developed an injection site reaction. The arm was red and swollen and
was described as being "cellulitis like", however the p.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse concerning a patient who
in approximately October 2005, was vaccinated intramuscularly with 0.5 ml of
pneumococcal 23v polysaccharide vaccine. Concomitant vaccination at the same
time included influenza virus vaccine (unspecified) (both vaccines were
administered at separate sites and via separate syringes). Subsequently the
patient developed an injection site reaction. No further details pertaining to
the site reaction were available. Unspecified me.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 44 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a
certified medical assistant (CMA) concerning a patient who was vaccinated with
pneumococcal 23v polysaccharide vaccine. Subsequently the patient experienced
swelling, pain at injection site and hot skin to touch. The outcome of the
events was not reported. In follow up, the certified medical assistant reported
that this patient had not developed hotness of swelling as originally reported.
The 44 year old female with diabetes mellitus, an allergy to codeine and hyperc.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 28. Information has been received from a
certified medical assistant (CMA) concerning a 65 year old patient who on
28-OCT-2005 was vaccinated with pneumococcal 23v polysaccharide vaccine.
Concomitant therapy included tetanus toxoid and influenza virus vaccine
(unspecified). Subsequently the patient experienced swelling, pain at injection
site, hot skin to touch, red and warm to touch at injection site, and achiness
all over. The outcome of the events was not reported. Follow up information has
been received.Paient has the following illness history - Medical History:
myocardial infarction Concurrent conditions: coronary artery disease, diabetes
mellitus, hypertension.Patient was receiving aspirin, LIPITOR, glipizide,
lisinopril, metoprolol, ACTOS. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MO, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 28. Information has been received from a
certified medical assistant (CMA) concerning a 70 year old patient who on
28-OCT-2005 was vaccinated with a dose of pneumococcal 23v polysaccharide
vaccine. Concomitant therapy included influenza virus vaccine (unspecified).
Subsequently, the patient experienced pain at injection site, hot skin to touch,
swelling, achiness all over, and red and warm to touch at injection site. The
outcome of the events was not reported. Follow up information has been received
from a p. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 58 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 31. Information has been received from a 58
year old female with hypothyroidism an allergy to sulfa, who on 31-OCT-2005 was
vaccinated subcutaneous in the right arm with a 0.5 ml dose of pneumococcal 23v
polysaccharide vaccine. Concomitant vaccine therapy administered on 31-OCT-2005
included a dose of influenza virus vaccine (unspecified) administered in the
left arm. Other concomitant medication included levothyroxine Na (SYNTHROID).
The patient reported that the next day, on 01-NOV-2005 she experienced a
s.Paient has the following illness history - Concurrent conditions:
hypothyroidism, Sulfonamide allergy.Patient was receiving SYNTHROID. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NE, USA. Female patient, 52 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 09. Information has been received from a
license practical nurse concerning a 52 year old female daycare provider with
sulfa allergy and no medical history, who on 09-NOV-2005, at 16:45, was
vaccinated intramuscular into the right deltoid with a first 0.5 ml dose of
pneumococcal 23v polysaccharide vaccine. On 09-NOV-2005, the patient was
vaccinated intramuscular with a third dose of influenza virus split virion 3v
vaccine inactivated (FLUZONE). Concomitant therapy included levothyroxine Na
(LEVOXYL). There wa.Paient has the following illness history - Concurrent
conditions: Sulfonamide allergy.Patient was receiving LEVOXYL. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from VA, USA. Female patient, 73 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 31. Edema peripheral; fatigue; pain; erythema
Information has been received from a physician and a registered nurse concerning
a 73 year old retired white male with no allergies or medical history who on
31-OCT-2005 was vaccinated IM in the left deltoid with a second 0.5ml dose of
pneumococcal 23v polysaccharide vaccine (Lot #649914/0578F). Concomitant therapy
included psyllium husk (Metamucil), aspirin daily, Vitamin B12 injection
monthly, and a dose of influenza virus vaccine (unspecified) given in the
right.Patient was receiving aspirin cyanocobalamin Metamucil.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MT, USA. Female patient, 60 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 26. Injection site pain; Swelling Initial and
follow up information has been received from a licensed practical nurse
concerning a 60 year old white female with arrhythmia. hormone replacement
therapy, no known allergies an a prior immunization with pneumococcal 23v
polysaccharide vaccine in 2000. On 26-OCT-2005, the patient was vaccinated
intramuscularly into the left arm with pneumococcal 23v polysaccharide vaccine
(Lot #651526/0604R). On that same day in the AM the patient was vaccinated
intramuscularly into.Patient was receiving Lanoxin Premarin verapamil. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MT, USA. Female patient, 62 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 27. Injection Site Pain Information has been
received from a health professional concerning a 62 year old white retired
female with hyperparathyroidism and no known allergies who on the morning of
27-OCT2005 was vaccinated IM into the left deltoid with a first dose of
pneumococcal 23v polysaccharide vaccine (lot #651523/0604R). Concomitant therapy
given IM in the morning into right deltoid included a dose of influenza virus
whole virion 3v vaccine inactivated (Fluzone) (influenza virus whole virion3v
vaccine in.Paient has the following illness history - hyperparathyroidism.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Swelling Information has been received from a nurse concerning a patient who on
an unspecified date was vaccinated IM in the arm with a dose of pneumococcal 23v
polysaccharide vaccine. Concomitant therapy included an unspecified influenza
virus vaccine given in the same arm. Subsequently, the patient developed
swelling. Medical attention was sought. Subsequently, the patient recovered. No
further information is available..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from MO, USA. Female patient, 17 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Nov 2005, 07. Injection site reaction; pain;
erythema; skim warm; swelling. Information has been received from a licensed
practical nurse concerning a 17 year old (also reported as 14 year old) white
male with diabetes mellitus juvenile onset who on 07-NOV-2005 was vaccinated
with a first dose of pneumococcal 23v polysaccharide vaccine in the left deltoid
(650649/0790P), intramuscularly in the left deltoid. Concomitant therapy that
day included a first dose of influenza virus split virion 3v vaccine inactivated
(Fluzone).Paient has the following illness history - Diabetes mellitus juvenile
onset.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Injection site reaction; chills; myalgia Information has been received from a
physician concerning a 61 year old male with diabetes who was vaccinated with a
dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy three days
prior to the pneumococcal 23v polysaccharide vaccine included a dose of
influenza virus vaccine (unspecified). Subsequently the patient experienced a
severe injection site reaction with chills and myalgia. It was noted that the
patient recovered on an unknown date. Unspecif.Paient has the following illness
history - Diabetes.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MT, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 25. Erythema; pain in extremity; edema; peripheral Information has
been received from a health professional concerning a 61 year old white female
with degenerative joint disease, hormone deficient, hyperparathyroidism, codeine
and "sodium pent" allergy who on 25-OCT-2005 later in the PM was vaccinated IM
in the right deltoid with a first dose of pneumococcal 23v polysaccharide
vaccine (Lot #651523/0604R). Concomitant therapy included a IM dose in the left
deltoid of influenza virus split virion 3v vaccine inact. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CT, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Pyrexia; erythema Information has been received from a registered nurse
concerning a 8 year old female with asthma who in late October 2005 was
vaccinated SQ in right arm with a dose of pneumococcal 23v polysaccharide
vaccine (lot #not provided). The patient was given a flu shot (unspecified) in
the same arm as pneumococcal 23v polysaccharide vaccine. Twelve hours post
vaccination the patient developed a 103 F fever and erythema. The fever
persisted for 12 hours. The patient was reported as recovered. There.Paient has
the following illness history - Asthma. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MT, USA. Female patient, 53 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 25. Pain in extremity; erythema; edema
peripheral Information has been received from a licensed practical nurse
concerning a 53 year old white female with a tetanus allergy and clindamycin
allergy, who on 25-OCT-2005 was vaccinated IM into the right arm with a fifth
dose of pneumococcal 23v polysaccharide vaccine (lot #651526/0604R). Concomitant
therapy given IM into the left arm included a second dose of influenza virus
whole virion 3v vaccine inactivated (Fluzone) (influenza virus whole virion 3v
vaccine inac.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, 18 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 01. Injection site pain; injection site
erythema Information has been received from a registered nurse concerning an 18
year old male with asthma who on 01-DEC-2005 was vaccinated with a first dose of
pneumococcal 23v polysaccharide vaccine (Lot #651318/1006P). Concomitant therapy
given into the other arm included a dose of influenza virus vaccine
(unspecified) (no reaction noted). On 01-DEC-2005 (previously report as
04-DEC-2005) the patient was seen in the doctor's office with an injection site
reaction descr.Paient has the following illness history - Asthma.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 86 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 10. Information has been received from a
pharmacist concerning an 86 yr old female inpt with a diagnosis of cardiac
arrhythmia who on 10Dec05 was vaccinated IM in the arm with a dose of
pneumococcal 23v polysaccharide vaccine (lot 651572/0741R) as a routine
immunization during hospital stay. Concomitant therapy included warfarin sodium
(Coumadin), atorvastatin calcium (Lipitor), isosorbide mononitrate (IMDUR),
tolterodine tartrate (Detrol LA), diltiazem hydrochloride (Cardizem CD), and an
unspecified influenza.Paient has the following illness history - Arrythmia;
hospitalization.Patient was receiving Lipitor, Cardizem CD, IMDUR, Detrol LA,
Coumadin. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WA, USA. Female patient, 58 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 05. Information has been received from a RN
concerning an 58 yr old male with asthma who on 05Dec05 was vaccinated IM into
the right deltoid with a first dose of pneumococcal 23v polysaccharide vaccine
(lot 650330/0748P). Concomitant therapy given into the other arm included a dose
of influenza virus vaccine (unspecified) (no reaction noted). That night, the pt
experienced an injection site reaction described as pain with tenderness,
swelling and redness. On 06Dec05, the pt was seen in the doctor's office.
The.Paient has the following illness history - Asthma.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 19. Information has been received from a medical assistant via a
company rep concerning a male physician who on approx 19Nov05 was vaccinated IM
into the arm with a 0.5ml dose of pneumococcal 23v polysaccharide vaccine.
Concomitant vaccination at the same time in the same arm included a dose of
influenza virus vaccine (unspecified). Subsequently, on approx 19Nov05, the pt
was very ill for two days and experienced body aches, fever and severe site
reaction involving a rash, soreness and swelling down his entire.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 23. Information has been received from a RN concerning a 72 yr old
male who on 23Nov05 was vaccinated IM in the arm with a 0.5ml dose of
pneumococcal 23v polysaccharide vaccine (lot unspecified). Secondary suspect
vaccinations included a dose of influenza virus vaccine (unspecified) given in
the same arm as the pneumococcal 23v polysaccharide vaccine. On 23Nov05 the pt
developed swelling and itching at the injection site. Unspecified medical
attention was sought and the pt was given over the counter medications.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a 55 yr old white
retired female with no allergies who in approx Oct 2005, was vaccinated with a
dose of pneumococcal 23v polysaccharide vaccine (lot not reported). Concomitant
suspect therapy included a dose of influenza virus vaccine (unspecified)
administered at the same time into the same arm. On 26Oct05 the pt developed
redness from the shoulder to elbow, swollen tender, axilla glands, and throbbing
pain. It was reported that the pt stated that.Paient has the following illness
history - Immunization. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from GA, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 03. Initial and follow up information has
been received from a pharmacist concerning a 68 yr old white male with shellfish
allergy who on 03Oct05 was vaccinated at 5:30PM IM into the left deltoid with a
0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 650331/0749P) and at
the same time vaccinated IM into the right deltoid with a dose of influenza
virus split virion 3v vaccine inactivated (Fluzone). Concomitant therapy
included clopidogrel bisulfate (Plavix), ramipril (Altace) and rosuvastatin
calcium.Paient has the following illness history - Shellfish allergy.Patient was
receiving Plavix, Altace, Crestor.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Jan 2006, 25. Information has been received from a RN concerning a male pt
(18 to 20 yrs of age) who on 25Jan06 was vaccinated SC in the left tricep with a
0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 649696/0490P).
Concomitant therapy included influenza virus 3v reassortant vaccine live
intranasal (Flumist), hep A virus vaccine inactivated (+) hep B virus vaccine
rHBsAg (yeast) (Twinrix), meningococcal ACYW conj vaccine (dip toxoid)
(Menactra), MMR vaccine, penicillin G benazathine (Bicillin) and
tuberculi.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a RN pharmacist concerning a pt who was
vaccinated with pneumococcal 23v polysaccharide vaccine. Concomitant therapy
that day included influenza virus vaccine (unspecified). Subsequently the pt
experienced cellulitis in the arm that the pneumococcal 23v polysaccharide
vaccine was given. Unspecified medical attention was sought..Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, child 00.9 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on May 2005, 11. Information has been received
from a health professional concerning an 11 month old Asian female with no
medical history or allergies who on 11May05, at 10:30AM, was accidentally
vaccinated in the left thigh with a first dose of pneumococcal 23v
polysaccharide vaccine (lot 650644/0887P). Concomitant vaccine that day, at
10:30AM, included a second dose in the right thigh of Hib conj vaccine (tet
toxoid) (Acthib) (lot UE392AA). There was no illness at the time of vaccination.
The child has manifested no addit.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a health professional concerning an adult pt
who in approx Feb 2005 was vaccinated with a dose of pneumococcal 23v
polysaccharide vaccine (lot 649695/0512P). In approx Feb 2005, the pt
experienced injection site reactions described as swelling, soreness, warmth,
erythema and induration. Unspecified medical attention was sought. It was noted
that the pt was treated with levofloxacin (Levaquin). Subsequently, the pt
recovered. A lot check will be performed. No product qualit.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
May 2005, 19. Information has been received from a 69 yr old female with
elevated triglycerides and depression who on 19May05 was vaccinated with a dose
of pneumococcal 23v polysaccharide vaccine in the left arm (route not reported).
Concomitant therapy included cetirizine hydrochloride (Zyrtec), fenofibrate
(Tricor) and amitriptyline hydrochloride. On 19May05 the pt developed injection
site reaction with swelling down and under the upper arm. The pt reported "It
looked like an octopus, swollen red, hot and sore". The pt.Paient has the
following illness history - Serum triglycerides increased; depression.Patient
was receiving Elavil, Zyrtec, Tricor.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CT, USA. Female patient, 77 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2005, 07. Information has been received from a
physician concerning a 77 yr old female pt who on 07Jun05 was vaccinated IM with
a first 0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot
650327/0792P). On 07Jun05 in the evening, the pt developed arm, redness, pain
and warmth. On 08Jun05, the pt also experienced fever and chills. The pt was
treated with ice, cephalexin (Keflex), and acetaminophen (Tylenol). The pt's
outcome was unk. The physician indicated that he would like an investigation
into that lot #. T.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on June 2005, 08. Information has been received from a medical technologist
concerning a male pt who on 08Jun05 or 09Jun05 was vaccinated with a first 0.5ml
dose of pneumococcal 23v polysaccharide vaccine (lot 647661/0055R). It was noted
that the pt had injection site reactions. On approx 09Jun05, the pt called the
doctor's office because he experienced temp to 103 deg F, chills, nausea,
weakness, redness, swelling, and soreness of the arm to the elbow. It was noted
that he was taking ibuprofen (Motrin) and or acetaminophen.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
June 2005, 07. Information has been received from a registered nurse concerning
a female who on 6/7/05 was vaccinated with a dose of Pneumococcal 23v
polysaccharide vaccine (0.5 ml lot 650454/0751P), intramuscularly. On 6/7/05 the
patients vaccinated arm became red and warm to touch. She developed a raised
area on the arm 38 mm x 45mm. She experienced some discomfort. It was not known
if this was her first dose or a booster dose. The symptoms resolved on their own
in a few days. Unspecified medical attention was sought. N.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on June 2005, 02. Information has been received from a registered nurse
concerning a 14 year old female with respiratory issues, immunodeficiency and an
allergy to amoxicillin + clavulanate potassium Augmentin and Sulfamethoxazole +
trimethoprim Bactrim who was vaccinated with a dose of Pneumococcal 23v
polysaccharide vaccine (lot 650084/0605P). Concomitant therapy included an
unspecified respiratory medication. It was reported that the patient received a
previous dose of Pneumococcal 23v polysaccharide vaccine in 2004. On 6.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Apr 2005, 25. Information has been received from a
pharmacist concerning a 70 year old female patient with a sulfa allergy, who on
4/25/05 at 13:00 was vaccinated subcutaneously in the RUQ with a 0.5 ml first
dose of Pneumococcal 23v polysaccharide vaccine. Illness at the time of
vaccination included a urinary tract infection and dehydration. At 20:00, the
patient developed injection site redness, erythema, swelling and soreness.
Unspecified medical attention was sought. The patient was treated with warm
compresses. No.Paient had Dehydration, Urinary tract infection.Paient has the
following illness history - Sulfonamide allergy.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient, 26 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2005, 13. Information has been received from a
health care worker concerning a 26 year old female with no medical history or
allergies reported. On 1/13/05 the patient was vaccianted with the first dose of
Pneumococcal 23v polysaccharide vaccine. There were no concomitant medication
reported. On 1/14/05 the patient developed redness, swelling and burning of
injection site. The patient sought unspecified medical attention. The events
subsided in a few days and no treatment was required. Additional information has
been.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 52 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2005, 14. Initial and follow up information has
been received from a registered nurse and a physician concerning a 52 year old
male (previously reported as 51 years old) with no adverse events following
prior vaccinations reported. On 6/14/05 at 4pm, the patient was vaccinated
intramuscularly with Pneumococcal 23v polysaccharide vaccine (lot 649913/0577P).
The patient had asthma at the time of vaccination. On 6/15/2005 in the PM,
within 24 hours, the patient developed swelling and erythema of the left arm
(previously.Paient had Asthma.Paient has the following illness history -
Immunisation.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 40 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2004, 01. Information has been received from a 41
year old female registered nurse with asthma and unspecified allergies. In June
2004, the nurse was vaccinated with Pneumococcal 23v polysaccharide vaccine.
Concomitant therapy included an unspecified therapy Naacort fexofenadine
hydrochloride + pseudoephedrine hydrochloride Allergra D, Fluticasone propionate
Flovent, and lansoprazole Prevacid. In June 04, the nurse developed arm swelling
when she received the Pneumococcal 23v polysaccharide vaccine. The nurse
reporte.Paient has the following illness history - Asthma,
hypersensitivity..Patient was receiving Allergra D, Flovent, Prevacid.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on June 2005, 01. Information has been received from a medical technologist
concerning a female patient who on 4/1/05 was vaccinated with a 0.5ml dose of
Pneumococcal 23v polysaccharide vaccine (lot 647661/005R). It was noted that the
patient had injection site reaction. On 6/6/05, the patient was seen in the
doctors office with a red and hot arm. It was noted that she was taking
Ibuprofen Motrin and or acetaminophen Tylenol. Unspecified medical attention was
sought. The patients outcome was unknown. It was noted that the pa.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from VA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2005, 22. Initial and follow up information has
been received from a medical assistant and a physician concerning a 65 year old
female violin teacher who is well nourished, well developed, and well groomed
and has a good build, with allergies to erythromycin (rash), penicillin
(swelling), and sulfa drugs (rash), non smoker, and a history of De Quevain's
tenosynovitis, Dupuytren's contracture (right fifth digit), a mammogram 6/10/05,
colonoscopy 8/2003 not complete, and a core biopsy 9/04 and non contributory
family.Paient has the following illness history - Rash, swelling, colonoscopy,
De Quervain's tenosynovitis, Dupuytren's contracture, biopsy, egg allergy, non
smoker, allergic reaction to antibiotics, penicillin allergy, sulfonamide
allergy..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KS, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on June 2005, 23. Information has been received from a physician and a company
representative concerning an 88 year old female patient with a history of
hypertension and no reported allergies who on 6/23/05 with vaccinated with a
dose of Pneumococcal 23v polysaccharide vaccine lot 647661/0055R. There was no
concomitant medication. Subsequently, on an unspecified date, the patient
developed redness, soreness, swelling and then hardness at the injection sight
that caused a great deal of pain. The company representative also re.Paient has
the following illness history - Hypertension.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a nurse practitioner concerning an adult
female patient (age not reported) who several weeks ago, on an unspecified date,
was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot
unknown). The patient reported to the nurse by phone that she developed an
injection site reaction that included redness and local pain lasting about 2
weeks. It was reported that the patient sought unspecified medical attention. At
the time of the report he patient outcome was u.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on June 2005, 09. Information has been received from a registered nurse
concerning a 5 year old female with respiratory issues who on 6/9/05 was
vaccinated wit a dose of Pneumococcal 23v polysaccharide vaccine lot
650082/0691P. Concomitant therapy included an unspecified respiratory
medication. On 6/10/05 the patient developed an injection site reaction. The
nurse reported that on 6/10/05 the patient developed fever (measurement not
reported), hives, rash and redness at the injection site. The patient was
treated with cefdin.Paient has the following illness history - Respiratory
disorder.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT
(PNEUMOVAX) on Oct 2004, 01. Information has been received from a 50 year old
male registered nurse, who in 10/04, was vaccinated with the first dose of
Pneumococcal 23v polysaccharide vaccine. Twenty four hours after the injection,
he developed flu like symptoms, soreness and a fever. The nurse reported that
the fever lasted about a day. The nurse did not seek medical attention. At the
time of this report, the nurse had recovered from the events. Additional
information has been requested.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2005, 18. Initial and follow up information has
been received from an office manager for the physician and a physician
concerning a 70 year old female with no known adverse drug reactions, no known
allergies and no pertinent medical history reported. On 7/18/05 the patient was
vaccianted with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine lot
650327/0792P. There were no concomitant medications reported. The same day,
following vaccination, the patient developed pain and redness at the injection
site, was war.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from GA, USA. Female patient, 54 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2005, 06. Initial and follow up information has
been received from a registered nurse via a company representative concerning a
54 year old female patient with an unknown medical history how on 7/6/05 at
8:30am was vaccinated in the left deltoid with a dose of Pneumococcal 23v
polysaccharide vaccine lot 650457/0973P. On 7/6/05 previously reported as
7/7/05, at 9:00pm, the patient developed a bad pain in the shoulder/arm and
chills. It was reported that the reaction was red and swollen and was pronounced
in the arm wh. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IA, USA. Female patient, 63 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2005, 28. Initial and follow up information has
been received from a physician concerning a 63 year old female admissions
representative with no known drug allergies who on the morning of 7/28/05 wad
inadvertently vaccinated IM in the left deltoid with a second 0.5ml dose of
Pneumococcal 23v polysaccharide vaccine 650452/0753P. Concomitant therapy
included simvastatin, lisinopril, aspirin, acebutolol, Brompheniramine maleate
pseudoephedrine Lorane, hydrochlorothiazide manufacturer unknown, and
glucosamine. Subsequent.Paient has the following illness history -
Immunisation.Patient was receiving simvastatin, lisinopril, aspirin, acebutolol,
Brompheniramine maleate pseudoephedrine Lorane, hydrochlorothiazide. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
July 2005, 25. Information has been received from a female who on 7/25/05 was
vaccinated in the left deltoid with a second dose of Pneumococcal 23v
polysaccharide vaccine. On 7/25/05, the patient developed soreness at the
injection site. The pt subsequently developed swelling and erythema 7cm by 3cm
on the inner aspect of the left bicep. The pt did not seek medical attention for
the experience. At the time of this report, the patients soreness at the
injection site and swelling and erythema on the inner aspect of the left.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CT, USA. Female patient, 67 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2005, 06. Information has been received from a
physician concerning a 67 year old who on 06-Jun-2005 was vaccinated
intramuscularly with a first 0.5 ml dose of pneumococcal 23v polysaccharide
vaccine (lot 650327/0792P). On 06-JUN-2005, the patient's arm was swollen and
warmth. The patient was treated with ice packs and elevation. The physician
requested an investigation into the lot number. The records of testing prior to
release of this lot have been checked by Quality Assurance and found to be
satisfactory, The.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CT, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2005, 06. Information has been received from a
physician concerning a 70 year old female who on 06-JUN-2005 was vaccinated
intramuscularly with a first 0.5 ml dose of pneumococcal 23v polysaccharide
vaccine (lot 650327/0792P). On 07-JUN-2005, the patient's arm was swollen with
cellulitis. The patient was treated with amoxicillin (+) clavolanate potassium
(AUGMENTIN). On 09-JUN-2005, the patient developed a fever and pain in the right
hip when walking. The physician requested an investigation into the lot
number..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CT, USA. Female patient, 78 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2005, 02. Information has been received from a
health professional concerning a 78 year old male on 02-JUN-2005 was vaccinated
with a dose of pneumococcal 23v polysaccharide vaccine (lot 650327/0792P).
Subsequently, the patient experienced a sore and red arm. Unspecified medical
attention was sought. The patient's outcome was unknown. No product quality
complaint was involved. The physician requested an investigation into the lot
number. The records of testing prior to release of this lot have been checked by
Q.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 86 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2005, 19. Initial and follow up information has
been received from an office manager for the physician and a physician
concerning an 86 year old male with no known adverse drug reactions, no know
allergies and no pertinent medical history reported. On 7/19/05, in th Am the pt
was vaccinated in the left arm with the first 0.5ml dose of Pneumococcal 23v
polysaccharide vaccine lot 650327/0792P. There were no concomitant medications
reported. That same day, following vaccination in the AM, the pt developed pain
and redne.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2005, 20. Initial and follow up information has
been received from an office manager for the physician and a physician
concerning a 65 year old retired female with no known adverse drug reactions, no
known allergies and no pertinent medical history reported. On 20-Jul-2005, in
the morning, the patient was vaccinated in the left arm with a 0.5 ml dose of
pneumococcal 23v polysaccharide vaccine (lot 650327/0792P). There were no no
concomitant medications reported. That same day, following vaccination in the
morning,.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2005, 27. Initial and follow up information has
been received from an office manager for the physician and a physician
concerning a 65 year old retired female with no known adverse drug reactions, no
known allergies and no pertinent medical history reported. On the morning of
27-JUL-2005, the patient was vaccinated into the right arm with a 0.5 ml, first
dose of pneumococcal 23v polysaccharide vaccine (lot650453-0791P). There were no
concomitant medications reported. That same day, following vaccination, the
patie.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient, 77 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on June 2005, 13. Information has been received from a
health care worker concerning a 77 year old female with cholesterol, acid
reflux, an unspecified "heart condition" and no allergies reported. On
13-JUN-2005 the patient was vaccinated with the first dose of pneumococcal 23v
vaccine (lot 647661-0055R). Concomitant therapy included esomeprazole magnesium
(NEXIUM), atorvastin calcium (LIPITOR) clopidogrel bisulfate (PLAVIX) and
aspirin. On 14-JUN-2005 the patient developed redness, swelling an burning of
injection site a.Paient has the following illness history - Concurrent
conditions: cholesterol high, acid reflux (esophageal), cardiac disorder.Patient
was receiving aspirin, LIPITOR, PLAVIX, NEXIUM.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2004, 01. Information has been received from a
health care worker concerning a 70 year old female with high cholesterol,
seasonal allergies, no food or drug allergies and a history of a prior
immunization with pneumococcal 23v vaccine in 2000. On 01-NOV-2004 the patient
was vaccinated with the second dose of pneumococcal 23v vaccine. Concomitant
therapy included risedronate sodium (ACTONEL), aspirin, unspecified vitamins,
atorvastatin calcium (LIPITOR) and triamcinolone acetomise (NASOCORT). On
02-NOV-2004 the pa.Paient has the following illness history - medical history:
immunization, concurrent conditions: cholesterol high, seasonal allergy.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from GA, USA. Female patient, 63 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Aug 2005, 01. Information has been received from a
certified medical assistant concerning a 63 year old white male with
gastroesophageal reflux disease, chronic obstructive pulmonary disease and
chronic bronchitis who on 01-AUG-2005 at 16:38 was vaccinated intramuscularly
into the left arm with a second dose of pneumococcal 23v vaccine (lot
649694/0386P). On 02-AUG-2005, the patient's left arm was sore,"felt hard" and
was not warm to the touch. The patient stated that he just doesn't fell well.
The patient experienced.Paient has the following illness history - concurrent
conditions: gastroesophageal reflux disease, chronic obstructive pulmonary
disease, bronchitis chronic.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient, 73 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2005, 29. Information has been received from a
physician concerning a 73 year old white female with penicillin allergy and
hospitalized for a minor unspecified GYN procedure and a history of splenectomy
(due to lymphoma)and knee replacement who on 29-JUL-2005 (before discharge from
hospital) was vaccinated with a first dose of pneumococcal 23v polysaccharide
vaccine. Concomitant therapy included estradiol (ESTRACE) and
medroxyprogesterone acetate (PROVERA). On 30-JUL-2005 the patient developed a
fever of over 102 F.Paient has the following illness history - Medical history:
surgical procedure, knee arthroplasty, splenectomy, lymphoma Concurrent
conditions: Hospitalization, Penicillin allergy.Patient was receiving ESTRACE,
PROVERA.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from e registered nurse concerning a female in her
50's clinically compromised with no drug allergies who was vaccinated with a
dose of pneumococcal 23v polysaccharide vaccine (0.5 ml) (intramuscularly).
There was no concomitant medication. Subsequently the patient experienced puffy
swelling from under ears to and including hands. Ibuprofen (ADVIL) was given for
the redness and swelling. The patient recovered. It was noted that the patient
had no history of reactions to an.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from e registered nurse concerning a female in her
50's clinically compromised with no drug allergies who was vaccinated with a
dose of pneumococcal 23v polysaccharide vaccine (0.5 ml) (intramuscularly).
There was no concomitant medication. Subsequently the patient experienced puffy
swelling from under ears to and including hands. Ibuprofen (ADVIL) was given for
the redness and swelling. The patient recovered. It was noted that the patient
had no history of reactions to an.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KS, USA. Female patient, 71 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2003, 20. Information has been received from a
physician concerning a 71-year-old white male who on 23-OCT-2003 was vaccinated
with a dose of pneumococcal 23v polysaccharide vaccine. There was no illness at
the time of vaccination. Concomitant therapy included aspirin, atorvastatin
calcium (LIPITOR), glimepiride (AMARYL) and amlodipine besylate (NORVASC).
Subsequently, the patient developed a high fever, body aches and flu like
symptoms. It was later discovered that the patient had received pneumococcal 23v
polys.Patient was receiving NORVASC, aspirin, LIPITOR, AMARYL.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KS, USA. Female patient, child 00.7 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Aug 2005, 08. Information has been received
from a registered nurse concerning an eight month old "healthy" male patient who
on 08-AUG-2005 was vaccinated with an expired dose of pneumococcal 23v
polysaccharide vaccine (0.5 ml) (intramuscularly) (lot 647363/0944N), in the
left vastus lateralis, instead pneumococcal 4 6B 9v 14 18C 19F conj vaccine.
There was no concomitant medication. The nurse reported that a follow up call
was placed to mother of the child who stated child seemed fine and no adverse
event. However, t. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 71 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Aug 2005, 17. Initial and follow up information has
been received from a physician concerning a 72 yr old white, retired, female who
on 17Aug05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine
(lot650370/0740P) into the left deltoid. On 17Aug05 the pt developed pain and
swelling at the injection site. Follow up information reported that the pt also
developed and erythematous rash at the injection site. Unspecified medical
attention was sought. At the time of the follow up report, the pt had
recovere.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from DC, USA. Female patient, 58 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Aug 2005, 16. Information has been received from a RN
concerning a 58 yr old female physician who on 16Aug05 was vaccinated with a
dose of pneumococcal 23v polysaccharide vaccine (lot 6499989/0579P), IM in the
left deltoid. On 16Aug05 the pt developed severe pain, redness and swelling in
left arm. There was severe swelling, redness and a large blister noted at the
injection site the following AM. The symptoms began a few hrs after receiving
the injection. The physician recovered. It was also reported that another adult
p. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Aug 2005, 18. Information has been received from a RN concerning her daughter a
24 yr old female with Crohn's disease and asthma who on 18Aug05 was vaccinated
with a dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy
included polypharmacy. On 18Aug05 the pt developed intense swelling at the
injection site and her entire body was aching. It was unk if medical attention
was sought or if laboratory diagnostic tests were performed. She was treated
with acetaminophen (Tylenol) and was recovering. There was n.Paient has the
following illness history - Crohn's disease; asthma. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from DC, USA. Female patient, 21 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Aug 2005, 09. Information has been received from a RN
concerning a 21 yr old female pt who on 09Aug05 at 10:15AM was vaccinated with a
dose of pneumococcal 23v polysaccharide vaccine (lot 6499989/0579P), IM in the
left arm. On 09Aug05 the pt developed severe pain and swelling in left arm, then
developed febrile illness with decreased WBC and increased alk phosphate. The pt
recovered. It was also reported that another adult pt had an adverse experience
after being vaccinated with pneumococcal 23v polysaccharide vaccine (W. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a female nurse who was
vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently,
she experienced a local injection site reaction and achiness. It was noted that
she was not able to go to work the day following her immunization. Unspecified
medical attention was sought. The pt's outcome was unk. No product quality
complaint was involved. Additional information is not expected..Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Aug 2005, 18. Information has been received from a 75 yr old female with cancer
and a history of urinary tract bacteria, splenectomy and no allergies, who on
approx 18Aug05 last week was vaccinated SC with a dose of pneumococcal 23v
polysaccharide vaccine. Concomitant therapy included (Leboxyl), esomeprazole
magnesium (Nexium), (Prevachol) and pancreatic enzymes. Last week, the pt
developed vomiting and diarrhea. Unspecified medical attention was sought. No
lab diagnostic studies were performed. The consumer reported tha.Paient has the
following illness history - Urinary tract infection; splenectomy,
cancer..Patient was receiving Nexium.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from GA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Aug 2005, 22. Information has been received from a physician concerning a 70
yr old female family friend who on 22Aug05 was vaccinated with a dose of
pneumococcal 23v polysaccharide vaccine. On 23Aug03, the pt's arm was swollen
almost to her elbow. The physician said, it looked like angioedema. No treatment
was needed. At the time of this report, the pt was recovering. It was noted that
the reporting physician was a family friend and the pt was vaccinated at another
doctor's office. No product quality complaint was invol.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
June 2005, 25. Information has been received from a registered pharmacist
concerning a 67 yr old male who was hospitalized for cholecystitis and was post
op cholecystectomy who on 25Jun05 was vaccinated IM with a 0.5mL dose of
pneumococcal 23v polysaccharide vaccine (lot 649978/0709P). On approx 25Jun05,
the pt developed a localized skin reaction, fever, and cellulitis. The pt was
treated with IV antibiotics for the cellulitis. It was noted that the pt has a
previous unspecified reaction to a tetanus toxoid vaccination. S.Paient has the
following illness history - Vaccination adverse reaction, hospitalization,
cholecystectomy; cholecystitis..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Aug 2005, 18. Information has been received from a registered pharmacist
concerning a 73 yr old female who was hospitalized for dehydration who on
18Aug05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide
vaccine. On approx 18Aug05, the pt developed a localized skin reaction, fever,
and cellulitis and was treated with ice packs. The pt was not treated with
antibiotics for the cellulitis. Subsequently, the pt recovered. The pharmacist
did not believe that the adverse events prolonged the pt's hospital.Paient has
the following illness history - Dehydration; hospitalization.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
July 2005, 14. Information has been received from a registered pharmacist
concerning a 78 yr old male who was hospitalized for a knee replacement who on
14Jul05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide
vaccine (lot 649978/0709P). On approx 14Jul05, the pt developed a localized skin
reaction, fever and cellulitis. The pt was treated with IV antibiotics for the
cellulitis. Subsequently, the pt recovered. The pharmacist did not believe that
the adverse events prolonged the pt's hospitalization a.Paient has the following
illness history - Hospitalization; knee arthroplasty.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
July 2005, 28. Information has been received from a registered pharmacist
concerning an 86 yr old male who was hospitalized for a knee replacement who on
28Jul05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide
vaccine (lot 649978/0709P). On approx 28Jul05, the pt developed a localized skin
reaction, fever and cellulitis. The pt was treated with oral cephalexin (Keflex)
for the cellulitis. Subsequently, the pt recovered. The pharmacist did not
believe that the adverse events prolonged the pt's hospit.Paient has the
following illness history - Hospitalization, knee arthroplasty.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT
(PNEUMOVAX) on July 2005, 28. Information has been received from a registered
pharmacist concerning an 73 yr old female who was hospitalized for a knee
replacement who on 28Jul05 was vaccinated IM with a 0.5mL dose of pneumococcal
23v polysaccharide vaccine (lot 649978/0709P). On approx 28Jul05, the pt
developed a localized skin reaction, fever and cellulitis. The pt was not
treated with antibiotics for the cellulitis. Subsequently, the pt recovered. The
pharmacist did not believe that the adverse events prolonged the pt's
hospitalizat.Paient has the following illness history - Hospitalization; knee
arthroplasty.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a certified medical assistant concerning an
adult pt who was vaccinated with pneumococcal 23v polysaccharide vaccine (0.5ml)
(IM). Subsequently, the pt experienced injection site reaction with injection
site redness, warmth and soreness within a day of vaccination. Unspecified
medical attention was sought. Additional information has been requested..Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Aug 2005, 27. Information has been received from a physician concerning a 61
yr old female with chronic obstructive pulmonary disease who on 27Aug05 was
vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. On 28Aug05
the pt developed redness and swelling at the injection site. On 29Aug05 the pt
was recovering from the redness and swelling at the injection site when she
developed a fever of 103 deg F. Unspecified medical attention was sought. At the
time of the report, the pt was recovering from the fever. A.Paient has the
following illness history - Chronic obstructive pulmonary disease..Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Aug 2005, 26. Information has been received from a 57 yr old female with
hypertension and drug hypersensitivity to cephalexin (Keflex) who on 26Aug05 was
vaccinated IM in the left arm with a dose of pneumococcal 23v polysaccharide
vaccine. Concomitant therapy included atenolol (Atenol), omeprazole (Prilosec)
and nizatidine (Axid). Subsequently on 26Aug05 the pt experienced pain at
injection site (left arm), dizziness, difficulty walking and red blotches in
upper part of her left arm. Unspecified medical attention was sou.Patient was
receiving Atenol, Axid, Prilosec.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a licensed practical nurse concerning a pt in
their mid 60's who was vaccinated IM into the deltoid muscle with a first 0.5ml
dose of pneumococcal 23v polysaccharide vaccine (649914/0578P). On approx
19Jul05 over this past week, the pt experienced localized redness and localized
swelling that looked like cellulitis from the deltoid area down to the elbow and
inner arm. The pt was seen in the clinic and was treated with cephalexin
(Keflex). In about 4 days, the reaction res.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a female consumer who was vaccinated with a
dose of pneumococcal 23v polysaccharide vaccine. Concomitant vaccine
administered at the same time included a dose of tetanus toxoid. Concomitant
therapy included prednisone. Subsequently the pt experienced chronic pain. The
pt's chronic pain persisted. Additional information is not expected..Patient was
receiving Prednisone. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a pharmacist concerning an adult male who was
vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently
the pt experienced a severe reaction of his arm. Unspecified medical attention
was sought. No product quality complaint was involved. No other information was
provided. Additional information is not expected..Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Aug 2005, 26. Information has been received from a 73 yr old male with
hypertension who otherwise experienced good health and had no allergies who on
26Aug05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine.
Concomitant therapy included hydrochlorothiazide (+) telmisartan (Micardis HCT)
and simvastatin. On 27Aug05 the pt developed red blotches near the injection
site. Unspecified medical attention was sought. At the time of the report the
pt's red blotches were still present. There was no product qua.Paient has the
following illness history - Hypertension.Patient was receiving Micardis HCT,
Zocor.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Aug 2005, 31. Information has been received from a healthcare professional
concerning a 63 yr old male who on 31Aug05 was vaccinated SC with a 0.5ml dose
pneumococcal 23v polysaccharide vaccine (lot 649914/0578P). On approx 31Aug05
the pt experienced erythema and soreness at the injection site. Unspecified
medical attention was sought. The pt recovered without treatment within 48 hrs.
The reporter would like to know if there have been any other problems with this
lot number. The records of testing prior to release of thi.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from GA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Aug 2005, 01. Information had been received from a
certified medical assistant concerning a 79 year old female with chronic
obstructive pulmonary disease and chronic respiratory acidosis, who on 8/1/05 at
15:00 was vaccinated IM into the left arm with a second dose of Pneumococcal 23v
polysaccharide vaccine lot 649694/0386P. On 8/2/05, the patient experienced a
local site reaction of redness, tenderness and edema. The pt stated that her arm
was sore, she had some swelling and had a low grade fever. That day the pt was
br.Paient has the following illness history - Chronic obstructive pulmonary
disease, respiratory acidosis..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, 80 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 06. Information has been received from a
medical assistant concerning an 80 year old male with hypertension and
hypercholesterolemia, and with no known drug allergies, who on 9/6/05 at 15:00pm
was vaccinated IM in the left arm with a third dose of Pneumococcal 23v
polysaccharide vaccine lot 647661/0055R. There was no illness at the time of
vaccination. The pt was noted to have been administered the first and second
doses of Pneumococcal 23v polysaccharide vaccine in Nov 1997 and Dec 2001.
Subsequently, on 9/6/0.Paient has the following illness history - Hypertension,
Cholesterol high.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Sept 2005, 01. Information has been received from a female who, in Sept 2005
was vaccianted with a dose of Pneumococcal 23v polysaccharide vaccine.
Subsequently within a day of vaccine administration, she had a local reaction
that included 2 red bands around her arm at the injection site. She also had
lymph node involvement on the arm the injection was given. It was reported that
the injection was given high on the arm, possible at the joint. The duration of
symptoms was about 2-3 days. At the time of the report the patie. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Aug 2005, 31. Information has been received from a healthcare professional
concerning a 73 year old female who on 8/31/05 was vaccinated subcutaneously
with a 0.5ml dose Pneumococcal 23v polysaccharide vaccine lot 649914/0578P. On
approximately 8/31/05 the pt experienced erythema and soreness at the inject
site. Unspecified medical attention was sought. The pt recovered without
treatment within 48 hours. The reporter would like to know if there have been
any other problems with this lot number. The records of testing pri.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Aug 2005, 30. Information has been received from a healthcare professional
concerning a 45 year old female who on 8/30/05 was vaccinated subcutaneously
with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine lot 649914/0578P.
On approximately 8/31/05 the patient experienced erythema and soreness at the
injection site. Unspecified medical attention was sought. The patient recovered
without treatment within 48 hours. The reporter would like to know if there have
been any other problems with this lot number. The record.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, 78 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Aug 2005, 03. Information has been received from a
medical assistant concerning a 78 year old retired female with hypertension,
hypercholesterolemia, COPD, and a sulfa allergy who on 8/3/05 at 9:30am was
vaccianted IM in the left arm with a first 0.5ml dose of Pneumococcal 23v
polysaccharide vaccine (lot 647661/0055R). There was no illness at the time of
vaccination. Subsequently the pt experienced burning at site of injection and
pain at site of injection. Follow up information received from a medical
assistant indicate.Paient has the following illness history - Hypertension,
Sulfonamide allergy, chronic obstructive pulmonary disease, cholesterol high..
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Sept 2005, 06. Information has been received from a physician concerning a 73
year old female with an allergy to sulfa drugs and a history of hip replacement
who on 9/6/05 was vaccinated with a 0.5ml dose of Pneumococcal 23v
polysaccharide vaccine. Concomitant therapy included gabapentin (Neurontin) and
alendronate sodium MSD. It was reported that on 9/6/05, shortly after being
vaccinated, the patients arm began itching. She also experienced redness,
swelling, and extreme pain in her arm from her elbow to her shoulder, Sh.Patient
was receiving Fosamax, Neurotin.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, 82 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 07. Information has been received from a
registered nurse concerning an 82 year old female with no medical history or no
known allergies who on the morning of 9/7/05 was vaccinated IM in the right
deltoid with the first dose of Pneumococcal 23v polysaccharide vaccine (lot
649111/0287P). There was no concomitant therapy or illness at the time of
vaccination. The RN reported that on 9/7/05, the pt developed what was described
as a possible allergic reaction. The pt was noted to have developed a red
swollen arm. O.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient, 58 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 07. Information has been received from a
registered nurse concerning a 58 year old female with asthma and cardiac
arrhythmia who the morning of 9/7/05 was vaccinated in the left deltoid with an
IM 0.5ml first dose of Pneumococcal 23v polysaccharide vaccine (lot
650457/0973P). Concomitant vaccination that morning included a SC first dose of
meningococcal ACYW polysaccharide vaccine (Menomune AlClYlW-135) (lot UE4804A)
in the left arm. There was no illness at the time of vaccination. On 9/14/05 the
patient called.Paient has the following illness history - Asthma,
Arrhythmia.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Sept 2005, 14. Information has been received from a registered pharmacist
concerning a 70 year old male who on 9/14/05 was vaccinated with Pneumococcal
23v polysaccharide vaccine 0.5ml (lot 651523/0604R), IM. On 9/14/05 the pt
experienced immediate local reaction with redness, swelling, and tenderness. The
swelling progressed the length of the left arm (where the injection was given)
and down the lateral chest wall on the left side. The pt did not have any
itching but said the area ached. It was noted that the pt received.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Sept 2005, 15. Information has been received from a nurse concerning a pt who
on 15Sep05 was vaccinated with pneumococcal 23v polysaccharide vaccine (0.5ml)
(lot 649981/0704P or 650451/0750P), IM. Subsequently, on 16Sep05, the pt called
the office complaining of local reaction described as large swollen, reddened,
hot area in left arm from deltoid down to elbow. Unspecified medical attention
was sought. No product quality complaint involved. Additional information has
been requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Sept 2005, 06. Information has been received from a nurse concerning a pt who
on 06Sep05 was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine
(0.5ml), IM (lot 649981/0704P or 650451/0750P). On 07Sep05 the pt complained of
hard firm area at site with swelling and more swelling at the elbow than the
vaccination site. Ice was prescribed to area and acetaminophen (Tylenol). The
nurse stated that the pt had improved. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Aug 2005, 22. Information has been received from a physician concerning a 58 yr
old male with many health problems who on 22Aug05 was vaccinated with
pneumococcal 23v polysaccharide vaccine. Concomitant therapy included multiple
mediations. In Aug 2005, the pt experienced urticaria and a papular rash that
became more macular. The rash persisted for 3 weeks. It started at the injection
site and spread over the trunk and other arm with no facial involvement. There
were no respiratory problems or other symptoms. Unspecified.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a pt (age and gender
not reported) with unk medical history and unk allergies who in approx Dec 2004
(winter 2004) was vaccinated IM in the arm with pneumococcal 23v polysaccharide
vaccine (lot unk). Subsequently, the pt developed severe local injection site
reactions in the same arm the injection was given but below the actual site of
injection. It was reported that the pt recovered on an unk date. The pt sought
unspecified medical attention. There.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 48 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 07. Information has been received from a RN
concerning a 48yr old female who on 07Sep05 was vaccinated with a dose of
pneumococcal 23v polysaccharide vaccine (0.5ml) (IM) (lot 550453/0791P).
Subsequently, within two days, the pt experienced injection site redness, mild
swelling and arthralgia. The pt was treated with ice, ibuprofen (Tylenol) and
ibuprofen, as needed. No product quality complaint involved. It was also
reported that another pt had an adverse reaction following vaccination with
pneumococcal 23v po.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 19. Information has been received from a
certified medical assistant (CMA) concerning a 65 yr old white female with an
unk medical history and unk allergies who on 19Sep05 at 17:00 was vaccinated IM,
left deltoid with 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot
649988/0692P). On the night of 19Sep05 (previously reported as within 48 hrs of
being vaccinated), the pt developed redness and swelling at the injection. The
pt had a mild pain and she took ibuprofen (Advil). She also felt low grade
fever. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 21. Initial and follow up information has
been received from a medical assistant concerning a 65 yr old white female with
a resolving vesicular rash, cardiac disorder, and an allergy to Tolech who on
21Sep05, at approx 9:30AM, was vaccinated IM in the left deltoid with a 0.5ml
dose of pneumococcal 23v polysaccharide vaccine (lot 650083/0746P). It was
reported that the pt was vaccinated with a prior dose of pneumococcal 23v
polysaccharide vaccine on 10Sep68 (approved for market 07Jul83). Concomitant
therapy incl.Paient has the following illness history - Immunization;
hypersensitivity; cardiac disorder; rash vesicular.Patient was receiving
Fosamax, aspirin, atenolol; Aciphex.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2005, 11. Information has been received from a
certified medical assistant (CMA) concerning a 72 yr old white male (198lb, 74")
with coronary artery disease, increased blood pressure and no illness at time of
vaccination and a history of pneumonia (May 20050 and unk allergies who on
11Jul05 was vaccinated IM, left deltoid, with 0.5mL dose of pneumococcal 23v
polysaccharide vaccine (lot 649988/0692P). On 12Jul05 (previously reported as
within 48 hrs of being vaccinated), the pt developed pain and redness over the
vacc.Paient has the following illness history - Pneumonia; Coronary artery
disease; blood pressure increased. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a male pt who in 1999
was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine.
Subsequently, in 1999, the pt developed an injection site reaction with redness
and induration after vaccination. Unspecified medical attention was sought.
Subsequently, the pt recovered. No other information was provided. There was no
product quality complaint. Additional information has been requested..Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 23. Information has been received from a
nurse practitioner concerning a 68 yr old Hispanic female with diabetes mellitus
and dizziness who on 23Sep05 was vaccinated IM in the right arm with a 0.5mL
dose of pneumococcal 23v polysaccharide vaccine (lot 650087/0815P, also reported
as 650083/0746P). Concomitant therapy included atorvastatin calcium (Lipitor),
trandolapril (Mavik), meclizine, estrogens, esterified (+) methyltestosterone
(Estratest), vitamins (Centrum), aspirin, and rabeprazole NA (Aciphex). On
24Se.Paient has the following illness history - Diabetes mellitus;
dizziness..Patient was receiving aspirin, Lipitor, Estratest, meclizine,
Centrum, Aciphex, Mavik. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 71 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 21. Information has been received from
health professional concerning a 71 yr old male, with atrial fibrillation,
diabetes, hypertension and cholesterolemia, and no known allergies, who on
21Sep05 was vaccinated with a SC dose of pneumococcal 23v polysaccharide vaccine
(lot 650327/0792P). Concomitant therapy included warfarin sodium (Coumadin). It
was reported that on 23Sep05 the pt's entire arm, that had received the
injection, had redness, swelling, pain, and was warm to the touch. The swelling
was past the e.Paient has the following illness history - Atrial fibrillation;
diabetes; hypertension; cholesterol high.Patient was receiving Coumadin.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from MD, USA. Female patient was vaccinated with PNEUMO, 23-VALENT
(PNEUMOVAX). Information has been received from a licensed practical nurse
concerning an 81 year old female who was vaccinated with a dose of Pneumococcal
23v polysaccharide vaccine (lot 650331/0749P). On approx 9/27/05 the pt
experienced swelling, tenderness, and redness at the injection site. The pt was
treated warm compresses and antihistamines. The symptoms resolved. The outcome
was reported as recovered. No further information was available. There was no
product quality complaint. Additional information has been re.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Sept 2005, 29. Information has been received from a healthcare professional
concerning a 62 year old female with diabetes, and allergies to sulfonamides and
codeine who at the end of Sept 2005 was vaccinated IM with a 0.5ml dose of
Pneumococcal 23v polysaccharide vaccine. Concomitant therapy included metformin
HCL (Glucophage), Levothyroxine NA (Synthroid), venlafaxine HCL (Efferxor),
atorvastatin CA (Lipitor), Benazepril HCL (Lotensin), estrogens, conjugated (Premarin)
and medroxyprogesterone acetate (Provera). The healt.Patient was receiving
Lipitor, Lotensin, Premarin, Synthroid, Provera, Glucophage, Effexor..Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 85 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 28. Information has been received from a
health professional concerning an 85 year old female with atrial fibrillation,
hypertension and osteoporosis who on 9/28/05 was vaccinated with an IM dose in
the deltoid of Pneumococcal 23v polysaccharide vaccine (lot 650327/0792P).
Concomitant therapy included warfarin sodium Coumadin for the treatment of
atrial fibrillation. It was reported that the patient was seen in the physicians
office on 9/29/05 since her shoulder to elbow, of the arm that received the
injection,.Paient has the following illness history - Atrial Fibrillation,
Hypertension, Osteoporosis..Patient was receiving Coumadin.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from VA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a health professional concerning an approx 64
year old male with an allergy to penicillin and no other past medical history
who was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot
650331/0749P). Concomitant therapy included dexamethasone and prochlorperazine
maleate Compazine. Subsequently, the pt developed painful welts at the injection
site. He went to the ER, but was not admitted. He was given moxifloxacin
hydrochloride Avelox as treatment. No lab.Paient has the following illness
history - Penicillin Allergy..Patient was receiving Decadron Tablets,
Compazine.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a license practical nurse concerning an
66-year-old female who was vaccinated with a dose of pneumococcal 23v
polysaccharide vaccine (lot 650331/0749P). On approximately 27-SEP-2005 the
patient experienced swelling, tenderness, and redness at the injection site. The
patient was treated warm compress and antihistamines. The symptoms resolved. The
outcome was reported as recovered. No further information was available. There
was no product quality complaint. Additiona.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Aug 2005, 17. Information has been received from a physician concerning an older
female who on 17-AUG-2005 was vaccinated with a dose of pneumococcal 23v
polysaccharide vaccine (lot 650330/0748P). On 17-AUG-2005 the patient developed
pain and swelling at the injection site. Unspecified medical attention was
sought. The patient's pain and swelling at injection site persisted. Additional
information has been requested..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CT, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Sept 2005, 03. Information has been received from a pharmacist concerning a
female in her 50"s who on approximately 03-SEP-2005 began self administrating
pneumococcal 23v polysaccharide vaccine daily (duration not reported).
Subsequently, the patient experienced dizziness. The patient was seen in the
clinic and was asked to bring the bottle of medication to the clinic. On
03-OCT-2005 the patient returned to the clinic and brought 9 empty vials of
pneumococcal 23v polysaccharide vaccine. The pharmacist indicated that t.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from GA, USA. Female patient, 27 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 27. Information has been received from a
certified medical assistant concerning a 27 year old female who on 27-SEP-2005
was vaccinated with pneumococcal23v polysaccharide vaccine (lot 650648/0967P),
0.5 ml, one dose. On 29-SEP-2005 the patient reported pain, swelling, redness
and warmth at the injection site. As of 03-OCT-2005 the patient was recovering
from her experiences. Additional information has been requested.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 47 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 29. Initial and follow up information has
been received from a pharmacist and physician's assistant concerning a 47 year
old unemployed black female with an allergy to penicillin noted as rash. On
29-SEP-2005, at 9:00 am, the patient was vaccinated intramuscularly in the left
deltoid arm with the first dose of pneumococcal 23v polysaccharide vaccine (lot
649979/0531P). There were no illness at the time of vaccination. Subsequently
the patient experienced an injection site reaction with an indurated red
area.Paient has the following illness history - concurrent condition: penicillin
allergy.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 58 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 20. Initial and follow up information has
been received from a medial assistant concerning a 58 year old white male with
benign prostatic hyperplasia (BPH), elevated cholesterol, "onychotic" toe nails,
sciatica and an allergy to sulfa, rosuvastatin calcium (CRESTOR), cefuroxime
axetil (CEFTIN), trees, grass, mold and dust who on 20-SEP-2005, AT
APPROXIAMTELY 10:30 am was vaccinated intramuscularly in the left deltoid with a
0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot 650083/0746P).
Concomitant.Patient was receiving saw palmetto, LAMISIL.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a nurse practitioner concerning a 60-year-old
male who in the last 10 days (approximately September 2005) was vaccinated with
a second dose of pneumococcal 23v polysaccharide vaccine (lot 649914/0578P). It
was reported that within one day of the vaccination ( approximately September
2005), the patient developed an injection site reaction. He also developed a
whole body rash, red pettichiae on both arms and chest, malaise, fever, and the
injection site was hard and tender.Paient has the following illness history -
Medical History: Immunization.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a pharmacist and physician's assistant
concerning a patient who was vaccinated with pneumococcal 23v polysaccharide
vaccine (lot 649979/0531P). Subsequently the patient experienced an injection
site reaction with an indurated red area five times the size of the injection
site, swelling, inflammation, nausea and fever. The patient was treated with
ibuprofen (MOTRIN). As OF 04-oct-2005, the patient was recovering from injection
site reaction site reaction with an indurate.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 67 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 21. Information has been received from a
certified medical assistant concerning a 67 yr old white male who at 09:00 on
21Sep05 was vaccinated IM in the right deltoid with a 0.5mL dose of pneumococcal
23v polysaccharide vaccine (lot 649988/0592P). It was reported that the pt had
since developed pain, redness, swelling, and warmth at and around the injection
site. On 23Sep05, the pt developed an allergic reaction with some erythema
around elbow area. The pt saw the physician and was treated with gatifloxacin
(Teq.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information ahs been received from a healthcare pharmacy student concerning an
approx 87 year old male with no know allergies and history of cold agglutination
disease who within the year approx 2005 was vaccianted with a dose of
Pneumococcal 23v polysaccharide vaccine. Concomitant therapy included
prednisone. On 8/16/05 the pt had a titer which showed a response to only 6
serotypes. There was no other information available regarding the pts adverse
event. The adverse event did not improve and the pt is not.Paient has the
following illness history - Cold agglutinins positive..Patient was receiving
Prednisone.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 04. Information has been received from a pharmacist concerning adult
female who on 04-OCT-2005 was vaccinated with a second dose of pneumococcal 23v
polysaccharide vaccine (lot 651524/0605R). It was noted that the patient
received her first dose prior to age 65. On 04-OCT-2005, immediately after
vaccination, the patient's entire upper arm was red and warm to touch. It
covered the entire upper arm with no defined border. Unspecified medical
attention was sought and the patient was instructed to use ice packs.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from VA, USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 28. Information has been received from a
health professional concerning an approximately 64-year-old female with no known
allergies who on 28-SEP-2005 was vaccinated with a dose of pneumococcal 23v
polysaccharide vaccine (lot 650331-0749P). Subsequently, in September 2005 the
patient developed swelling from her shoulder to her elbow. She was given
antibiotics. It was unknown if the patient was on other medications, and the
patient's status at the time of the report was unknown as well. Additional
informatio.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 06. Information has been received from a 79 year old female consumer
with emphysema who on 06-OCT-2005 was vaccinated (route unknown) with a dose of
pneumococcal 23v polysaccharide vaccine (lot number unknown). On 06-OCT-2005 the
patient experienced rash after getting injection. The patient mention that the
rash started below the injection site and spread down the arm. The caller
indicated that by the next day, 07-OCT-2005, the rash was gone and only some
discoloration was left. At the time of the report it. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 61 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 05. Information has been received from a
registered nurse concerning a 61 year old female patient with seizure disorder,
chronic anemia, gastroesophageal reflux disease , aguegenic myeloid metaplasia
and seasonal allergy who on 05-OCT-2005 was vaccinated intramuscularly in her
left arm with a first dose of pneumococcal 23v polysaccharide vaccine. There was
no concomitant medication. On 06-OCT-2005 the patient developed cellulitis at an
area other than injection site. The cellulitis developed in her left arm.Paient
has the following illness history - Concurrent conditions: convulsion disorder,
anemia, gastroesophageal reflux disease, myeloid metaplasia, seasonal allergy.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from GA, USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 04. Initial and follow up information has
been received from a physician, the husband of a 69 yr old female pt with no
known medical history and no known drug reaction or allergies reported, who on
04Oct05 was vaccinated (route unk) in the deltoid with a first dose of
pneumococcal 23v polysaccharide vaccine (lot unk). On 05Oct05 the pt developed
an injection site, cellulitis like reaction, characterized by erythema,
tenderness, swelling and pain. It was also reported that the pt experienced
warmth. The pt was t. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 06. Information has been received from a pharmacist concerning an 88
year old female who on 06-OCT-2005 was vaccinated with a dose of pneumococcal
23v polysaccharide vaccine (lot 650456/0974P). Subsequently, the patient
developed large raised welts at the site. No prescription drug treatment was
required. The patient's outcome was unknown. No further information is
available.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 08. Information has been received from a pharmacist concerning a 70
year old female who on 08-OCT-2005 was vaccinated with a dose of pneumococcal
23v polysaccharide vaccine (lot 650456/0974P). On 08-OCT-2005, the patient
developed large raised welts at the site of injection. It was noted that
hydrocortisone cream was ordered to reduce the welt in this patient. At the time
of this report, the patient's outcome was unknown. No further information is
available.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 37 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 08. Information has been received from a
physician concerning a 37 year old male patient with an unknown medical history,
who on 10/08/2005, was vaccinated with a second dose of pneumococcal 23v
polysaccharide vaccine 651329/1047P), one year after his first vaccination,
which was in October 2004. It was noted that the patient requested the vaccine
even through he had been vaccinated one year earlier. The vaccine was
administered by the medical assistant with a physician order. One day after the
vaccination, on. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OR, USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 07. Information has been received from a
64-year-old female with asthma and no drug allergies who on 07-OCT-2005 was
vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. There was no
illness at the time of vaccination. Concomitant therapy included fluticasone
propionate (FLOVENT), ALBUTEROL, montelukast Na, and thyroid. On 07-OCT-2005,
after vaccination, the patient's right arm swelled up to three times the normal
size at the injection site area. The patient also developed pain and redness
in.Paient has the following illness history - Concurrent conditions:
asthma.Patient was receiving ALBUTEROL, FLOVENT, SINGULAIR, thyroid. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 06. Information has been received from a pharmacist technician
concerning a patient (age and sex not specified) who on 06-OCT-2005 was
vaccinated with pneumococcal 23v polysaccharide vaccine (lot 650456/0974P). On
06-OCT-2005 , within 24 hours, the patient developed an injection site reaction
of swelling and redness. The patient sought unspecified medical attention. It
was reported they have requested a check of lot 650456/0974p. At the time of
this report, the outcome of the events were unknown. The recor.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a pharmacist purchaser concerning a senior
citizen patient ( age and gender not specified) who was vaccinated
intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine
(lot 650452/0753P) in a senior center during an immunization clinic. On an
unspecified date" recently", the patient developed "severe pain at the injection
site", so much so that the patient " could not sleep at night". It was also
reported that the patient had "swelling present". It.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 42 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 26. Information has been received from a
health professional concerning a 41 year old Caucasian male patient with cerumen
impaction and otalgia and no known allergies who on 26-SEP-2005 was vaccinated
with a dose of pneumococcal 23v polysaccharide vaccine (intramuscularly) (0.5
ml) (lot 649694/0386P). On 27-Sept-2005 at 8:00 am the patient experienced pain,
redness of 6 centimeter by 4 centimeter at local site where vaccine was
administered. The patient also had "shooting pain up and down the arm, right arm
a.Paient has the following illness history - Concurrent conditions: cerumen
impaction, ear pain.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient, child 12 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2006, 18. redness and tenderness at site of
injection, fever and headache started about 24 hours after vaccine received. Pt
is started on Keflex..Paient had Whip worms.Paient has the following illness
history - NKDA, ADD, Obesity, Chronic rhinitis.Patient was receiving Strattera,
Mebendazole. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Sept 2005, 14. Information has been received from a health professional
concerning an 83 yr old male who on 14Sep05 was vaccinated with a dose of
pneumococcal 23v polysaccharide vaccine (Lot 650649/0790P). On 14Sep05 the pt
complained of upper arm swelling and redness at the injection site, fever and
chills. The pt took over the counter medication. Unspecified medical attention
was sought. No product quality complaint was involved. No other information was
provided. Additional information has been requested..Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 08. Information has been received from a pharmacy tech concerning a pt
(age and sex not specified) who on 08Oct05 was vaccinated with pneumococcal 23v
polysaccharide vaccine (650456/0974P). On 08Oct05, within 24 hrs, the pt
developed an injection site reaction of swelling and redness. The pt sought
unspecified medical attention. It was reported they have requested a check of
medical attention. It was reported, they have requested a check of Lot
650456/0974P. At the time of this report, the outcome of the events.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a pharmacist concerning an adult female who
was vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine
(lot 651524/0605R). It was noted that the pt received her first dose prior to
age 65. Subsequently, the pt's arm had redness, and warm, and was tender. It was
noted to be band like. Unspecified medical attention was sought and the pt was
instructed to use ice packs for comfort. The pt was recovering. A product
quality complaint was not involved. Addition.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT
(PNEUMOVAX). Information has been received from a physician concerning a female
pt in her sixties who in approx Oct 2005, was vaccinated IM with a 0.5mL dose of
pneumococcal 23v polysaccharide vaccine. On approx 05Oct05, the pt developed
upper shoulder swelling, redness and tenderness. Unspecified medical attention
was sought. A product quality complaint was not involved. Additional information
has been requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a nurse practitioner concerning a pt (age and
gender not reported) with unk medical history and unk allergies who on an
unspecified date was vaccinated with a 0.5mL dose of pneumococcal 23v
polysaccharide vaccine (lot unk). Subsequently, the pt developed cellulitis as a
result of the vaccination. It was also reported that the pt was treated with
antibiotics (unspecified) and recovered from cellulitis on an unspecified date.
The reporter felt that the pt's cellulitis was re.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Sept 2005, 28. Information has been received from a health professional
concerning an 82 yr old female who on 28Sep05 was vaccinated with a dose of
pneumococcal 23v polysaccharide vaccine (lot650649/0790P). On 28Sep05 the pt
complained of redness, swelling, and warmth at the injection site and fever. The
pt took over the counter medication. Unspecified medical attention was sought.
No product quality complaint was involved. No other information was provided.
Additional information has been requested..Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a health professional concerning a 79 year
old female on 29-SEP-2005 was vaccinated with a dose of pneumococcal 23v
polysaccharide vaccine (lot 650649/0790P). On 29-SEP-2005 the patient complained
of swelling and redness at the injection site and fever. The patient took over
the counter medication. Unspecified medical attention was sought. No product
quality complaint was involved. No other information was provided. Additional
information has been requested..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 51 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 02. Information has been received from
certified medical assistants concerning a 51 yr old white male (281.5lb, 6'4")
factory worker with allergies to aspirin and NSAID (not specified) who on
02Oct05 (also reported as 12Oct05), at 16:15, was vaccinated IM, into deltoid
muscle, with 0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot
649981/0709P). On the next morning (also reported within the next several
hours), at 7:30AM, the pt developed angioedema of face and head (also reported
as swelling of his fa. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a female child (age
not provided) with asthma who was initially vaccinated (date not provided) with
a dose of pneumococcal 23v polysaccharide vaccine (lot 651318/1006).
Subsequently the patient developed marked, painful redness and swelling at the
site of injection. The patient's outcome was not reported. There was no product
quality complaint involved. The physician also provided information regarding
another patient's experiences with pneumococ.Paient has the following illness
history - Concurrent conditions: Asthma. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a pharmacy purchaser concerning a senior
citizen patient (age and gender not specified) who on an unspecified date was
vaccinated intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide
vaccine (lot 650452/0753P) in a senior center during an immunization clinic. On
an unspecified date. "recently", the patient developed "severe pain at the
injection site", so much so the patient "could not sleep at night". It was also
reported that the patient had "swelling.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 07. Information has been received from a physician concerning an
adult patient who " over the last week", on approximately 07-OCT-2005, was
vaccinated with 0.5 ml intramuscular dose of pneumococcal 23v polysaccharide
vaccine (lot 650453/0791P). It was reported that the patient developed a severe
local reaction at the injection site including, redness, swelling, and pain. It
was reported that the patient recovered or was recovering. Unspecified medical
attention was sought. The reporter expressed concern abo.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a 64 year old female with chronic obstruction
pulmonary disease, emphysema, arthritis, diabetes and cardiac failure congestive
who was vaccinated with pneumococcal 23v polysaccharide vaccine. Concomitant
therapy included " too many" medications (therapy unspecified). Subsequently the
patient experienced injection site reaction. The patient's outcome was not
reported. The patient also reported her experiences while on therapy with
ezetimibe. Additional information has.Paient has the following illness history -
Concurrent conditions: chronic obstructive pulmonary disease, emphysema,
arthritis, diabetes, cardiac failure congestive. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 12. Information has been received from a 69
year old female with lupus and allergic to sulfa who on 12-OCT-2005 was
vaccinated with pneumococcal 23v polysaccharide vaccine. The patient reported
that she received a flu vaccine at the same time that she received the
pneumococcal 23v polysaccharide vaccine. On 12-OCT-2005 the patient reported
that she felt " dizzy, weak, and generally debilitated" after receiving
pneumococcal 23v polysaccharide vaccine. The patient did not seek medical
attention. Laboratory di.Paient has the following illness history - Concurrent
conditions: lupus erythematosus, sulfonamide allergy. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 70 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 14. Information has been received from a 70
year old female with high cholesterol, hypertension, glaucoma,and penicillin
allergy who on 14-OCT-2005 was vaccinated with pneumococcal 23v polysaccharide
vaccine (0.5 ml), subcutaneously. Concomitant therapy included atorvastatin
calcium (LIPITOR), valsartan ( DIOVAN), amlodipine besylate (NORVASC) and
atenolol. On 14-OCT-2005, "later that night" the patient experienced severe pain
in the region of the injection and red blotches on arm. The next day she had a
ras.Paient has the following illness history - Concurrent conditions:
cholesterol high, hypertension, glaucoma, penicillin allergy.Patient was
receiving NORVASC, atenolol, LIPITOR, DIOVAN.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 07. Information has been received from a physician concerning an
adult patient who " over the last week", on approximately 07-OCT-2005, was
vaccinated with a 0.5 ml intramuscular dose of pneumococcal 23v polysaccharide
vaccine (lot 650453/0791P). It was reported that the patient developed a severe
local reaction at the injection site including, redness, swelling, and pain. The
patient was seen at the emergency room. It was reported that the patient had
recovered or was recovering. The reporter expressed con.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 07. Information has been received from a physician concerning an
adult patient who "over the last week" on approximately 07-OCT-2005 was
vaccinated with a 0.5 ml intramuscular dose of pneumococcal 23v polysaccharide
vaccine. (lot 650453/0791P). It was reported that the patient developed a severe
local reaction at the injection site including, redness, swelling and pain. The
patient was seen at the emergency room. The patient also developed hives and was
treated with diphenhydramine hydrochloride (BENADRYL),.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 17. Information has been received from a physician concerning an
adult patient who on 17-OCT-2005 was vaccinated intramuscularly with a 0.5 ml
dose of pneumococcal 23v polysaccharide vaccine (lot 649695/0512P). On
17-OCT-2005 the patient developed an injection site reaction including redness
and swelling , and the area was itchy. Unspecified medical attention was sought.
Outcome was reported as recovering. No product quality complaint was involved.
Additional information has been requested..Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 41 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 16. Information has been received from a
consumer concerning her 41 year old daughter with a history of cancer who on
16-OCT-2005 was vaccinated intramuscularly with a dose of pneumococcal 23v
polysaccharide vaccine (Lot 650453/0791P). Concomitant therapy included an
unspecified cancer therapy. It was reported that on 16-OCT-2005 the patient's
arm had swelled and that she had red welts covering her arm near the injection
site. The patient's mother also reported that her arm" hurts very much" near the
injecti.Paient has the following illness history - Medical History: cancer.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a pharmacist concerning a 60 year old male
who in approximately 1995 was vaccinated intramuscularly with a 0.5 ml dose of
pneumococcal 23v polysaccharide vaccine. In approximately 1995 the patient
developed an injection site reaction with redness, swelling and pain.
Unspecified medical attention was sought. Subsequently, the patient recovered.
Additional information has been requested..Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 18. Information has been received from a
physician concerning a 69 year old white male with a codeine allergy who on
18-OCT-2005 at 7:10 pm was vaccinated intramuscularly in the right deltoid with
a second dose of pneumococcal 23v polysaccharide vaccine (lot 651523/0604R).
Concomitant vaccination on 25-OCT-2005 intramuscularly seventh dose in the left
deltoid of influenza virus split virion 3v vaccine inactivated (lot U1B33BA). It
was reported that it had been 9 years since the patient received his first
dose.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 48 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 13. Information has been received from a
registered nurse concerning a 48 year old male with asthma and no known
allergies. On 10/13/05 the pt was vaccinated IM with a 0.5ml dose of
Pneumococcal 23v polysaccharide vaccine (lot 650453/0791P). Concomitant therapy
included unspecified therapy two unnamed inhalers. On 10/14/05 the pt developed
a localized reaction of arm with swelling, redness an skin was warm to touch.
The pt was treated with diphenhydramine hydrochloride Benadryl. It was reported
that it was unkn.Paient has the following illness history - Asthma.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from RI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a pharmacy technician concerning a male pt
who was vaccinated SC with a 0.5ml dose of Pneumococcal 23v polysaccharide
vaccine (lot 650083/0746P). Subsequently the pt experienced a local site
reaction post vaccination. The pt called the office on approximately 10/12/05 to
report a red, raised, warm area at the injection site, and feeling of fatigue.
Unspecified medical attention was sought. The outcome was reported as recovered.
There was no product quality complaint. Addit.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 14. Information has been received from a
health professional concerning a 65 year old female with no pertinent medical
history who on 10/14/05 was vaccinated intramuscularly in the left deltoid with
a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650648/0967P).
there was no concomitant medication. There was no illness at the time of
vaccination. Following vaccination (date not specified) the pt experienced upper
arm swelling to the elbow, redness at the injection site and skin was warm to
touch at.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 19. Information has been received from a certified medical
assistant concerning an 84 year old female with an allergy to penicillin,
vancomycin and gentamicin. On 10/19/05, the pt was vaccianted with Pneumococcal
23v polysaccharide vaccine. Concomitant therapy included metoprolol succinate
Toprol XL tablets, alendronate sodium and cyclobenzaprine HCL. On 10/19/05, the
pt developed from the injection site to the elbow, her arm was red, swollen and
very warm. The pt sought unspecified medical attention. There wer.Patient was
receiving Fosamax, Flexeril, Toprol XL tablets.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 17. Information had been received from a
pharmacist concerning a 66 year old female with an allergy to codeine who on
10/17/05 was vaccinated IM in the left arm with a 0.5ml dose of Pneumococcal 23v
polysaccharide vaccine (lot 650327/0792P). It was reported that the pt came into
the pharmacy yesterday, 10/19/05, and complained of a swollen left arm at the
injection site. It was reported that the adverse event onset was within 72
hours. Unspecified medical attention was sought. The patient was treated with
oral.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 84 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 18. Information has been received from an 84
year old female with hypertension and an allergy to cephalexin Keflex who on
10/18/05 was vaccinated SC with a 0.5ml dose of Pneumococcal 23v polysaccharide
vaccine. Concomitant therapy included amlodipine besylate Norvasc. On 10/18/05,
the pts arm became very sore and red. The flab on the underside of her arm also
became very swollen. No medical attention was sought and no diagnostic lab test
were performed. At the time of the report, the pt had not recovered. A
pro.Patient was receiving Norvasc. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a female in her 30's
with an undefined illness who was initially vaccinated (date not provided) with
a dose of Pneumococcal 23v polysaccharide vaccine(lot 651318/1006). Subsequently
the pt developed pain, redness and swelling at the site of injection. No
treatment was ordered. The pts outcome was not reported. There was no product
quality complaint involved. The physician also provided information regarding
another pts experiences with Pneumococcal 2.Paient had sickness. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a 68 year old female
with a history of multiple allergies and one time vaccination with Pneumococcal
23v polysaccharide vaccine who was vaccinated (date not provided) with a dose of
Pneumococcal 23v polysaccharide vaccine (lot 651318/1005). Subsequently the pt
developed pain, redness and swelling at the injection site extending into
axillary region and posterior cervical area on same side. The pt was treated
with cephalexin (Keflex). The pts outcome.Paient has the following illness
history - Hypersensitivity, Immunisation. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 01. Information has been received from a health professional
concerning an approx 80 year old pt who in Oct 2005 was vaccinated with a dose
of Pneumococcal 23v polysaccharide vaccine. In Oct 2005, the pt experienced
cellulitis and was hospitalized. Unspecified medical attention was sought. No
product quality complaint was involved. No other information was provided.
Additional information is not expected..Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 15. Information has been received from a pharmacist concerning a 75
year old female with an allergy to penicillin and sulfa drugs, and no other
medical history who on 10/15/05 was vaccinated with a dose of Pneumococcal 23v
polysaccharide vaccine (kit 647661/0055R). Concomitant therapy included
levothyroxine NA Synthroid, escitalopram oxalate Lexapro, Loratadine Lorazepam,
rabeprazole sodium Aciphex and zolpidem tartrate Ambien. On 10/15/2005 the pt
developed a huge red knot at the injection site which was accom.Patient was
receiving Lexapro, Synthroid, Lorazepam, Aciphex, Ambien.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from RI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 05. Information has been received from a pharmacy technician
concerning a male pt who on approx 10/5/05 was vaccinated SC with a 0.5ml dose
of Pneumococcal 23v polysaccharide vaccine vaccine lot 650083/0749P).
Subsequently, in Oct 2005, the pt experienced a local site reaction post
vaccination. The pt called the office to report a red, raised, warm and achy
area at the injection site. He was treated with cold compresses and
acetaminophen Tylenol as needed. Unspecified medical attention was sought. The
outcome w.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from RI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 05. Information has been received from a pharmacy technician
concerning a female pt who on approx 10/5/05 was vaccinated SC with a 0.5ml dose
of Pneumococcal 23v polysaccharide vaccine (lot 650083/0746P). Subsequently, in
Oct 2005, the pt experienced a local site reaction post vaccination. the pt
called the office to report a red, raised, warm, and achy area at injection
site. He was treated with cold compresses and acetaminophen Tylenol as needed.
Unspecified medical attention was sought. The outcome was repor.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 85 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 20. Information has been received from a
health professional concerning an 85 year old female with hypertension and
hypohydremia and no allergies who on 10/20/2005 was vaccinated SC with a 0.5ml
dose of Pneumococcal 23v polysaccharide vaccine. Concomitant therapy included
enalapril maleate. On 10/21/05 the pt stated that the site was swollen and red
down to the elbow on the back side of the arm. The pt saw the physician on
10/22/05 where the condition was observed and verified. there were no labs or
diagnostics.Patient was receiving Enalapril Maleate.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT
(PNEUMOVAX) on Oct 2005, 20. Information has been received from a certified
medical assistant CMA and a registered Nurse concerning an over 65 adult male
with no pertinent medical history or allergies who on 10/20/05 was vaccinated IM
with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649697/1038P).
the day after the injection, on 10/21/05, the pt experienced swelling, redness,
induration, warmth and pain at the injection site. The swelling was described as
almost like cellulitis. Unspecified medical attention was sought.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 19. Information has been received from a
health professional concerning a 72 year old female with penicillin allergy,
sulfonamide allergy and dexamethasone allergy who on 10/19/05 was vaccinated
with Pneumococcal 23v polysaccharide vaccine (lot 650649/0790P). On 10/19/05,
the pt experienced raised red hot area at the injection site. Unspecified
antibiotics were started on 10/21/05. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a health professional concerning a pt who was
vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine and had a
local reaction. No other information was provided. Additional information is not
expected.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 24. Information has been received from a physician concerning a pt
who was vaccinated with a first and second dose of Pneumococcal 23v
polysaccharide vaccine, the first in 1995 and the second on 10/24/05 (lot
650302/1039P, 0.5ml, IM). On 10/25/05 the pt was diagnosed with cellulitis of
the arm. Unspecified medical attention was sought. There was no product quality
complaint involved. Additional information has been requested..Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a public health nurse concerning an adult
female pt who was vaccinated with a second dose of Pneumococcal 23v
polysaccharide vaccine. It was noted that the date of the first dose is unknown.
Subsequently the pt experienced redness and severe swelling at the injection
site, which resolved with no treatment. The adverse event improved and the pt
recovered. No further information was available regarding the adverse event.
There was no product quality complaint reported. The p.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from VA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 18. Information has been received from a health professional
concerning a 31 year old female who on 10/18/2005 was vaccianted with a 0.5ml
dose IM in the left deltoid of Pneumococcal 23v polysaccharide vaccine, (lot
640453/0791P). Concomitant therapy included atorvastatin calcium Lipitor. That
night, on 10/18/2005, the pt experienced a red and swollen left arm and she had
pain in her shoulder blade and arm pit. The symptoms subsided on their own and
she received no treatment. No medical attention was sought. Th.Patient was
receiving Lipitor. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, child 20.1 years of age, was vaccinated with
PNEUMO, 23-VALENT (PNEUMOVAX) on Oct 2005, 18. Information has been received
from a certified medical assistant concerning a 25 month old male with no
medical history and no drug allergies who on 10/18/05 in the AM was vaccinated
with a dose of Pneumococcal 23v polysaccharide vaccine 0.5ml IM lot
649695/0512P, in the right thigh. There was no concomitant medication. On
10/19/05 the patient experienced a red, tender and swollen at injection site. It
was also reported as patient got a severe erythematous 6cm circular region at
injection site. The pt was t.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 24. Information has been received from a health professional
concerning an adult female who on 24OCT05 was vaccinated with a 0.5mL dose of
pneumococcal 23v polysaccharide vaccine (lot 659697/1038P). On 24Oct05 the pt
experienced a swollen arm and pain at the injection site. She was seen by the
physician and was ordered acetaminophen (Tylenol). At the time of this report,
the pt was recovering. Additional information has been requested..Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 22. Information has been received from a RN concerning a 39 yr old
female with a history of pneumonia 2 yrs in a row. On 22Oct05 the pt was
vaccinated IM in the left deltoid with a 0.5mL dose of pneumococcal 23v
polysaccharide vaccine (lot 649697/1038P). That same day, the pt developed
redness, swelling at site, and a fever noted as 102.5. The pt sought unspecified
medical attention. It was reported that there was no treatment. The fever
resolved itself (date unk). At the time of the report, the pt had
recovere.Paient has the following illness history - Pneumonia.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 54 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a
physician concerning a 54 yr old Caucasian male pt with sarcoidosis, thrombocy,
and no known drug reactions/allergies, who on 24Oct2005 was vaccinated SC with a
first dose pneumococcal 23v polysaccharide vaccine. There was no concomitant
medication. On 24Oct05 the pt developed a local reaction. The left tricep and
upper arm of the pt had warmth and erythema. It was reported that the doctor
gave the pt a shot of methylprednisone sodium succinate (Solumedrol) and gave
cefd.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 26. Information has been received from a RN concerning a male (age
not specified) who on approx 26Oct05, the past 48 hrs, was vaccinated with a
0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot 649981/0704P). On
approx 26Oct05, the past 48 hrs, the pt developed a significant injection site
reaction and cellulitis from armpit to wrist. It was also reported that symptoms
started within 12 to 24 hrs of receiving the vaccine. The pt sought unspecified
medical attention. There were no lab diagnostic studies.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AZ, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 27. Information has been received from a healthcare worker
concerning a 76 yr old female with hypertension. On 27Oct05 the pt was
vaccinated IM with a 0.5mL dose of pneumococcal 23v polysaccharide vaccine
(lot649913/0577P). Concomitant therapy included unspecified therapy reported as
several other medications. On 27Oct05 the pt developed swelling at the injection
site and area surrounding the injection site. The pt sought unspecified medical
attention. At the time of this report, the pt was recovering from the.Paient has
the following illness history - Hypertension.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 24. Information has been received from a licensed practical nurse
concerning an adult female pt with unk medical history and unk drug
reactions/allergies, who on 24Oct05 was vaccinated in the right deltoid IM with
0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot649979/0531P). The pt
called the office within 4 hrs complaining of redness, warmth to injection site,
body aches and vomiting. She was ordered promethazine hydrochloride (Phenergan)
by mouth. Subsequently, within 24 hrs vomiting and body aches.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2005, 13. Information has been received from a
health professional concerning a 68 yr old white retired male with no pertinent
medical history who on 13Jul05 was vaccinated IM in the deltoid with a second
0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot 649988/0692P). There
was no concomitant medication. Two hrs after the injection on 13Jul05 the pt
experienced upper arm swelling, redness and skin warm to touch at the injection
site. Unspecified medical attention was sought no laboratory or diagnostic
tests.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 17. Information has been received from a physician concerning an
adult pt who on 17Oct05 was vaccinated IM with 0.5mL pneumococcal 23v
polysaccharide vaccine (lot 649695/0512P). On 17Oct05 the pt developed an
injection site reaction included redness and swelling. Unspecified medical
attention was sought. Outcome was reported as recovering. No product quality
complaint was involved. Additional information has been requested..Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 20. Information has been received from a
certified medical assistant (CMA) and a registered nurse (RN) concerning a 72 yr
old retired Caucasian adult male (also reported as over 65) with CAD, HTN,
cardiomyopathy, NIDDM, and hypercholesterolemia who on 20Oct05 at 13:30 (also
reported as the second week of October and a couple weeks ago) was vaccinated IM
with a second dose of 0.5ml dose of pneumococcal 23v polysaccharide vaccine
(lot649697/1038P). On 20Oct05 (also reported as the day after the injection),
the pt.Paient has the following illness history - Coronary artery disease;
Hypertension; cardiomyopathy; diabetes mellitus non insulin dependent;
hypercholesterolaemia..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from SC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a 65 year old male
with lymphoma who was inadvertently vaccinated with a 1.0mL dose of pneumococcal
23v polysaccharide vaccine. Subsequently the pt complained of tenderness and
erythema at vaccination site (unspecified), as well as low grade fever. Medical
attention was sought. The pt's outcome was unk. Additional information has been
requested..Paient has the following illness history - Lymphoma.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 26. Information has been received from a
licensed practical nurse concerning 3 pt's who were vaccinated with pneumococcal
23v polysaccharide vaccine (lot650327/0792P) and subsequently developed severe
injection site reactions, which extended from the deltoid area to the entire
arm. All 3 pts sought medical attention, outcomes were unk. The nurse requested
a lot check be performed on lot 650327/0792P. The records of testing prior to
release of this lot have been checked by QA and found to be satisfactory. The
lo.Paient has the following illness history - Arthritis.Patient was receiving
Norvasc. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, 71 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a RN
concerning a 71 yr old Caucasian male pt with hypertension and benign prostatic
hyperplasia (BPH) who on 25Oct05 at 1:30PM was vaccinated with a first dose of
pneumococcal 23v polysaccharide vaccine (lot649989/0579P), IM in the right
deltoid. There was no illness at the time of vaccination. On 26Oct05 in the PM
the pt developed swelling/redness right upper arm, and slight burning sensation
began. The pt was seen in the physician's office on 27Oct05. It was also
report.Paient has the following illness history - Hypertension; Benign prostatic
hyperplasia.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AZ, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a healthcare worker concerning a pt (age and
gender not specified) who on an unspecified date, was vaccinated with
pneumococcal 23v polysaccharide vaccine. On an unspecified date, the pt
developed swelling at the injection site and headaches. At the time of this
report, the outcome of the events were unk. Additional information has been
requested.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 27. Information has been received from a nurse practitioner concerning
an adult pt (age and gender not reported) with an unk medical history and unk
allergies who on 27Oct05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v
polysaccharide vaccine (651524/0605R). Subsequently, the pt developed an
injection site reaction including swelling, redness, pain and local heat. The pt
was reported as recovering. There was no product quality complaint involved.
Additional information has been requested.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 21. Information has been received from a female consumer (age not
reported) with no reported medical history and an allergy to ampicillin who on
21Oct05 was vaccinated with a 0.5mL dose of pneumococcal 23v polysaccharide
vaccine (lot 651318/1006P). Concomitant therapy included losartan potassium
HCTZ. The pt reported that on 22Oct05 she developed two separate rashes on the
arm she received the injection and that same arm was sore. Subsequently, the pt
recovered three days after the injection, 24Oct05. There was.Paient has the
following illness history - Penicillin allergy.Patient was receiving Hyzaar.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a
pharmacist concerning a healthy 54 yr old female pt with a shellfish allergy who
on 24Oct05 was vaccinated IM in the left arm with a 0.5mL dose of pneumococcal
23v polysaccharide vaccine (lot unk). Concomitant therapy included a dose of
influenza virus vaccine, given about a week before. On approx 25Oct05, within 24
hrs of the vaccination, the pt experienced severe pain, developed red streaks
down the arm and cellulitis. She was treated first with clindamycin and then
wi.Paient has the following illness history - Shellfish allergy.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a
pharmacist and the step daughter of a 64 yr old male with asthma. On 25Oct05,
the pt was vaccinated with pneumococcal 23v polysaccharide vaccine
(lot649988/0692P). On an unspecified date, the pt developed redness and swelling
of the injection site arm. The pt was prescribed antibiotics. It was further
reporter that the pt developed significant swelling, redness and pain from the
top of his shoulder down past his elbow. The pt sought unspecified medical
attention. At the.Paient has the following illness history - Asthma.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 58 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 25. Initial and follow up information has
been received from a pharmacist and the daughter of a 58 yr old female with
asthma. On 25Oct05, the pt was vaccinated with pneumococcal 23v polysaccharide
vaccine (lot649988/0692P). In Oct 2005, the pt developed redness and swelling of
injection site arm. The pt was prescribed antibiotics. It was further reported
that the pt developed significant swelling, redness from the top of shoulder to
the middle of forearm and pain. The pt sought unspecified medical attention.
At.Paient has the following illness history - Asthma.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a
pharmacist and a friend concerning a 69 yr old female. On 25Oct05, the pt was
vaccinated with pneumococcal 23v polysaccharide vaccine (lot649988/0692P). In
Oct 2005, the pt developed redness and swelling of injection site arm. It was
further reported that the pt developed significant swelling, redness and pain
from the top of the shoulder down to the middle of the forearm. The pt sought
unspecified medical attention. At the time of this report, the outcome of the
events.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 73 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a
pharmacist and a fried concerning a 73 yr old male who on 25Oct05 was vaccinated
with pneumococcal 23v polysaccharide vaccine (lot 649988/0692P). In Oct 2005,
the pt developed redness and swelling of the injection site arm. It was further
reported that the pt developed significant swelling, redness and pain from top
of the shoulder down to his wrist. The pt sought unspecified medical attention.
At the time of this report, the outcome of the events were unk. Additional
in.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 26. Information has been received from a registered nurse
concerning a female (age not specified) who on approx 10/26/05, the past 48
hours was vaccinated with a 0.5 ml dose of Pneumococcal 23v polysaccharide
vaccine (lot 649981/0704P). On approx 10/26/05, the past 48 hours, the pt
developed significant injection site reaction, fever, chills, swelling and
redness from elbow to deltoid at injection site. it was also reported that
symptoms started within 12 to 24 hours of receiving the vaccine. The pt sought
unsp.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 25. Information has been received from a registered nurse
concerning a female age not specified who on approx 10/26/05, the past 48 hrs
was vaccinated with a 0.5 ml dose of Pneumococcal 23v polysaccharide vaccine
(lot 649981/0704P). On approx 10/26/05, the past 48 hrs, the pt developed
significant injection site reaction, fever, chills, swelling and redness from
elbow to deltoid at injection site. It was also reported that symptoms started
within 12 to 24 hours of receiving the vaccine. The pt sought unspecifie.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 24. Information has been received from a nurse concerning an 8 year
old female who on 10/24/05 was vaccinated with a dose of Pneumococcal 23v
polysaccharide vaccine. On 10/24/05, the pt was concomitantly vaccinated with a
dose of hepatitis A vaccine inactive. Subsequently, the pt developed injection
site redness, a rash, fever, and vomiting. unspecified medical attention was
sought. Subsequently, the pt recovered. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT
(PNEUMOVAX) on Oct 2005, 26. Information has been received from a physician's
assistant concerning a 55 year old female who on 10/26/05 was attending a clinic
and was vaccinated IM with a 0.5ml second dose of Pneumococcal 23v
polysaccharide vaccine. The pt reported that she had received the Pneumococcal
23v polysaccharide vaccine six years ago and was requesting another. The
reporter noted that she had heard from another health care professional that on
10/7/05 the pt developed a cellulitis like reaction. Unspecified medical
attention.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 52 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 31. Information has been received from a
healthcare worker concerning a 52-year-old female with a history of organ
transplant and no known drug reactions or allergies who on 31-OCT-2005 at 13:30
pm. was vaccinated intramuscular with a 0.5 ml first dose of pneumococcal 23v
polysaccharide vaccine (lot 650327/0792P). It was reported that the patient had
the flu on 26-OCT-2005, however, there was no illness at the time of
vaccination. On 01-NOV-2005, the patient developed swelling, stiffness, and a
rash on the up.Paient has the following illness history - medical history: organ
transplant concurrent conditions: flu.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse concerning an adult
patient with unknown medical history and unknown drug reactions or allergies,
who "over the last ten days" in October 2005, was vaccinated intramuscularly
with a 0.5 ml dose pneumococcal 23v polysaccharide vaccine (Lot# unknown).
Subsequently, in October 2005 the patient developed a local reaction at the
injection site including soreness, warmth, erythema and swelling. Unspecified
medical attention was sought. The patient was repor.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 24. Information has been received from a licensed practical nurse
concerning a pt over 40 yrs old who on approx 10/24/05 was vaccinated with a
dose of Pneumococcal 23v polysaccharide vaccine (lot 651523/0604R). ON approx
10/24/05, the pt experienced a more extreme reaction than usual which included
extreme soreness, redness, pain and swelling at the injection site and limb and
site tenderness. Unspecified medical attention was sought. Subsequently, the pt
recovered. It was noted that the pt did not have a react.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 31. Information has been received from a LPN concerning a physician in
the office who on approx 10/31/05 was vaccinated with a dose of Pneumococcal 23v
polysaccharide vaccine (lot 651523/0604R. On approx 10/31/05, the physician
experienced a more severe reaction than usual to the vaccine. The reaction
included pain and swelling at the injection site. Unspecified medical attention
was sought. Subsequently, the physician recovered. A investigation into the lot
number was requested. No product quality complaint wa.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 26. Information has been received from a healthcare worker concerning
a male pt who on 10/26/05 was vaccinated in the arm with a dose of Pneumococcal
23v polysaccharide vaccine (lot 650329/0747P). On approx 10/26/05 the pt
experienced numbness in arm, tightness in the chest, low grade fever, and hot
red spots on his body. As of 10/28/05 th pt was improving. Additional
information has been requested. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 26. Information has been received from a registered nurse
concerning a 79 year old female who on 10/26/05 was vaccinated with a second
dose of Pneumococcal 23v polysaccharide vaccine (lot 647661/0055R). She called
the following day to complain of pain, redness, and swelling at site of
injection. The nurse practitioner advised acetaminophen Tylenol for pain and ice
packs. She was advised to call the next day if not better. At the time of the
report, she had not called. The pt was considered to be recovering. It.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 28. Information has been received from a registered nurse
concerning a 69 year old female who on 28-OCT-2005 was vaccinated with a second
dose of pneumococcal 23v polysaccharide vaccine (lot 647661/0055R). On
31-OCT-2005 the patient called with entire arm sore, stiff, difficulty sleeping
on and moving the arm. Unspecified medical attention was sought. The patient was
considered to be recovering. It was also reported that two other patient's had
an adverse experience following vaccination with pneumococcal 2.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a certified medical assistant concerning a
female patient who was vaccinated intramuscularly in the right arm with a dose
of pneumococcal 23v polysaccharide vaccine (lot 631319/1007P). Subsequently she
developed a red, warm, swollen arm at the injection site. It was also reported
that she developed a "cellulitis type reaction" and fever. The patient sought
medical assistance and was recovering at the time of the report..Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a certified medical assistant (CMA)
concerning a male patient who was vaccinated intramuscularly in left arm with a
dose of pneumococcal 23v polysaccharide vaccine (lot 651319/1007P). Subsequently
the patient developed a red , blotchy arm and fever. The CMA also stated that he
developed a red, warm, swollen arm at injection site. The patient sought medical
attention and was recovering at the time of this report. Additional information
has been requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 30. Information has been received from a 75 year old female with no
allergies and unremarkable medical history who on 30-OCT-2005 was vaccinated
with pneumococcal 23v polysaccharide vaccine, in her left arm. Concomitant
medication included phenytoin (DILANTIN) and atorvastatin calcium (LIPITOR). On
30-OCT-2005 the patient experienced swelling of elbow, rash 3 inches below and 6
inches above elbow, redness, and warm to touch in area of injection. At the time
of the report she was still experiencing most of th.Patient was receiving
LIPITOR, DILANTIN. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 28. Information has been received from a 30 year old female patient
with asthma and" post partum" thyroiditis, who on 28-OCT-2005 was vaccinated
intramuscularly into the arm with a dose of pneumococcal 23v polysaccharide
vaccine (lot 650648/0967P). There was no concomitant medication. On 28-OCT-2005,
about five hours after vaccination, the patient experienced sleepiness. On
29-OCT-2005 the patient experienced soreness at injection site, queezy stomach,
chills, sweating, headache, muscle cramping and developi.Paient has the
following illness history - Concurrent conditions: asthma, thyroiditis.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 26. Information has been received from a nurse concerning a patient
with a history of pneumococcal 23v polysaccharide vaccination and unknown
allergies who on approximately 26-OCT-2005 ("within the last week") was
vaccinated with a second dose of pneumococcal 23v polysaccharide vaccine (lot
unknown). Subsequently, on an unknown date in 2005, the patient developed
redness and swelling at the injection site. The patient sought unspecified
medical attention. It was unknown if the patient recovered. There was n.Paient
has the following illness history - Medical History: Immunization.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 27. Information has been received from a health professional
concerning an adult female who on approximately 27-OCT-2005 was vaccinated in
the deltoid with an 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot
650302/1039P). Within an hour of vaccination, the patient called the physician
complaining of painful, red, swollen arm at the site of injection. The physician
prescribed diphenhydramine HCL (BENADRYL) and told her to call back if no
improvement. The patient called back the next day and report.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a health professional concerning an adult
male patient who was vaccinated with a dose of pneumococcal 23v polysaccharide
vaccine (lot 651329/1047P). Subsequently, the patient complained of redness,
warmth and soreness at the injection site. Unspecified medical attention was
sought. At the time of this report, the patient's outcome was unknown. No
product quality complaint was involved. Additional information is not
expected..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 24. Information has been received from a licensed nurse practitioner
concerning an adult female patient, with unknown medical history and unknown
drug reactions/allergies, who on 24-OCT-2005 was vaccinated in the left deltoid
intramuscularly with 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot
649979/0531P). The patient called the office the same day complaining of
vomiting, body aches, redness and heat in the deltoid about 10 centimeters in
diameter. She was seen in the office, given promethazine.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 03. Information has been received from a health professional
concerning a 50 year old female with a drug hypersensitivity to codeine, high
cholesterol, high blood pressure and diabetes who on 03-NOV-2005 was vaccinated
subcutaneously with 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot
650302/1039P). Concomitant therapy included "Meglazine" (NOS), valsartan
(DIOVAN), ezetimibe (+) simvastin, amlodipine besylate (NORVASC), calcium
(unspecified) and chondroitin sulfate sodium (+) dimethyl sufone (+).Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 01. Information has been received from a health professional
concerning a pt who, on 11/1/05, was vaccinated with a first IM dose in the
right deltoid of Pneumococcal 23v polysaccharide vaccine (lot 650457/0937P). It
was reported that the pt had a pretty significant allergic reaction and would be
coming into the physicians office the week of 11/7/05. Follow up information
from a woman working in a physicians office indicated that on 11/3/05 the pt
called reporting a a local reaction to Pneumococcal 23v polysacc.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 27. Information has been received from a consumer concerning his 74
year old wife, with no medical history and no allergies, who on 10/27/05 was
vaccianted once with a 0.5ml IM dose of Pneumococcal 23v polysaccharide vaccine.
Concomitant vaccine included a dose of Influenza virus vaccine unspecified. It
was reported that, on 10/27/05, the pt had an injection site reaction with a
large red mark, sensation of warmth, an inability to lift her arm for two days
post dose, and with a transient lump that had moved sli.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NM, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 01. Information has been received from a certified medical
assistant concerning an adult pt who on 6/30/04w as vaccinated with a dose of
Pneumococcal 23v polysaccharide vaccine. IN Oct 2005, the pt was inadvertently
vaccianted IM with an 0.5ml dose of Pneumococcal 23v polysaccharide vaccine. In
Oct 2005, the pt developed injection site reaction to include redness, swelling,
pain and warmth. Unspecified medical attention was sought. The pts outcome was
unknown. Additional information has been requested..Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 04. Information has been received from a physician concerning a 59
year old female with chronic obstructive pulmonary disease who on 11/4/05 was
vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot
650648/0967P). Subsequently, on 11/05/05, the pt experienced a severe local
reaction. The pt then experienced chills, a fever of 102 deg F, pain and redness
at the injection site, and presented to the ER on 11/6/05. the pt was released
and treated with antibiotic. On 11/7/05, it was noted that the s.Paient has the
following illness history - Chronic obstructive pulmonary disease..Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 01. Information has been received from a registered nurse concerning a
male who in Oct 2005, was vaccinated with Pneumococcal 23v polysaccharide
vaccine. Subsequently the pt developed a severe local site reaction described as
arm pain. Unspecified medical attention was sought. It was also reported that
other pts experienced an adverse event Following vaccination with Pneumococcal
23v polysaccharide vaccine WAES0510USA09350 WAES0511USA01104 and
WAES0511USA01106. Additional information has been requested..Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 22. Information has been received from a registered nurse concerning a
61 year old female who on 10/22/05 was vaccinated with Pneumococcal 23v
polysaccharide vaccine. Subsequently, the pt developed a severe local site
reaction described as sore arm, pain, chills and vision changes (she saw the
color red). Unspecified medical attention was sought. It was also reported that
other pts experienced an adverse event following vaccination with Pneumococcal
23v polysaccharide vaccine WAES0510USA09350, WAES0511USA01104.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a pt who was over 50
years old who was vaccinated with a first dose of Pneumococcal 23v
polysaccharide vaccine. Subsequently the pt experienced local swelling at the
injection site. No additional information was available. Additional information
had been requested.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 24. Information has been received from a
registered nurse concerning a 65 year old female, who on 10/24/05 at 11:30 was
vaccinated into the left deltoid with a first dose of Pneumococcal 23v
polysaccharide vaccine (lot 650302/1039P). There was no illness at the time of
vaccination. ON 10/24/05, the pt developed itching and half moon sized redness.
By the evening, the pt experienced pain at the site. On 10/25/05, the pts pain
was radiating into her left breast, and she complained of swelling and pain in
her enti. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 01. Information has been received from a health professional
concerning an adult female who on 11/1/05 was vaccinated in the deltoid with a
0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 650302/1039P). ON
11/1/05, post vaccination, the pt called the office complaining of arm soreness,
redness, swelling, and arm was warm to tough. The physician ordered
diphenhydramine HCL Benadryl and told the pt to call back. She subsequently
called back and said she was fine. At the time of this report, the pts
out.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a female pt who was
vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot
650648/0967P). Subsequently the pt experienced a severe local reaction. It was
noted that the physician did not feel comfortable using the remaining doses in
the vial and would like an investigation into Pneumococcal 23v polysaccharide
vaccine (lot 650648/0967P). The records of testing prior to release of this lot
have been checked and found to be satisfactory.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a male who was
vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine (lot
650648/0967P). Subsequently the pt experienced a severe local reaction. It was
noted that the physician did not feel comfortable using the remaining doses in
the vial and would like an investigation into Pneumococcal 23v polysaccharide
vaccine (lot 650648/0967P). The records of testing prior to release of this lot
have been checked and found to be satisfactory. The. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 83 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 20. Information has been received from a
licensed professional nurse concerning an 84 year old male who on 10/20/05 was
vaccinated IM in the deltoid with a 0.5ml dose of Pneumococcal 23v
polysaccharide vaccine (lot 649695/0512P). On approx 10/20/05 the Pt experienced
swelling, redness and pain of the injection site. The pt was treated in the ER
and was released. No diagnostic or laboratory studies were performed.
Subsequently, the LPN reported that the pt recovered. The LPN requested a check
of the lot number..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OK, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 01. Information has been received from a physician concerning an
adult female who in Nov 2005, was vaccinated with a dose of Pneumococcal 23v
polysaccharide vaccine. The physician reported that in Nov 2005, the pt
developed injection site swelling and redness that extended onto her chest. The
pt was seen in the ER, but was not admitted. In Nov 2005, the pts injection site
swelling and redness resolved. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT
(PNEUMOVAX) on Oct 2005, 12. Information has been received from a physician
concerning a male who on 10/12/05 was vaccinated with Pneumococcal 23v
polysaccharide vaccine (0.5ml), in the arm. Concomitant therapy that day
included influenza virus vaccine (unspecified), in the opposite arm. On 10/14/05
the pts arm was swollen (arm vaccinated with Pneumococcal 23v polysaccharide
vaccine). The physician did not think that the Pneumococcal 23v polysaccharide
vaccine caused the swelling. The pt was prescribed an antibiotic and swelling
was go.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician, via a company representative,
concerning a male pt age unknown, with unknown medical history and unknown drug
reactions/allergies, who on an unspecified date was vaccinated route unknown,
with a dose of Pneumococcal 23v polysaccharide vaccine (lot known). The
physician reported that the day after the injection the pt experienced a case of
breakthrough. The physician also reported that there has been about two other
cases that are nearly identical. Unspecified.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 07. Information has been received from a health professional
concerning a 46 year old female who on 11/7/05 was vaccinated with a dose of
Pneumococcal 23v polysaccharide vaccine (lot 650541/1004P). On 11/8/08 the pt
experienced a large knot at the area of the injection site. She also had pain in
her arm and trouble moving her arm. Unspecified medical attention was sought. No
product quality complaint was involved. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Sept 2005, 26. Information has been received from a physician concerning a 52
yr old female diabetic, who on 26Sep05 was vaccinated IM with a 0.5mL dose of
pneumococcal 23v polysaccharide vaccine. On 28Sep05 about two days post
vaccination, the pt experienced generalized arthralgia. Unspecified medical
attention was sought. The pt was placed on naproxen. No diagnostic lab studies
were performed. At the time of this report, the pt had not recovered. No product
quality complaint was involved. Generalized arthralgia was cons.Paient has the
following illness history - Diabetes.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 07. Information has been received from a physician concerning a
male pt who sometime this week was vaccinated with pneumococcal 23v
polysaccharide vaccine. Subsequently the pt developed swelling, redness and
cellulitis. It was not known if this was the first dose of vaccine. The
physician gave him cortisone injection and was doing fine now. The pt recovered.
Additional information has been requested..Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 01. Information has been received from a RN
concerning a 69 yr old female who in 1999 and on approx 01Nov05 was vaccinated
with a first and second dose (lot 649693/0496P) of pneumococcal 23v
polysaccharide vaccine (0.5ml) (IM), respectively. On 08Nov05 the pt experienced
significant swelling from her elbow to her shoulder. It was also reported that
the pt developed painful, swollen, red arm. The pt was reportedly recovering.
Additional information has been requested.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 24. Information has been received from a physician concerning an
adult pt who on 24Oct05 was vaccinated with an IM 0.5mL first dose pneumococcal
23v polysaccharide vaccine (lot 650302/1039P). On 25Oct05 the pt was diagnosed
with cellulitis. Unspecified medical attention was sought. There was no product
quality complaint involved. Additional information has been requested..Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 24. Information has been received from a physician concerning a
female who on 24Oct05 was vaccinated with IM with a 0.5mL second dose of
pneumococcal 23v polysaccharide vaccine (650302/1039P). It was reported that the
pt's first dose of pneumococcal 23 polysaccharide vaccine was administered 5-10
yrs ago. On 25Oct05 the pt was diagnosed with cellulitis in her arm. Unspecified
medical attention was sought. There was no product quality complaint involved.
Additional information has been requested..Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 24. Information has been received from a health professional
concerning an adult female who on 25Oct05 was vaccinated with a 0.5mL dose of
pneumococcal 23v polysaccharide vaccine (lot 649697/1038P). On 24Oct05 the pt
experienced a fever, swelling and arm pain at the injection site. She was seen
by the physician and was ordered acetaminophen (Tylenol). At the time of this
report, the pt was recovering from swelling and arm pain at the injection site
but her fever persisted. Additional information has been reques.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a nurse practitioner concerning an 80 yr old
female pt with a history of three previous vaccinations with pneumococcal 23v
polysaccharide vaccine, who in the last 10 days (approx Sep 2005) was vaccinated
with a fourth dose of pneumococcal 23v polysaccharide vaccine (lot
649914/0578P). It was reported that within one day of the vaccination (approx
Sep 2005), the pt developed an injection site reaction. Her arm was sore and
weak, and she also developed malaise, fatigue. Ther.Paient has the following
illness history - Immunization.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a nurse practitioner concerning a 59 yr old
male pt who in the last 10 days (approx Sep 2005) was vaccinated with a second
dose of pneumococcal 23v polysaccharide vaccine (lot 649914/0578P). It was
reported that within one day of the vaccination (approx Sep 2005), the pt
developed a severe injection site reaction. He also developed a cellulitis,
fever and chills. He was treated with an antibiotic. It was noted that the pt
did receive the pneumococcal 23v polysaccharide vac.Paient has the following
illness history - Immunization.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 27. Information has been received from a nurse practitioner concerning
an adult pt (age and gender not reported) with an unk medical history and unk
allergies who on 27Oct05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v
polysaccharide vaccine (lot651524/0605R). Subsequently, the pt developed an
injection site reaction which included swelling, redness, pain and local heat.
The pt was treated with antibiotics (unspecified). The pt was reported as
recovering. There was no product quality complaint involv.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 11. Information has been received from a physician concerning an
adult pt (gender and age not provided) who on 11Nov05 was vaccinated ID with
0.5mL dose of pneumococcal 23v polysaccharide vaccine (lot not provided). On
11Nov05 the pt developed an inflammatory reaction at the injection site. The pt
was reported as recovering. There was no product quality complaint involved.
Additional information has been requested.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 21. Information has been received from a physician via a company
rep concerning an 83 yr old male a history of previous vaccination with a first
dose of pneumococcal 23v polysaccharide vaccine who three weeks ago, on approx
21Oct05 was vaccinated with a dose of pneumococcal 23 polysaccharide vaccine
(lot not provided). Three weeks ago, on approx 21Oct05 the pt developed a local
injection site cellulitis reaction. The pt was treated with antibiotics for 10
days. In Nov 2005, the pt developed bronchitis. The pt w.Paient has the
following illness history - Immunization.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a licensed practical nurse concerning an
adult female who in August 2005, was vaccinated IM with 0.5mL dose of
pneumococcal 23v polysaccharide vaccine (lot 647661/0055R). In Aug 2005, the pt
developed injection site reactions to include pain, local warmth, redness and
swelling. The pt's were reported as recovered. There was no product quality
complaint involved. Additional information has been requested.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 33 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 18. Information has been received from a
licensed professional nurse (LPN) concerning a 33 yr old female who on 18Oct05
was vaccinated IM in the deltoid with a 0.5ml dose of pneumococcal 23v
polysaccharide vaccine (lot 7091P). Concomitant therapy included hormonal
contraceptives (unspecified). On approx 18Oct05 the pt experienced injection
site swelling, redness and pain. Unspecified medical attention was sought.
Subsequently, the pt recovered. The LPN requested a check of the lot number.
Additional information.Paient has the following illness history -
Contraception.Patient was receiving Hormonal contraceptives.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 76 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 18. Information has been received from a
licensed professional nurse (LPN) concerning a 76 yr old female who on 18Oct05
was vaccinated IM in the deltoid with a 0.5ml dose of pneumococcal 23v
polysaccharide vaccine (lot reported as 7091P). The LPN reported that the pt was
on multiple drugs concomitantly. On approx 18Oct05 the pt experienced injection
site swelling, redness and pain. Unspecified medical attention was sought, no
diagnostic or laboratory studies were performed. Subsequently, the pt recovered.
Addit.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a nurse practitioner concerning a pt (age and
gender not reported) with an unk medical history and unk allergies who on an
unspecified date was vaccinated with a 0.5mL dose of pneumococcal 23v
polysaccharide vaccine (lot unk). Subsequently, the pt developed cellulitis as a
result of the vaccination. It was reported that the pt recovered from cellulitis
on an unspecified date. The reporter felt that the pt's cellulitis was related
to therapy with pneumococcal 23v polysaccha. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient, 58 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 08. Initial and follow up information has
been received from licensed practical nurse (LPN) and a healthcare provider
concerning a 58 yr old white female pt, with hypertension, diabetes and
gastrooesophageal reflux disease and unk drug reactions/allergies, who on
08Nov05 was vaccinated IM in the left deltoid with a 0.5mL first dose of
pneumococcal 23v polysaccharide vaccine (lot651329/1047P). On 08Nov05, follow up
information from the healthcare provider indicated that the pt's left deltoid
area became red, swo.Paient has the following illness history - Diabetes;
hypertension; gastrooesophageal reflux disease..Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician a pt who in Oct/Nov05, who along
with 6 other pt's was vaccinated with pneumococcal 23v polysaccharide vaccine
(lot 650331/0749P and 649989/0579P). Some pt's were first time vaccinated while
others received a previous injection at least 5 yrs ago. Concomitantly they were
vaccinated in separate sites with a dose of influenza virus vaccine
(unspecified). Subsequently, the pt developed severe local reactions. The pt was
reported as recovered. The records of testin. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse concerning a female
patient (age and gender not provided) who on unspecified date was vaccinated
with a dose of pneumococcal 23v polysaccharide vaccine (lot # 650331/0749P).
Subsequently, the patient developed injection site reaction which was
uncomfortable and very painful. The patient required treatment with an
antibiotic PO (unspecified) and methylprednisolone. The patient was reported as
recovered. Injection site reaction was considered to be an othe. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 10. Information has been received from a licensed practical nurse
(LPN) concerning a 59 yr old female with no medical history and no known
allergies who on 10Nov05 was vaccinated IM with 0.5mL dose of pneumococcal 23v
polysaccharide vaccine (lot 651328/1046P). There was no concomitant medication.
Subsequently, the pt developed red, hot, painful and grapefruit size areas at
the injection site. On 14Nov05, the pt was seen in the office and was treated
with compresses. The pt was reported as not recovered. There w.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a medical assistant concerning a male pt
greater than 65 yrs of age who was vaccinated with the second dose of
pneumococcal 23v polysaccharide vaccine. It was reported that no other
vaccinations were given with the pneumococcal 23v polysaccharide vaccine. The pt
was reported as generally healthy with no major health problems. Subsequently,
the pt developed injection site cellulitis which lasted at the most for 3 days.
The pt recovered from the injection site cellulitis. No. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a RN concerning a male (age not provided) who
in early Oct 2005 was vaccinated with a dose of pneumococcal 23v polysaccharide
vaccine (lot 650331/0749P). Subsequently, the pt developed injection site
reaction. The pt was reported as recovered. There was no product quality
complaint involved. The registered nurse also provided information regarding
another pt's experiences with pneumococcal 23v polysaccharide vaccine
(WAES0511USA02165, 0511USA03746). Additional information. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 10. Information has been received from a 71 yr old female with high
cholesterol who on 10Nov05 was vaccinated IM in the right deltoid with a 0.5mL
dose of pneumococcal 23v polysaccharide vaccine (lot 651318/1006P). Concomitant
therapy included simvastatin, latanoprost (Xalatan), antihistamine,
acetaminophen/oxycodone hydrochloride (Percocet) and naproxen. On 10Nov05 the pt
experienced transient pain on the medial aspect of the injection arm from arm
pit to elbow with erythema, warmth, nausea, and difficulty sle.Paient has the
following illness history - Cholesterol high.Patient was receiving Percocet;
cough,cold and flu therapies; Xalatan; naproxen; Zocor.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 15. Information has been received from a registered nurse concerning a
51 year old sister who on approx 10/15/05 was vaccinated with a dose of
Pneumococcal 23v polysaccharide vaccine. The RN reported that on approximately
10/15/05, immediately after being vaccinated, her sister developed edema like a
softball and redness at the injection site. Unspecified medical attention was
sought. At the time of this report, the pts edema and redness at the injection
site persisted. The follow up it was reported that the re.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Mar 2005, 01. Information has been received from a pharmacist concerning a
female pt who in March 2005, was vaccinated with a dose of Pneumococcal 23v
polysaccharide vaccine. IN March 2005, the pt experienced redness, swelling and
tenderness from the elbow to the shoulder. Unspecified medical attention was
sought. It was noted that the pharmacist was unsure of how long the pts symptoms
lasted. Subsequently, the pt recovered. No product quality complaint was
involved. Additional information has been requested..Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from SD, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician, via a company representative,
concerning a female patient in her mid 60's with diabetes who was on an
unspecified date was vaccinated intramuscularly with a 0.5 ml dose of
pneumococcal 23v polysaccharide vaccine (lot unknown). The patient could not
remember getting a previous vaccination. However, after the vaccination, the
office personnel discovered that the patient had received it 3 months earlier.
Concomitantly she was on several medications ( therapy un.Paient has the
following illness history - MEDICAL HISTORY: Immunization, CONCURRENT
CONDITIONS: diabetes. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 01. Information has been received from a physician concerning a pt
who in Nov 05 was vaccinated with a dose of Pneumococcal 23v polysaccharide
vaccine. In Nov 2005, the pt developed localized reaction in the vaccinated arm.
The arm was red and swollen. The pt recovered. The pt has a previous dose of
Pneumococcal 23v polysaccharide vaccine in 2004. There was no product quality
complaint involved. Additional information has been requested.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, child 8 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a
registered nurse concerning an 8 year old female with sickle cell disease who on
11/7/05 was vaccinated IM with a dose of Pneumococcal 23v polysaccharide vaccine
(lot 647635/0864N). It was reported that the vaccine had expired in June of
2005. Following the vaccination (on an unspecified date) the pt developed a
severe local site reaction of redness and swelling. The child was taken to see a
physician and was treated with oral diphenhydramine hydrochloride Benadryl.
The.Paient has the following illness history - Sickle cell disease..Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from , USA. Female patient, 90 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 31. Information has been received from a
medical assistant concerning a 90 year old female who on approx 10/31/05 was
vaccinated IM with 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot
650084/0605P). The pt was also vaccinated separately with influenza virus
vaccine unspecified. Concomitant therapy included metoprolol succinate Toprol XL
tablets, aspirin and prednisone. On 10/31/05, the pt developed cellulitis. The
pt was treated with antibiotics. The pt was reported as not recovered.
Additional info.Patient was receiving Aspirin, Toprol XL tablets, Prednisone..
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 31. Information has been received from a
physician concerning a 64 year old retired female with hypertension, arthritis
and mild scoliosis who on 10/31/05 at 1:45pm was vaccinated IM in left arm with
a second dose (first dose was 20 years ago) of Pneumococcal 23v polysaccharide
vaccine (lot 650327/0792P). Concomitant therapy included estrogens, conjugated (Premarin),
ramipril (Altace), and acetaminophen + propoxyphene napsylate (Darvocet N). On
11/1/05 at 8:00 am, the pt developed severe swelling of left upper.Paient has
the following illness history - Immunisation, Hypertension, Arthritis,
Scoliosis.Patient was receiving Darvocet N, Premarin, Altace.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 62 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 08. Information has been received from a
health professional concerning a 62 yr old white female pt with right leg
cellulitis who on 08Nov05 was vaccinated IM in the right deltoid with a second
dose of pneumococcal 23v polysaccharide vaccine (lot 651328/1046P). Concomitant
therapy included esomeprazole magnesium (Nexium), citalopram hydrobromide (Celexa),
alprazolam, furosemide (Lasix), albuterol, and amoxicillin/clavulanate potassium
(Augmentin). On 08Nov05 the pt developed 7 cm erythema, heat, and pain at
inj.Paient has the following illness history - Cellulitis of leg.Patient was
receiving Albuterol, alprazolam; Augmentin; Celexa, Nexium, Lasix (Furosemide)..
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 73 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 27. Information has been received from a
physician concerning a 72 yr old retired male pt with an allergy to lidocaine
who on 27Sep05 was vaccinated in the left upper arm with a first dose of
pneumococcal 23v polysaccharide vaccine (lot650454/0751P). On approx 27Sep05 the
pt developed left upper extremity with cellulitic type reaction ie swelling. He
was afebrile. The pt's outcome was unk. No further information is available..
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from SD, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician, via a company representative,
concerning a 42 year old male, with type I diabetes mellitus, blood pressure and
cholesterol, who on an unspecified date was vaccinated intramuscularly with a
0.5 ml dose of pneumococcal 23v polysaccharide vaccine (Lot# unknown).
Concomitant therapy included blood pressure (therapy unspecified) and
cholesterol (therapy unspecified) medications, and insulin. Subsequently, the
day after the vaccinations and for the whole week, on a.Paient has the following
illness history - concurrent conditions: type I diabetes mellitus, blood
pressure, cholesterol. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KS, USA. Female patient, 63 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 14. Information has been received from a
nurse concerning a 63 year old Caucasian male with no medical history who on
14-NOV-2005 at 3:30 pm was vaccinated with a first dose of pneumococcal 23v
polysaccharide vaccine (lot#650330/0748P), in the left deltoid intramuscularly.
There were no illness at the time of vaccination. On 15-NOV-2005 the patient
developed severe left arm pain and difficulty lifting arm. The patient came in
on 15-NOV-2005 for follow up visit. The patient's doctor diagnosed it as a
localiz.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 73 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 16. Information has been received from a
certified medical assistant concerning a 73 yr old female pt with hypertension,
hypothyroidism and high cholesterol, no known allergies, and a history of
immunization, who on 16Nov05 was vaccinated (route unk) with a second dose
(0.5mL) of pneumococcal 23v polysaccharide vaccine (Lot649914/0578P).
Concomitant therapy included levothyroxine Na (Synthroid), glucosamine,
ibuprofen, lansoprazole (Prevacid), potassium (unspecified) and
hydrochlorothiazide (manf not reported)..Paient has the following illness
history - Immunization; hypertension; hypothyroidism, cholesterol high. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 30 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 15. Information has been received from a 30
year old female with a penicillin allergy who on 15-NOV-2005 was vaccinated
"subdermally" with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine
(Lot# unknown). Concomitant therapy included hormonal contraceptives
(unspecified). ON 15-NOV-2005 the patient administered the pneumococcal 23v
polysaccharide vaccine in error. She was "supposed to receive a TB test". On
15-NOV-2005, a few after vaccination, she "developed a severe skin irritation,
swelling, pain.Paient has the following illness history - concurrent conditions:
penicillin allergy.Patient was receiving hormonal contraceptives.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a health professional concerning a female
patient who was vaccinated with a dose of pneumococcal 23v polysaccharide
vaccine. Subsequently the patient experienced pain and swelling with erythema on
the injection arm which listed for a couple of days. Medical attention was not
sought. There was no product quality complaint involved. The patient recovered.
No further information is expected.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a pharmacist concerning a patient who was
vaccinated intramuscularly in the deltoid with a "standard" 0.5 ml dose of
pneumococcal 23v polysaccharide vaccine 9lot 647661/0055R or 650083/0746P).
Subsequently patient the patient developed arm swelling. Unspecified medical
attention was sought. The patient's outcome was unknown. There was no product
quality complaint involved. Additional information has been requested..Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a certified medical assistant concerning a
patient who on an unspecified date was vaccinated with a dose of pneumococcal
23v polysaccharide vaccine (lot#649914/0578P). Subsequently, the patient
developed a reaction at the injection site with redness with discoloration,
swelling, hardness, and pain. The patient's outcome was not reported. No product
quality was involved. Additional information has been requested.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient, 79 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 26. Information has been received from a
registered nurse concerning a 79 year old white female (148 pounds) with a
history of previous immunization with pneumococcal 23v polysaccharide vaccine
(1998) who on 26-OCT-2005 was vaccinated intramuscularly, into deltoid muscle,
with a dose of pneumococcal 23v polysaccharide vaccine (lot#647661/0055R). On
27-OCT-2005 the patient developed redness at the injection site and experienced
severe pain which lasted for 5 days. On approximately 01-DEC-2005, the patient
reco.Paient has the following illness history - medical history: immunization.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 28. Information has been received from a
registered nurse concerning a 69 year old white female (169 pounds 61") who on
28-OCT-2005, at 10:00 am was vaccinated intramuscularly, into deltoid muscle
with a second dose os pneumococcal 23v polysaccharide vaccine
(lot#647661/0055R). On 28-OCT-2005 the patient's entire arm was sore and she had
difficulty sleeping related to arm pain. It was noted that there was no redness
or edema, only pain. On 01-NOV-2005, the patient recovered. Additional
information is not e. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from WI, USA. Female patient, 71 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a
health professional concerning a 71 year old, white, male reported weight was
158 pounds (lb) and whose reported height was 5"9", who on 25-OCT-2005 at 10:30
am in the doctor's office was vaccinated intramuscularly in the right (Rt)
deltoid muscle with pneumococcal 23v polysaccharide vaccine (lot#647661/0055R).
It was reported that the patient had not received any prior doses of
pneumococcal 23v polysaccharide vaccine. On 26-OCT-2005. It was reported the
patient exper. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 61 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 17. Information has been received a 61 year
old female nurse with diabetes mellitus non insulin dependent who on an unknown
date in approximately 1999 received her first dose of pneumococcal 23v
polysaccharide vaccine and on 17-NOV-2005 was vaccinated with a second dose of
pneumococcal 23v polysaccharide vaccine (Lot#651322/1044P). Concomitant therapy
included metformin HCl (GLUCOPHAGE), hydrochlothiazide (+) telmisartan (MICARDIS
HCT), estrogens, conjugated (PREMARIN) and atorvastatin calcium (LIPITOR). On
1.Paient has the following illness history - concurrent conditions: diabetes
mellitus non-insulin dependent.Patient was receiving LIPITOR, PREMARIN, MICARDIS
HCT, GLUCOPHAGE.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 58 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 18. Edema peripheral; injection site
erythema; injections site discoloration; injection site warmth; local reaction;
malaise; erythema Information has been received from a a medical assistant and a
58 year old female consumer with a history of "some times medications have the
reverse of their intended effect" and allergies to penicillin and indomethacin
sodium (Indocin) who on 18-NOV-2005 at approximately 12:00 PM was vaccinated
with a dose of pneumococcal 23v polysaccharide vaccine (lot #650648/0967P).
There w.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 90 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 10. Information has been received from a
certified medical assistant concerning a 90 year old female patient with
osteoarthritis, osteopenia, gastroesophageal reflux disease, psoriasis, and no
known allergies, who on 10-NOV-2005 was vaccinated (route unknown) with a 0.5 ml
first dose of pneumococcal 23v polysaccharide vaccine. Concomitant therapy
included calcium (unspecified), vitamins (unspecified) and propranolol HCL
(Inderal). On 10-NOV-2005, the patient had a reaction at the injection site
which included.Paient has the following illness history - CONCURRENT CONDITIONS:
Osteoarthritis, Osteopenia, Gastroesophageal reflux disease, Psoriasis.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Injection site reaction. Information has been received from a registered nurse
concerning a female patient (age not provided) who on unspecified date was
vaccinated with a dose of pneumococcal 23v polysaccharide vaccine
(lot#650331/0749P). Five days after vaccination the patient developed injection
site reaction. The patient was reported as recovered. Additional information has
been requested.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 18. Injection site swelling; injection site erythema; injection site
warmth Information has been received from a registered nurse concerning a 78
year old male with no medical history who on 18-NOV-2005 was vaccinated with a
first dose of pneumococcal 23v polysaccharide vaccine (lot 650083/0746P). There
was no concomitant medication. Subsequently in November 2005, the patient
experienced severely swollen, red and warm injection site. No diagnostic
laboratory tests were performed. Additional information has been.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 78 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 18. Injection site swelling; injection site
erythema; injection site warmth Information has been received from a registered
nurse concerning a 78 year old female who in 1998 was vaccinated with her first
dose of pneumococcal 23v polysaccharide vaccine. On 16-NOV-2005 the patient
received an influenza virus vaccine (unspecified) in the right arm. On
18-NOV-2005 the patient received a booster dose of pneumococcal 23v
polysaccharide vaccine (651329/1047P) 0.5 milliliters one time in the left
deltoid IM. Concomitan.Patient was receiving Fosamax Zetia Zocor.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CT, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 14. Blood pressure decreased; erythema; feeling hot; injection site
erythema; injection site swelling; edema peripheral Information has been
received from a physician concerning an 81 year old female with hypertension who
on 14-NOV-2005 was vaccinated with a second dose of pneumococcal 23v
polysaccharide vaccine (650329/0747P). Concomitant therapy included "high blood
pressure pills". The physician reported that on 15-NOV-2005 the patient
developed a red swollen underside of the arm where the injection was give.Paient
has the following illness history - hypertension cholesterol levels
raised.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from GA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 19. Injection site urticaria; burning sensation; injection site
urticaria; injection site reaction Initial and follow-up information has been
received from a 61 year old female patient, with no known pertinent medial
history or drug reactions/allergies reported who on 19-OCT-2005 was vaccinated
intramuscularly with a dose of pneumococcal 23v polysaccharide vaccine (lot #
unknown). Concomitant therapy included loratadine (Claritin) and diphenhydramine
HCL (Benadryl). On approximately 21-OCT-2005 the patient expe.Patient was
receiving Claritin Benadryl. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CT, USA. Female patient, 67 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 28. Injection site pain; injection site
erythema Information has been received from a registered nurse concerning a 67
year old female patient with a history of immunization in 2000 and unknown drug
reactions/allergies reported who one 28-OCT-2005 was vaccinated intramuscularly
in the left deltoid with a 0.5ml booster dose pneumococcal 23v polysaccharide
vaccine (lot #649914/0578P). Concomitant therapy included metoprolol succinate
(Toprol XL tablets) raloxifen hydrochloride (Evista) and vitamins
unspecified..Paient has the following illness history - Immunisation. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from VA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Local reaction Information has been received from a registered nurse concerning
a 44 year old female with hypothyroidism and type 2 diabetes mellitus and a
history of obesity who in November 2005 was vaccinated subcutaneously with a
0.5ml dose of pneumococcal 23v polysaccharide vaccine (lot #649697/1038P). In
November 2005, the patient developed a local reaction after receiving her first
dose of pneumococcal 23v polysaccharide vaccine. The patient sought unspecified
medical attention. At the time of the rep.Paient has the following illness
history - Obesity hypothyroidism Type II diabetes mellitus.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from SC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician and a healthcare worker
concerning a patient who was vaccinated subcutaneously with a 0.5ml dose of
pneumococcal 23v polysaccharide vaccine. Subsequently the patient developed
"swelling and heated skin in the area of the injection." It was reported that
the patient sought unspecified medical attention and was not hospitalized. At
the time of the report is was unknown if the patient recovered. Additional
information has been requested..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, 62 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 14. Cellulitis Information has been received
from a registered nurse concerning a 62 year old white male teacher with no know
drug allergies, who on 14-NOV-2005 at 10:00 was vaccinated IM into the right
deltoid with a first 0.5ml dose of pneumococcal 23v polysaccharide vaccine (Lot
#651318/1006P). On 14-NOV-2005, the patient experienced a swollen right arm and
"flu symptoms." On 15-NOV-2005 the patient went to the emergency room. His arm
was red and edematous from the deltoid to the forearm area was warm and
pa.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 85 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 01. Information has been received from a
registered nurse concerning an 85-year-old female with Alzheimer's disease who
on 01-NOV-2005 was vaccinated intramuscularly in the left deltoid with a 0.5 ml
second dose of pneumococcal 23v polysaccharide vaccine (lot#651318/1006P).
Concomitant vaccination on 03-NOV-2005 in the right arm included a dose of
influenza virus vaccine (unspecified). It was noted that the patient received a
first dose of pneumococcal 23v polysaccharide vaccine five years prior. On an
unspe.Paient has the following illness history - concurrent conditions:
Alzheimer's disease.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NE, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 11. Information has been received from a health professional
concerning a 60 year old female, with no medical history, who on 11-NOV-2005 was
vaccinated with a 0.5 ml intramuscular dose in the right arm of pneumococcal 23v
polysaccharide vaccine (Lot#650082/0691P). Concomitant therapy on the same day
included an intramuscular dose in the left arm of methotrexate. It was reported
that the patient was seen by a physician on 18-NOV-2005 complaining of a little
swelling where she received her vaccine. The patien.Patient was receiving
methotrexate.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 85 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 01. Information has been received from a
Physician's Assistant (PA) concerning a female patient with a known phenol
allergy who in November 2005, was vaccinated with a dose of pneumococcal 23v
polysaccharide vaccine. In November 2005, the patient developed an injection
site reaction because of the phenol allergy. The phenol allergy was known before
the injection was given. Medical attention was sought. The patient's outcome was
unknown. Follow up information has been received from the PA concerning the
85.Paient has the following illness history - Medical history: dysuria,
concussion with no loss of consciousness, hematuria, skin abrasion Concurrent
conditions: hypersensitivity, hyponatremia, osteoporosis, pelvic pain, urinary
tract infection, knee pain, hypothyroidism, hypertension.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 80 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Aug 2005, 22. Information has been received from a
health professional concerning an 80 year old white female with penicillin
allergy and no illness at the time of vaccination who at 2:00 pm on 22-AUG-2005
was vaccinated intramuscularly with a second dose of pneumococcal 23v
polysaccharide vaccine (lot 649912/0529P). On 22-AUG-2005, the patient called
the office with complaint of a red arm, swollen, painful arm. The patient was
unable to use affected arm for 2 days due to the pain. The patient was
instructed to use co.Paient has the following illness history - Concurrent
conditions: Penicillin allergy. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT
(PNEUMOVAX). Information has been received from an approx 60 to 65 yr old
physician who on an unspecified date was vaccinated IM with a 0.5mL second dose
of pneumococcal 23v polysaccharide vaccine. Subsequently, the physician
developed a local reaction and flu like symptoms. The physician sought
unspecified medical attention, and subsequently recovered. Additional
information has been requested..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 72 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Aug 2005, 30. Information has been received from a
health professional concerning a 72 yr old white female, with allergy to
amoxicillin (diarrhea) and a history of immunization in 1999, who on 30Aug05 was
vaccinated at 11:00AM IM in the left deltoid with a second dose of pneumococcal
23v polysaccharide vaccine (lot 649912/0529P). On 30Aug05 4:00PM, the pt called
the doctor's office and stated that she had welt at site, arm is painful from
hand to shoulder, generalized weakness, and no nausea. Subsequently, on an
unspecif.Paient has the following illness history - Immunization; diarrhea;
penicillin allergy.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 14. Information has been received from a female in her twenties or
thirties who on 14Nov05 was vaccinated IM with a 0.5mL dose of pneumococcal 23v
polysaccharide vaccine. On an unspecified date, the pt had a reaction at the
injection site. The area was raised, red, and painful. Subsequently, on an
unspecified date, the pt recovered. Unspecified medical attention was sought. A
product quality complaint was not involved. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a licensed practical nurse concerning an
adult pt, with unk medical history and unk drug reactions/allergies, who in
early Nov 2005, was vaccinated IM with a 0.5mL dose of pneumococcal 23v
polysaccharide vaccine (lot 649694/0386P). In Nov 2005, the pt developed an
injection site reaction to include redness, pain, local heat and swelling. The
pt was treated with antibiotics and subsequently, fully recovered. No product
quality complaint was involved. No additional informati.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 07. Information has been received from a licensed practical nurse (LPN)
concerning a 55 yr old male with diabetes and no known allergies who on approx
07Nov05 was vaccinated IM with 0.5mL dose of pneumococcal 23v polysaccharide
vaccine (lot651328/1046P). Concomitant therapy included diabetic medication
(therapy unspecified). Subsequently, the pt developed red, hot, painful and
grapefruit size areas at the injection site. Medical attention was sought. The
pt was treated with compresses. The pt was reported as no.Paient has the
following illness history - Diabetes.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from FL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning an adult female who on
an unspecified date was vaccinated with the first 0.5mL dose of pneumococcal 23v
polysaccharide vaccine. On approx 14Nov05, week of 14Nov05, the pt developed
injection site redness, swelling and fever. The pt sought unspecified medical
attention. At the time of this report, the pt had recovered from the events
(date unk). Additional information has been requested..Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 30. Information has been received from a RN concerning a 78 yr old
female who on 30Nov05 was vaccinated with a second dose of pneumococcal 23v
polysaccharide vaccine (lot 650648/0967P), IM in the deltoid. On 30Nov05 the pt
had a local reaction described as redness, pain and swelling. At the time of the
report, the pt was considered to be not recovered. Unspecified medical attention
was sought. The reporter would like a lot investigation for lot 650648/0967P).
The records of testing prior to release of this lot.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 29. Information has been received from a RN concerning a 65 yr old
male with diabetes, heart disease and reaction to tuberculin test who on 29Nov05
was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (0.5ml)
(lot650648/0957P), IM in the deltoid. On 30Nov05 the pt experienced a severe
local reaction with redness, severe pain and massive swelling from the elbow to
shoulder in arm where pneumococcal 23v polysaccharide vaccine was given. At the
time of the report, the pt was considered to be not r.Paient has the following
illness history - Diabetes; cardiac disorder; nonspecific reaction to tuberculin
test..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered respiratory therapist concerning
a patient who was vaccinated with a dose of pneumococcal 23v polysaccharide
vaccine. Subsequently the patient experienced an adverse event. The patient's
outcome was unknown. Additional information has been requested.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient, 78 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 07. Information has been received from a
healthcare professional concerning a 78-year-old retires white female patient
with no known drug allergies, who on 07-NOV-2005 at 14;00 was vaccinated in the
left deltoid with a second dose of pneumococcal 23v polysaccharide vaccine
(Lot#650648-0967P). She was not ill at the time of vaccination. The patient
called the physician's office the day after vaccination, on 08-NOV-2005 and
reported that on 07-NOV-2005 at approximately 15:00 her left arm was red,
swollen and ve.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 01. Information has been received from a registered nurse a female
patient who on approximately 01-NOV-2005 (three weeks ago) was vaccinated with a
dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the patient
experienced an injection site reaction. The patient's outcome was unknown.
Additional information has been requested..Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Dec 2004, 01. Information has been received from a registered nurse concerning a
female patient who on 01-DEC-2004 was vaccinated with a dose if pneumococcal 23v
polysaccharide vaccine. Subsequently, the patient experienced an injection site
reaction. The patient's outcome was unknown. Additional has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 03. Information has been received from a health professional
concerning a physician who on approximately 03-NOV-2005 'within the last two
weeks" was vaccinated intramuscularly with a 0.5 ml dose of pneumococcal 23v
polysaccharide vaccine (lot#649914/0578P). Within the last two weeks, the
physician developed nausea, vomiting and diarrhea. Unspecified medical attention
was sought. Subsequently, the patient recovered. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 78 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 26. Initial and follow up information has
been received from a licensed visiting nurse concerning a 78 year old retired
white female with a general symptom, "Wygesic". On 26-SEP-2005, at 10:30 am, the
patient was vaccinated intramuscularly into the right deltoid with the first
dose of pneumococcal 23v polysaccharide vaccine (Lot#649979/0531P). On
26-SEP-2005, the patient developed injection site reaction. The patient was
treated with a topical cream. On 26-SEP-2005, at 7:00 pm, the patient developed
itching,.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a medical assistant concerning a female
patient greater than 65 years of age who was vaccinated with the second dose of
pneumococcal 23v polysaccharide vaccine. It was reported that no other
vaccinations were given with the pneumococcal 23v polysaccharide vaccine. The
patient was reported as generally healthy with "no major health problems".
Subsequently, the patient developed injection site cellulitis which lasted at
the most for 3 days. The patient recovered from the. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a medical assistant concerning a female
patient greater than 65 years of age who was vaccinated with the second dose of
pneumococcal 23v polysaccharide vaccine. It was reported that no other
vaccinations were given with the pneumococcal 23v polysaccharide vaccine. It was
reported as generally healthy with "no major health problems". Subsequently, the
patient experienced injection site cellulitis which lasted at the most for 3
days. The patient recovered from the inject. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a medical assistant concerning a female
patient greater than 65 years of age who was vaccinated with the second dose of
pneumococcal 23v polysaccharide vaccine. It was reported that no other
vaccinations were given with the pneumococcal 23v polysaccharide vaccine. The
patient was reported as generally healthy with "no major health problems".
Subsequently, the patient experienced injection site cellulitis which lasted at
the most for 3 days. The patient recovered from t. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a medical assistant concerning a female
patient greater than 65 years of age who was vaccinated with the second dose of
pneumococcal 23v polysaccharide vaccine. It was reported that no other
vaccinations were given with the pneumococcal 23v polysaccharide vaccine. The
patient was reported as generally healthy with "no major health problems".
Subsequently, the patient experienced injection site cellulitis which lasted at
the most for 3 days. The patient recovered from t. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician and a licensed practical nurse
concerning a patient who was vaccinated with a dose of pneumococcal 23v
polysaccharide vaccine. Subsequently the patient developed cellulitis.
Unspecified medical attention was sought. After several days, the patient
recovered. No product quality complaint was involved. Additional information has
been requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MA, USA. Female patient, 64 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 06. Information has been received from a
nurse practitioner concerning a 64 year old male with a bupropion hydrochloride
(WELLBUTRIN) allergy, who on 06-DEC-2005 was vaccinated subcutaneously into the
left arm with a 0.5 ml first dose of pneumococcal 23v polysaccharide vaccine
(lot#649697/1038P). Within hours, the patient experienced an injection site
reaction to include pain, redness, swelling and local heat all the way to the
elbow. It was noted that to was hard for the patient to move his arm due to the
pa.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, 71 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a
physician concerning a 71 year old male patient who on 25-OCT-2005 was
vaccinated into right deltoid muscle with a dose of pneumococcal 23v
polysaccharide vaccine (lot#650331/0749P). Concomitantly the patient was
vaccinated into left deltoid muscle with a dose of influenza virus vaccine
(unspecified). On 26-OCT-2005, the patient developed severe upper arm swelling,
erythema and edema. The patient was reported as recovered. There was no product
quality complaint invol. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from RI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician and a medical assistant
concerning a patient who was vaccinated with a dose of pneumococcal 23v
polysaccharide vaccine. Subsequently the patient developed erythema, swelling,
and pain of the upper forearm. Unspecified medical attention was sought.
Subsequently the patient recovered. No product quality was involved. Additional
information has been requested..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient, 75 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 30. Information has been received from a
physician concerning a 75 year old male with hypertension, hypothyroidism, high
cholesterol, no known allergies and a history of atrial fibrillation, who on
30-NOV-2005 was vaccinated intramuscularly into the right arm with a second 0.5
ml dose of pneumococcal 23v polysaccharide vaccine (lot#651329/1047P). The
patient's list of concomitant medications was not available. On 02-DEC-2005 the
patient experienced rash at the injection site and on the legs and trunk. The
do.Paient has the following illness history - Medical history: Atrial
fibrillation, Concurrent conditions: hypertension, hypothyroidism, cholesterol
high.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 10. Information has been received from a health professional
concerning a male in his mid 60's who on approximately 10-NOV-2005 was
vaccinated in the deltoid with a first dose of pneumococcal 23v polysaccharide
vaccine (lot651329/1047P). Subsequently, the patient developed fever, and
erythema and edema at injection site. Subsequently, the patient recovered. No
further information is available.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 10. Information has been received from a health professional
concerning a female in her mid 60's who on approximately 10-NOV-2005 was
vaccinated in the deltoid with a first dose of pneumococcal 23v polysaccharide
vaccine (lot 651329/1047P). Subsequently, the patient experienced fever,
erythema and edema at injection site. Subsequently, the patient recovered. No
further information is available.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 10. Information has been received from a health professional
concerning a female in mid 60's who on approximately 10-NOV-2005 was vaccinated
in the deltoid with a first dose of pneumococcal 23v polysaccharide vaccine (lot
651329/1047P). Subsequently, the patient experienced fever, and erythema and
edema at injection site. Subsequently, the patient recovered. No further
information is available.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 10. Information has been received from health professional
concerning a female in her mid 60's who on approximately 10-NOV-2005 was
vaccinated in the deltoid with a first dose of pneumococcal 23v polysaccharide
vaccine (lot 651329/1047P). Subsequently, the patient experienced fever, and
erythema and edema at injection site. Subsequently, the patient recovered. No
further information is available.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on July 2006, 18. Pt come into health center 2 days after
Pneumonia injection, c/o tenderness and redness right arm, evaluated by MD
7/20/06 who described erythema, swelling at distal aspect right upper arm with
tenderness, erythema right axilla, MD no adenopathy. MD prescribed Medrol dose
pack. Benadryl 25 mg TID x 7 days. cold compresses to right upper arm, Advil
PRN, will be follow up in one week.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 63 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 09. Information has been received from a
female nurse who on 09-NOV-2005 was vaccinated with pneumococcal 23v
polysaccharide vaccine (lot 650083/0746P). The patient reported that on
09-NOV-2005 approximately four hours post injection she experienced injection
site pain, itching, local swelling, and the site feeling "firm and felt thick".
She reported that on a later unspecified date she developed a rash and open
sores at the injection site. At the time of this report the patient was
recovering from the event. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Dec 2005, 08. Information has been received from a medical assistant
concerning a female (age not reported) who on 12/8/05 was vaccinated with
Pneumococcal 23v polysaccharide vaccine (lot 650329/0747P). That same day the pt
experienced a sore arm. At the time of this report it was unknown if the pt had
recovered from the sore arm. Additional information has been requested.. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT
(PNEUMOVAX) on Dec 2005, 05. Information has been received from a NP concerning
a 35 year old female who one week ago (on approx 12/5/05) was vaccinated IM with
0.5 ml dose of Pneumococcal 23v polysaccharide vaccine. On approx 12/5/05 the pt
experienced severe cellulitis. The NP reported that the pt is presently
recovering. No product quality complaint was involved. Additional information is
not expected..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MO, USA. Female patient, 40 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 05. Information has been received from a
licensed practical nurse concerning a 40 year old female with multiple sclerosis
who on 12/5/05 at 11:45am was vaccinated, IM into the left deltoid with a first
dose of Pneumococcal 23v polysaccharide vaccine (lot 650649/0790P). Concomitant
therapy included interferon beta la Avonex. On 12/5/05 at 6:00pm, the pt
developed a sore swollen left arm and a fever body temp of 100. The pt was
treated with acetaminophen and codeine phosphate Tylenol with codeine 3. At the
time o.Paient has the following illness history - Multiple sclerosis.Patient was
receiving Avonex. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a female pt with a
history of hospitalization, who was vaccinated with a dose of Pneumococcal 23v
polysaccharide vaccine. It was noted that the pt went home from the hospital,
three weeks later when she was seen in the clinic she was vaccinated again IM
with another 0.5ml dose of Pneumococcal 23v polysaccharide vaccine. Recently
after the second vaccination, the pt experienced a skin reaction. Unspecified
medical attention was sought. The pts outcome.Paient has the following illness
history - Hospitalization.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a health professional concerning a pt who was
vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine. Subsequently,
the pt developed hugh large welts at the injection site. No medical attention
was sought. The pts outcome was unknown. No product quality complaint was
involved. Additional information has been requested.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a nurse concerning an elderly pt who was
vaccinated SC with a dose of Pneumococcal 23v polysaccharide vaccine (lot
650649/0790P). Subsequently, the pt developed a hugh rash and swelling at the
injection site. Medical attention was sought. Subsequently, the pt recovered.
The nurse requested that a lot check be preformed. The records of testing prior
to release of this lot have been checked and found to be satisfactory. The lot
complies with the standards and was released. I.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient, 46 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 07. Initial and follow up information has
been received from a registered nurse concerning a 46 year old female with
allergies to corticosteroids Unspecified (steroids) who on 11/7/05 was
vaccinated IM in the right deltoid muscle with Pneumococcal 23v polysaccharide
vaccine, (lot 650541/1004P). On 11/8/05, reportedly at 2:04pm, the pt reported
that she developed a large knot on area where she received the injection and she
couldn't move her arm. The pt reported that she had to leave work and take pain
medicatio. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient, 34 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 04. Information has been received from a RN
concerning a 34 year old female with no medical history who on 11/4/05 was
vaccinated IM in the left arm with a first dose of Pneumococcal 23v
polysaccharide vaccine (lot 650541/1004P). There was no illness at the time of
vaccination. On 11/4/05 the pts left arm became red, swollen, hot to touch and
tender. On 11/5/05 the pt developed a fever to 103. On 11/6/05 the pt developed
shortness of breath and a dry, hacky cough. She denied nasal congestion or chest
pain. No m. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician and a licensed Practical nurse
concerning a pt who was vaccinated with a dose of Pneumococcal 23v
polysaccharide vaccine. Subsequently the pt developed cellulitis. Unspecified
medical attention was sought. After several days, the pt recovered. No product
quality complaint was involved. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician and a licensed practical nurse
concerning a pt who was vaccianted in a different office with a dose of
Pneumococcal 23v polysaccharide vaccine. Subsequently the pt developed
cellulitis. Unspecified medical attention was sought. After several days, the pt
recovered. No product quality complaint was involved. Additional information has
been requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MO, USA. Female patient, 49 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 08. Information has been received from a
licensed practical nurse concerning a 49 year old female with an allergy to
morphine and iodine. On 12/8/05, at 3:15pm, the pt was vaccinated IM in the left
arm (also reported as the right arm) with a 0.5ml dose of Pneumococcal 23v
polysaccharide vaccine (lot 650329/0747P). The next day, on 12/9/05, the pt
called to office complaining of a sore arm, nausea, and earache, chills and a
fever. She called back a few days later and left a voice mail message stating
that her ri.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CT, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a nurse from a doctors office concerning a
female of unknown age who was vaccinated with a dose of Pneumococcal 23v
polysaccharide vaccine (date unknown). Subsequently, following vaccination the
pt experienced swelling of her arm and face. Unspecified medical attention was
sought. The nurse did not report any details but did say that the pt recovered.
There was no product quality complaint involved. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Dec 2005, 12. Information has been received from a health professional
concerning an adult female with no reported previous medical history who on
12/12/05 at 11:00 am (also reported as 12/13/05, was vaccinated with a 0.5ml IM
first dose in the deltoid area of Pneumococcal 23v polysaccharide vaccine (lot
651859/0877R). On 12/13/05 th pt developed a red blotchy rash and there was
itching at the injection site. There were no treatments for the conditions. The
status of the pt was reported as unknown. Unspecified medical at.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 85 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 10. Information has been received from a
health professional concerning an 85 year old female also reported as male with
no relevant medical history or illness at time of vaccination who at 2:00pm on
10/10/2005 was vaccinated in the left deltoid with a second dose of Pneumococcal
23v polysaccharide vaccine (lot 650649/0790P). AT 1:00 am on 10/11/05 the pt
experienced dizziness. The dizziness progressed throughout the day on 10/11/05
to the point that the pt felt that she could not ambulate without assistance. T.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a nurse concerning a elderly pt who was
vaccinated SC with a dose of Pneumococcal 23v polysaccharide vaccine (lot
650649/0790P). Subsequently, the pt developed a hugh rash and swelling at the
injection site. The pt was seen in the ER and released. Subsequently, the pt
recovered. The nurse requested that a lot check be performed. The records of
testing prior to release of this lot have been checked and found to be
satisfactory. The lot complies with the standards and was re.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a certified medical assistant concerning a
patient who in approximately December 2005, was vaccinated intramuscularly with
a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (Lot#649697/1038P). In
approximately December 2005, the patient experienced a reaction that extended
from his/her shoulder to his/her hand. It was noted to be extremely painful, and
severe erythema was noted. The reporter indicated that the patient had a
cellulitis-like reaction. The patient.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Dec 2005, 14. Information has been received from a nurse from a physician's
office concerning a woman in her 40's who on 14-DEC-2005 was vaccinated with a
dose of pneumococcal 23v polysaccharide vaccine. On 15-DEC-2005 the patient
developed a local reaction characterized by a red, swollen arm. The patient
developed a local reaction characterized by a red, swollen arm. The swelling was
3-4 inches in diameter around the injection site. Unspecified medical attention
was sought and at that the time of the report the pati.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Sept 2005, 09. Information has been received from a
licensed practical nurse concerning a 65-year-old female patient with an allergy
to Penicillin, who on 09-SEP-2005 at 09:15 am, was vaccinated subcutaneously
with a second dose of pneumococcal 23v polysaccharide vaccine (649694/0386P). It
was noted that at the time of vaccination the patient had weight loss and
abdominal pain. The licensed practical nurse reported that on 09-SEP-2005, the
patient developed an injection site reaction which included redness, pain,
local.Paient had abdominal pain, weight decreased.Paient has the following
illness history - concurrent conditions: Penicillin allergy.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NJ, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a healthcare worker concerning a 71 year old
female with a history of osteoporosis and no allergies, who on 30-NOV-2005 was
vaccinated with a 0.5 ml intramuscular dose of pneumococcal 23v polysaccharide
vaccine (Lot#651318/1006P). Concomitant therapy included alendronate sodium (MSD),
calcium (unspecified), vitamin D (unspecified), simvastin (MSD), and folic acid.
On 01-DEC-2005 the patient's arm, at the injection site, became red, warm,
painful, and swollen. She also h.Paient has the following illness history -
Medical history: Osteoporosis.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician's assistant concerning a patient
who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine
(lot#650453/0791P). Subsequently the patient developed a fever, and injection
site swelling, pain and redness. Unspecified medical attention was sought.
Subsequently, the patient recovered. The reporter expressed a concern about the
lot number. No product quality complaint was involved. The records of testing
prior to release of this lot have been ch.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NJ, USA. Female patient, 71 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 18. Initial and follow up information was
received from a physician and a registered nurse concerning a 71 year old
retired white female with no known allergies, diabetes mellitus non-insulin
dependent and a thyroid disorder who on 18-NOV-2005 was vaccinated
intramuscularly with a 0.5 ml dose pneumococcal 23v polysaccharide vaccine
(lot#651318/1006P). Concomitant therapy included levothyroxine Na fluoxetine,
metformin, trazodone HCL, "dislosenant", gabapentin, atorvastatin calcium (LIPITOR)
and "prophylthiurac.Paient has the following illness history - Concurrent
conditions: diabetes mellitus non-insulin dependent, thyroid disorder.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered technician concerning a pt who
was vaccinated with pneumococcal 23v polysaccharide vaccine
(lot651330/1048P;exp: 4/26/07). Subsequently, the pt experienced red, hot sore
arm at injection site within 48 hrs post vaccination. Treatment is unk. The
registered tech had no other available information and placed a nurse
practitioner on the phone. The nurse practitioner stated that she is not
comfortable using this lot 1048P until a lot check is performed. The
record.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Dec 2005, 14. Information has been received from a physician concerning a 68
yr old (also reported as 86 yr old) female with no known allergies with sickle
cell disease, asthma and arthritis who on 14Dec05 was vaccinated with
pneumococcal 23v polysaccharide vaccine, .5ml. There was no concomitant
medication. On 16Dec05 the pt experienced urticaria and rash. Unspecified
medical attention was sought. The pt's urticaria and rash persisted. Additional
information has been requested..Paient has the following illness history -
Sickle cell disease; asthma; arthritis.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a medical assistant concerning a 55 yr old
male who on an unspecified date was vaccinated IM with pneumococcal 23v
polysaccharide vaccine. It was unk if the pt received the vaccination in the
leg. On an unspecified date, the pt developed a red, painful, local unspecified
date, the pt developed a red, painful, local reaction after receiving
pneumococcal 23v polysaccharide vaccine. The pt sought unspecified medical
attention. It was reported that as a result of these reactio.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 46 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 23. Information has been received from a
physician's office concerning a 46 yr old white male with a sulfonamide allergy,
drug hypersensitivity to naproxen (Naprosyn) and doxycycline, gastrooesophageal
reflux disease, chronic obstructive pulmonary disease and depression. On
23Oct05, in the AM, the pt was vaccinated with the first dose of pneumococcal
23v polysaccharide vaccine. At the time of vaccination, the pt was noted to have
abdominal pain, nausea, vomiting and a small bowel obstruction. On 23Oct05, at
1:2.Paient had Abdominal pain; nausea; small intestinal obstruction; vomiting.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a male who is over 65
yrs old who was vaccinated with pneumococcal 23v polysaccharide vaccine IM
several years ago. The physician reported that the pt was given two doses of
pneumococcal 23v polysaccharide vaccine within a three year time frame. The pt
experienced severe illness, fever and malaise. This occurred several years ago.
Unspecified medical attention was sought. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Dec 2005, 13. Information has been received from a health professional
concerning a female who on 13Dec05 was vaccinated with a 0.5ml IM dose of
pneumococcal 23v polysaccharide vaccine (lot 651859/0877R). On 13Dec05 the pt
developed a red blotchy rash and there was itching at the injection site. There
were no treatments for the condition. The status of the pt was reported as unk.
Unspecified medical attention was sought. No product quality complaint was
involved. Additional information has been requested..Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MO, USA. Female patient, 51 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 08. Information has been received from a
licensed practical nurse concerning a 51 yr old white male with no preexisting
allergies, birth defects, or medical conditions reported. On 08Dec05, at 3:10 PM
(also reported as 3:20PM), the pt was vaccinated IM in the right arm (also
reported as left arm) with a 0.5mL dose of pneumococcal 23v polysaccharide
vaccine (lot 650329/0747P). On 09Dec05, the pt complained of soreness of the
right arm, but was not seen by the physician. The pt recovered on 12Dec05. A
product qua. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a health professional concerning a 60 yr old
male with no known history or allergies who was vaccinated with a 0.5ml dose of
pneumococcal 23v polysaccharide vaccine (lot650329/0747P). Subsequently, the pt
experienced a large local site reaction. Unspecified medical attention was
sought and the client has since recovered. There was no product quality
complaint involved. Additional information has been requested..Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a medical assistant concerning a patient (age
not specified) who on unspecified date was vaccinated intramuscularly with
pneumococcal 23v polysaccharide vaccine. It was unknown if the patient received
the vaccination in the leg. On an unspecified date, the patient developed a
"red, painful, local reaction after receiving pneumococcal 23v polysaccharide
vaccine". The patient sought unspecified medical attention. It was reported that
"as a result of those reactions the o.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient, 68 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 25. Information has been received from a
medical assistant concerning a 68 year old white female who on 25-OCT-2005 was
vaccinated in the left deltoid with a second dose pneumococcal 23v
polysaccharide vaccine, intramuscular (lot#"06072"). In the evening of
25-OCT-2005, the same day as the vaccination, the patient's arm was warm to the
touch and red. The patient was instructed to apply ice and take Ibuprofen
(ADVIL). The on 27-OCT-2005, it became worse and the patient went to the
emergency room where she was.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT
(PNEUMOVAX) on July 2005, 05. Information has been received from a health
professional concerning a 71 year old female with gastroesophageal reflux
disease, an allergic to ciprofloxacin hydrochloride (CIPRO) and pneumococcal 23v
polysaccharide vaccine and a history of mastectomy with reconstruction for
cancer who on 05-JUL-2005 was vaccinated subcutaneously in the right deltoid
with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine
(lot#649694/0386P). Concomitant therapy included alendronate sodium (FOSAMAX),
rabeprazole sodium.Paient has the following illness history - Medical History:
Mastectomy, surgery, breast cancer Concurrent conditions: Gastroesophageal
reflux disease, allergic reaction to antibiotics, hypersensitivity.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse concerning a patient who
was vaccinated intramuscularly with a dose of pneumococcal 23v polysaccharide
vaccine (Lot#650087/0815P). Subsequently the patient developed a generalized
rash. Subsequently, the patient recovered. There was no product complaint. It
was noted that the reporter a lot check to be done on the lot. The records of
testing prior to release of this lot have been checked by Quality Assurance and
found to be satisfactory. The lot co. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse concerning a patient who
was vaccinated intramuscularly with a dose of pneumococcal 23v polysaccharide
vaccine (Lot3650087/0815P). On 14-OCT-2005 the patient developed severe itching
and injection site pain, heat and puffiness. Unspecified medical attention was
sought. She took aspirin for two days, and used ice packs. Subsequently, the
patient recovered. No other information was available. There was no product
quality complaint. The nurse request.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 14. Information has been received from a registered nurse concerning a
female patient who on 14-OCT-2005 was vaccinated with at least a second dose of
pneumococcal 23v polysaccharide vaccine (Lot#650087/0815P). After the
vaccination with pneumococcal 23v polysaccharide vaccine, on approximately
14-OCT-2005, the patient experienced rash, hives, swelling of lips and swelling
of eyes. She sought medical attention and was treated with Ibuprofen (ADVIL),
diphenhydramine (BENADRYL), and Ibuprofen (MOTRIN). The pat.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse (RN) concerning a patient
who was vaccinated with an IM dose of pneumococcal 23v polysaccharide vaccine
(Lot # 650087/0815P). The RN reported that the patient subsequently experienced
injection site soreness, low grade fever and chills. Unspecified medical
attention was sought. Subsequently, the patient recovered from the injection
site soreness, low grade fever and chills. The reported requested a lot check.
The records of testing prior to release of th.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Oct 2005, 14. Injection site pain; injection site erythema; injection site
induration Information has been received from a registered nurse (RN) concerning
a female who on 14-OCT-2005 was vaccinated with IM with a dose of pneumococcal
23v polysaccharide vaccine (lot #650087/0815P). The RN reported that on
14-OCT-2005 the patient developed injection site pain/throbbing, redness and
hardness. Unspecified medical attention was sought. Subsequently the patient
recovered from the injection site pain/throbbing, redness and har.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from ID, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Dec 2005, 22. Pain, Myalgia Information has been received from a health
professional concerning her husband who on 22-DEC-2005 was vaccinated with a
dose of pneumococcal 23v polysaccharide vaccine (lot #651330/1048P). On
22-DEC-2005, the patient developed achy deep muscle soreness. Unspecified
medical attention was sought and the patient was treated with acetaminophen
(Tylenol) and ice. At the time of the report the patient had not recovered. A
product quality complaint was no involved. Additional information has been
re.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from ID, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Dec 2005, 22. Injection site pain Information has been received from a health
professional concerning a female patient who on 22-DEC 2005 was vaccinated with
a dose of pneumococcal 23v polysaccharide vaccine (lot #651330/1048P). On
22-DEC-2005 the patient experienced an achy deep soreness in the injection arm.
It was noted that this may have been her second vaccination with pneumococcal
23v polysaccharide vaccine. At the time of this report the patient had not
recovered. Unspecified medical attention was sought. No produ.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered technician concerning a patient
who was vaccinated with pneumococcal 23v polysaccharide vaccine
(lot#651330/1048P). Subsequently the patient experienced red, hot sore arm at
injection site within 48 hours post vaccination. Treatment is unknown. The
registered technician had no other available information and placed a nurse
practitioner on the phone. The nurse practitioner stated that "she is not
comfortable using this lot 1048P until a lot check is perform.Patient was taken
to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered technician concerning a patient
who was vaccinated with pneumococcal 23v polysaccharide vaccine
(lot#651330/1048P). Subsequently the patient experienced red, hot sore arm at
injection site within 48 hours post vaccination. Treatment is unknown. The
registered technician had no other available information and placed a nurse
practitioner stated that "she is not comfortable using this lot 1048P until a
lot check is performed". The records of testing prior to.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from ID, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Dec 2005, 15. Information has been received from a medical assistant
concerning a female patient who on 15-DEC-2005 was vaccinated with a dose of
pneumococcal 23v polysaccharide vaccine (LOT#651330/1048P). The reporter
mentioned that it may have been the patient's second dose. On an unspecified
date in December 2005, the patient developed joint soreness that felt like
bursitis after vaccination. The patient sought medical attention and was treated
with acteminophen (TYLENOL) and ice. The joint soreness did not improv.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NM, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse (RN) concerning an
approximately 80 year old female with diabetes who in November 2005, was
vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. The RN
reported that in November 2005, after vaccination, the patient's arm "swelled up
like a softball". Unspecified medical attention was sought. Subsequently, the
patient's arm swelling fully resolved. Additional information has been
requested..Paient has the following illness history - Concurrent conditions:
diabetes.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a certified medical assistant concerning a
patient who in approximately December 2005 was vaccinated intramuscularly with a
0.5 ml dose of pneumococcal 23v polysaccharide vaccine (Lot#649697/1038P). In
approximately December 2005, the patient developed a local injection site
reaction which was hot to the touch. Severe erythema was also noted.
Subsequently, the patient recovered. The physician indicated he was concerned
about this lot number. The records of testing prio.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 50 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 21. Information has been received from a
license practical nurse concerning a 50-year-old white adult female with an
allergy to codeine who on 21-NOV-2005 at 9:30 am was vaccinated subcutaneous
with a 0.5 ml second dose of pneumococcal 23v polysaccharide vaccine
(Lot#649694/0386P). The patient was noted to be suffering from anxiety and
depression at the time of vaccination. On 21-NOV-2005, the patient developed an
injection site reaction to include redness, pain, local heat and swelling, noted
to be a celluli.Paient had anxiety: depression.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a medical assistant concerning a female
patient who was vaccinated with a pneumococcal 23v polysaccharide vaccine
(lot#651859/0877R). Subsequently, the patient experienced swelling at the site
of injection, numbing of the lips, and itching eyes. No product quality
compliant was involved. No other information was provided. The patient
recovered. It was also reported that another patient had a similar reaction.
Additional information has been requested.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Dec 2005, 09. Information has been received from a nurse via company
representative concerning her 64 year old husband who in the middle of December
("2nd or 3rd Friday of December"), on approximately 09-DEC-2005 was vaccinated
with 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot# not provided).
The night after receiving vaccination, on approximately 10-DEC-2005 the patient
experienced chills, feeling of malaise and developed fever. The patient was
given acetaminophen (TYLENOL) to take care of the symptoms.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician via company representative
concerning a elderly female (age not provided) who was vaccinated with a dose of
pneumococcal 23v polysaccharide vaccine (lot# not provided). Subsequently the
patient developed reaction (not further specified). The patient's outcome was
not reported. There was no product quality complaint involved. Additional
information has been requested.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient, 50 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 04. Injection site pain; Injection site
reaction; Injection site swelling Information has been received from a health
professional concerning a 50 year old white female registered nurse with
sarcoidosis who on 04-JAN-2006 at 09:30 was vaccinated SC into the right arm
with a first dose of pneumococcal 23v polysaccharide vaccine (lot
#651322/1044P). On 06-JAN-2006 at 08:30 the patient experienced tenderness,
soreness, swelling at the injection site and a "ring" around the injection site
)1-1 1/2 inches). Unspecif.Paient has the following illness history -
Sarcoidosis..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Dyspnea; injection site erythema; injection site swelling; mass Information has
been received from a 45 year old female with hypertension and borderline
diabetes who in October 2004 was vaccinated with pneumococcal 23v polysaccharide
vaccine. Concomitant therapy included pioglitazone hydrochloride )Actos) and
"antihypertensive medications". The patient had previously been vaccinated with
pneumococcal 23v polysaccharide vaccine between 4 and 8 years prior to October
2004. upon vaccination, the patient experi.Paient has the following illness
history - Hypertension Borderline diabetes.Patient was receiving Actos.Patient
was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NC, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Nov 2005, 17. Erythema; Pain in extremity; Skin warm; Edema peripheral
Information has been received from a health care professional and a 54 year old
female white consumer with hypertension, hyperlipidemia, allergic rhinitis and
no allergies who on 17-NOV-2005 at 1)30 PM was vaccinated with a second dose of
pneumococcal 23v polysaccharide vaccine (lot #650329/0747P). Concomitant therapy
included HCTZ/triamterene and simvastatin (MSD). Subsequently on 17-NOV-2005 the
patient's right arm was swollen ("size of baseball"),.Paient has the following
illness history - hypertension hyperlipidemia rhinitis allergic.Patient was
receiving hydrochlorothiazide Zocor.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Injection site swelling; pyrexia; injection site erythema; injection site pain
Information has been received from a physician's assistant concerning a patient
who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot
#650453/0791P). Subsequently the patient developed a fever and injection site
swelling, pain and redness. Unspecified medical attention was sought.
Subsequently the patient recovered. The reporter expressed a concern about the
lot number. No product quality complaint was in.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Injection site swelling; Pyrexia; Injection site erythema; Injection site pain.
Information has been received from a physician's assistant concerning a patient
who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot
#650453/0791P). Subsequently the patient developed a fever and injection site
swelling, pain and redness. Unspecified medical attention was sought.
Subsequently, the patient recovered. The reporter expressed a concern about the
lot number. No product quality complaint was.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physicians assistant concerning a pt who
was vaccinated with a dose of Pneumococcal 23v polysaccharide vaccine
650453/0791P. Subsequently the pt developed cellulitis with a fever, and
injection site swelling, pain and redness. The pt went to the ER. Subsequently,
the pt recovered. The reporter expressed a concern about the lot number. No
product quality complaint was involved. The records of testing prior to release
of this lot have been checked and found to be satisfact.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse concerning an adult pt,
with unknown medical history and drug reaction/allergies, who on an unspecified
date was vaccinated IM in the left deltoid with a 0.5ml dose of Pneumococcal 23v
polysaccharide vaccine (lot 651318/1006P). Subsequently, on an unspecified date,
the pt experienced cellulitis of left arm. Unspecified medical attention,
treatment was sought. No product quality complaint was involved. The nurse is
requesting a lot check. The records of t.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse, via a company
representative, concerning a pt age and sex unknown, who on an unspecified date
was vaccianted route unknown with a second dose of Pneumococcal 23v
polysaccharide vaccine. The pt had previously received Pneumococcal 23v
polysaccharide vaccine, but this history was unknown when the pt was given the
second dose. Subsequently, on an unspecified date the pt experienced arm
soreness. Unspecified medical attention was sought. The pts outcome was.Paient
has the following illness history - Immunisation.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from RI, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician and a medical assistant
concerning a pt who was vaccinated with a dose of Pneumococcal 23v
polysaccharide vaccine. Subsequently the pt developed erythema, swelling and
pain of the upper forearm. Unspecified medical attention was sought.
Subsequently the pt recovered. No product quality complaint was involved.
Additional information has been requested..Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse concerning an adult pt,
with unknown medical history and drug reactions/allergies, who on an unspecified
date was vaccinated IM in the left deltoid with a 0.5ml dose of Pneumococcal 23v
polysaccharide vaccine (lot 651318/1006P). Subsequently, on an unspecified date,
the pt experienced cellulitis of left arm. Unspecified medical
attention/treatment was sought. No product quality complaint was involved. The
nurse is requesting a lot check. The records of t.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CO, USA. Female patient, 56 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 10. Information has been received from a
certified medical assistant concerning a 57 year old white female smoker with
chronic obstructive pulmonary disease and a history of upper respiratory tract
infection who on 10-JAN-2006 was vaccinated intramuscularly in the left deltoid
with a second dose of pneumococcal 23v polysaccharide vaccine (lot
650648/0967P). Concomitant therapy include albuterol MDI, tiotropium bromide
(SPIRIVA), and PREDNISONE taper finished 08-JAN-2006. At the time if
vaccination, the patien.Paient had respiratory disorder.Paient has the following
illness history - Medical History: Upper Respiratory Tract Infection, Concurrent
Conditions: Chronic Obstructive Pulmonary Disease, smoker.Patient was receiving
ALBUTEROL, PREDNISONE, SPIRIVA.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a nurse concerning a patient who was
vaccinated with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently
the patient developed an allergic like reaction post vaccination. The reaction
included a swollen, large red area about six inches in diameter around the
injection site. The patient sought unspecified medical attention. At the time of
this report, the outcome was unknown. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Jan 2006, 12. Information has been received from a healthcare worker, and a
company representative concerning her 68 year old husband, with no allergies
with diabetes, hyperlipidemia, gastroesophageal reflux disease and
cardiovascular disorder, who on 12-JAN-2006 was vaccinated with a dose of
pneumococcal 23v polysaccharide vaccine (lot#551330/1048P) (0.5 ml),
intramuscularly. Concomitant therapy included amlodipine besylate (NORVASC),
fluvastatin sodium (LESCOL), hydrochlorothiazide (manufacturer unknown),
ramipril (AL.Paient has the following illness history - Concurrent conditions:
diabetes, Hyperlipidemia, Gastroesophageal reflux disease, Cardiovascular
disorder.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was
reported from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT
(PNEUMOVAX) on Dec 2005, 27. Information has been received from a registered
nurse concerning a female (age unknown), with unknown medical history and
unknown drug reactions/allergies reported, who on 27-DEC-2005 was vaccinated
intramuscularly with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine
(650457/0937P). On 27-DEC-2005 the patient experienced a sore achy arm which was
red and hot to touch with swelling to the elbow. Subsequently, on "about"
30-DEC-2005, the symptoms resolved and the patient recovered. Unspecified
med.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Jan 2006, 10. Information has been received from a registered nurse
concerning a female with drug hypersensitivity to "some antibiotics" who on
10-JAN-2006 was vaccinated intramuscularly with a dose of pneumococcal 23v
polysaccharide vaccine (lot#650457/0973P). On 10-JAN-2006 the patient
experienced a sore and achy arm that was hot to touch and with swelling halfway
down the arm. Unspecified medical attention was sought. On approximately
13-JAN-2006, the patient recovered. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a female who was
vaccinated with pneumococcal 23v polysaccharide vaccine. Subsequently the
patient's arm hurt so much she could not sleep. The patient went to the
emergency room was given medicine, and sent home. The patient recovered.
Additional information has been requested.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 46 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 13. Initial and follow-up information has
been received from a healthcare worker and a physician concerning a 46 year old
male software developer with diabetes and high blood pressure who on 13-JAN-2006
was vaccinated intramuscularly (previously reported as subcutaneous), into the
right arm, with a 0.5 ml first dose of pneumococcal 23v polysaccharide vaccine
(lot#651321/1036P). Concomitant therapy included metformin HCL (GLUCOPHAGE),
olmesartan medoxomil (BENICAR), rosiglitazone maleate (AVANDIA) and
rosuvasti.Paient has the following illness history - Concurrent conditions:
diabetes, blood pressure high.Patient was receiving GLUCOPHAGE, BENICAR, AVANDIA,
CRESTOR. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a registered nurse concerning a male who in
January 2006, was vaccinated with a first dose of pneumococcal 23v
polysaccharide vaccine. In January 2006, after the vaccination, the patient
developed a swollen arm and difficulty breathing. The patient was treated with
unspecified antibiotics and diphenhydramine hydrochloride (BENADRYL). At the
time of this report, the patient was recovering. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Dec 2005, 28. Information has been received from a healthcare worker
concerning a 56 year old female with a penicillin allergy and allergy to
ticlopidine hydrochloride (TICLID) who on 28-DEC-2005 was vaccinated
subcutaneously with a first 0.5 ml dose of pneumococcal 23v polysaccharide
vaccine (Lot#650329/0747P). Concomitant therapy included levothyroxine Na (SYNTHROID)
and estrogens, conjugated (PREMARIN). The healthcare worker reported that on
30-DEC-2005 the patient's "arm was red and swollen" and there were "there.Patient
was receiving PREMARIN, SYNTHROID.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KS, USA. Female patient, 81 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 26. Initial and follow up information has
been received from a registered nurse concerning a 81 year old (also reported as
"71" years old) white male retired pharmacist, with an allergy to celecoxib (CELEBREX),
who on 26-OCT-2005 (also reported as 26-OCT-2005), was vaccinated
intramuscularly at 2:20 pm in the left deltoid with a second dose of
pneumococcal 23v polysaccharide vaccine (Lot#unknown). It was reported that the
patient was vaccinated in 1999 with a dose of pneumococcal 23v polysaccharide
vaccine. O.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KS, USA. Female patient, 80 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 17. Initial and follow up information has
been received from a registered nurse concerning an 80 year old retired female
patient, with multiple drug allergies (codeine ("codine"), quinine,
cyclobenzaprine hydrochloride (FLEXERIL), acetaminophen (+) hydrocodone
bitartrate (Lortab), celecoxib ("CELEBRAN" CELEBRA), and acetaminophen (+)
propoxyphene napsylate (DARVOCEY-N), who at 11:20 am on 17-JAN-2006 was
vaccinated intramuscularly in the left deltoid with a dose of pneumococcal 23v
polysaccharide vaccine (Lot#.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KS, USA. Female patient, 77 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Oct 2005, 10. Initial and follow up information has
been received from a registered nurse concerning 78 year old (also reported as
80) retired female patient, with an unknown medical history and unknown drug
reactions/allergies, who on 10-OCT-2005 at 11:30 AM was vaccinated
intramuscularly in the right deltoid with a dose of pneumococcal 23v
polysaccharide (Lot# 649989/0579P). On 10-OCT-2005, the patient developed a
severe local cellulitis-like reaction. Follow up information indicated that on
the evening of 10-OCT-2005,.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from PA, USA. Female patient, 69 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 10. Initial and follow up information has
been received from a nurse practitioner who initially reported that "over the
years" several patients were vaccinated (route unknown) with pneumococcal 23v
polysaccharide vaccine (Lot #'s unknown) and subsequently experienced local
abscesses. Follow up information from the nurse practitioner indicated that
there was only one patient who developed a local abscess following vaccination
with pneumococcal 23v polysaccharide vaccine in her office. The nurse
practitioner clar.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a health professional concerning a female
patient who was vaccinated with a dose of pneumococcal 23v polysaccharide
vaccine. Subsequently the patient experienced pain and swelling with erythema on
the injection arm which lasted for a couple of days. Medical attention was not
sought. There was no product quality complaint involved. No further information
is expected.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from KS, USA. Female patient, 78 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 21. Information has been received from a
registered nurse (R.N.) concerning a 78 year old female with no past medical
history , who on 21-NOV-2005 at 14:0 PM was vaccinated intramuscularly with a
0.5 ml dose of pneumococcal 23v polysaccharide vaccine (lot# 650330/0748P).
There was no concomitant medication. On the morning of 22-NOV-2005, the patient
developed swelling of her arm to her wrist and complained of numbness. It was
reported that the patient recovered. Additional information has been
requested..Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IN, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
A company representative reported that on an unspecified date a pt (NOS) was
vaccinated with pneumococcal 23v polysaccharide vaccine (lot not provided). The
pt developed cellulitis and was treated with an unspecified anti inflammatory
medication. Subsequently, the pt recovered from the cellulitis. Additional
information has been requested.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MO, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received via a company rep from a physician concerning a
male pt who on an unspecified date was revaccinated (after 5 yrs) with
pneumococcal 23v polysaccharide vaccine (lot not provided). Subsequently, the pt
developed an unspecified injection site reaction. The pt recovered from the
injection site reaction without any intervention. Additional information has
been requested.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a nurse concerning a pt who was vaccinated
with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently the pt
developed an allergic like reaction post vaccination. The reaction included a
swollen, large red area about 6 inches in diameter around the injection site.
The pt sought unspecified medical attention. At the time of this report, the
outcome was unk. Additional information has been requested..Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Jan 2006, 23. Initial and follow up information has been received from a
physician concerning a 39 to 40 yr old female, with unk medical history or drug
reaction/allergies reported, who on 23Jan06 was vaccinated (route unk) with a
dose of pneumococcal 23v polysaccharide vaccine (lot unk). There was no
concomitant medication. On 24Jan06 the pt developed redness and swelling of the
injected arm, pain, fever of 102, and shaking chills. On 25Jan06 the physician
saw the pt and sent her to the ER. It was noted that the pt had.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient, 75 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Nov 2005, 01. Information has been received from a
physician concerning a white, 75 yr old, retired female, whose reported weight
was 131 pounds with allergies to penicillin, naproxen sodium (Aleve) and
Neosporin who on 01Nov05 was vaccinated SC with a 0.5cc dose of pneumococcal 23v
polysaccharide vaccine (lot 650082/0691P). The physician reported that this was
the pt's 3rd vaccination of pneumococcal 23v polysaccharide vaccine following an
every 5 yr pattern. The pt was seen by the physician on 23Jan06. The pt
reported. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from CA, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a health professional concerning a female pt
who was vaccinated with a dose of pneumococcal 23v polysaccharide vaccine (lot
651859/0877R). Subsequently, the pt experienced swelling at the site of
injection, numbing of the lips, and itching eyes. No product quality complaint
was involved. No other information was provided. The pt recovered. It was also
reported that another pt had a similar reaction (WAES0512USA04076). Additional
information has been requested.. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MI, USA. Female patient, 65 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Dec 2005, 12. Initial and follow up information has
been received from a 65 yr old white female registered nurse with asthma,
hypertension, sulfonamide allergy, atropine and epinephrine drug
hypersensitivity, who on 12Dec05 (previously reported as 22Dec05) was vaccinated
(route unk) in her right upper arm with a first dose of pneumococcal 23v
polysaccharide vaccine (lot unk). Concomitant therapy included Lisinopril (manf
unk), hydrochlorothiazide (manf unk), fluticasone propionate (+) salmeterol
xinafoate (Advair), albut.Patient was receiving Albuterol, Albuterol sulfate,
Advair, hydrochlorothiazide, Lisinopril. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient, 50 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 26. Information has been received from a
registered nurse concerning a 50 year old female with HIV disease, hypertension,
shellfish allergy and sulfonamide allergy who on 26-JAN-2006 was vaccinated
(route unknown) with a first dose of pneumococcal 23v polysaccharide vaccine.
There was no concomitant medication. On 27-JAN-2006 the patient developed
swelling at the injection site, a red 1.25 inch area, tenderness, firmness, and
induration after vaccination with pneumococcal 23v polysaccharide vaccine. The
patient.Paient has the following illness history - HIV Disease; Hypertension;
Shellfish Allergy; Sulfonamide Allergy.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from MD, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Jan 2006, 31. Information has been received from a physician concerning a
female patient who on 31-JAN-2006 was vaccinated with a dose of pneumococcal 23v
polysaccharide vaccine (lot# 650302/1039P). On 31-JAN-2006, the patient
experienced a swollen arm "twice the size" and was warm to the touch.
Unspecified medical attention was sought. At the time of this report the patient
had not recovered. No product quality complaint was involved. Additional
information has been requested..Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from NY, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician, via a company representative,
concerning a patient who on an unspecified date was vaccinated (route unknown)
with a dose of pneumococcal 23v polysaccharide vaccine (Lot # 649697/1038P).
"Within the last 2 months", the patient developed "redness and swelling of the
arm where the injection was given". Subsequently, on an unspecified date, the
patient recovered. Unspecified medical attention was sought. No product quality
complaint was involved. Additional inform.Patient was taken to emergency room.
Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from IL, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Oct 2005, 13. Initial and follow up information has been received from a
physician concerning an approximately 59 year old white male retired
pharmaceutical executive with an allergy to Penicillin who on 13-OCT-2005 was
vaccinated in the right deltoid with a 0.5 ml intramuscular dose of pneumococcal
23v polysaccharide vaccine (Lot#650453/0791P). Concomitant therapy included
glyburide, atorvastatin calcium (LIPITOR), lisinopril (ZESTRIL),
hydrochlorothiazide (manufacturer unknown), levothyroxine Na (SYNTHROID) and
Allopu.Paient has the following illness history - Concurrent conditions:
Penicillin allergy.Patient was receiving Allopurinol, LIPITOR, Glyburide,
HYDRODIURIL, SYNTHROID, ZESTRIL.Patient was taken to emergency room. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from AL, USA. Female patient, 66 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 02. Initial and follow up information has
been received from a physician concerning his wife, a 67 year old white female,
with no pertinent medical history and no history and no drug reactions/allergies
reported, who on 02-FEB-2006 at approximately 9:30 am was vaccinated (route
unknown) with another 0.5 ml dose of pneumococcal 23v polysaccharide vaccine
(Lot# unknown). Concomitant therapy included paroxetine HCL (PAXIL), and
levothyroxine sodium (SYNTHROID). Within a few hours of vaccination, on
02-FEB-2006.Paient has the following illness history - Medical History:
immunization.Patient was receiving SYNTHROID, PAXIL.Patient was taken to
emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician, via a company representative,
concerning a patient who, on unspecified date, was vaccinated with a dose of
pneumococcal 23v polysaccharide vaccine (Lot# not reported). On an unspecified
date, ("not recently") the patient developed arm swelling around the injection
site. The patient sought unspecified medical attention. Outcome was not
reported. There was no product quality complaint involved. Attempts are being
made to obtain additional identifying inform.Patient was taken to emergency
room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX) on
Nov 2005, 02. Information has been received from a registered nurse concerning
an adult patient who on 02-NOV-2005 was vaccinated with pneumococcal 23v
polysaccharide (0.5 ml) (subcutaneous) (Lot#649912/0529P). On 02-NOV-2005 the
patient experienced injection site soreness, warmth, erythema, swelling and
general malaise. The patient was considered to be recovering. Unspecified
medical attention was sought. Attempts are being made to obtain additional
information to distinguish the individual patients mentioned in thi.Patient was
taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from OH, USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX)
on Jan 2006, 25. Initial and follow up information had been received from a
registered nurse and another healthcare professional at the doctors office,
respectively concerning a 79 year old white female patient, with allergies to
amlodipine besylate (NORVASC), atropine sulfate (+) diphenoxylate hydrochloride
(LOMOTIL), acebutolol hydrochloride (SECTRAL), verapamil hydrochloride (CALAN),
alendronate sodium (MSD), and metoprolol tartrate (LOPRESSOR), who on the
morning of 25-JAN-2006 was vaccinated intramuscularly in the left.Paient has the
following illness history - Concurrent conditions: multiple allergies. Patient
recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from TX, USA. Female patient, 86 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Jan 2006, 31. Initial (via a company rep) and follow up
information has been received from a RN concerning a retired 85 yr old white
female, with a penicillin allergy, an allergy to alendronate sodium, codeine,
aspirin and chlorpheniramine maleate (+) phenylpropanolamine hydrochloride
(Ornade), and a history of immunization and vaccination adverse reaction, who at
11:30am on 31Jan06 was vaccinated IM in the right arm with a dose of
pneumococcal 23v polysaccharide vaccine (lot 650456/0974P). There was no illness
at the ti.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from VA, USA. Female patient, 60 years of age, was vaccinated with PNEUMO,
23-VALENT (PNEUMOVAX) on Feb 2006, 06. Initial and follow up information has
been received from a licensed practical nurse concerning a 60 yr old white
female restauranteer who on 06Feb06, at 9:00AM was vaccinated IM, into the right
deltoid with a first dose of pneumococcal 23v polysaccharide vaccine
(lot651322/1044P). On 06Feb06, in the evening, it was noted that her arm was
red, hot, swollen and hard from the injection site to elbow and halfway around
her arm. The pt was able to use arm but hurt. Medical attention was sought and
the pt was adv.Patient was taken to emergency room. Patient recovered.
PNEUMO, 23-VALENT (PNEUMOVAX)(produced by MERCK & CO. INC.) problem was reported
from , USA. Female patient was vaccinated with PNEUMO, 23-VALENT (PNEUMOVAX).
Information has been received from a physician concerning a female with a
history of unspecified hypersensitivity reactions who was recently vaccinated
with a dose of pneumococcal 23v polysaccharide vaccine. Subsequently, the pt
developed severe allergic reaction and rash. Medical attention was sought and
the pt was treated with 2 courses of unspecified therapies. The pt's outcome was
unk. Additional information has been requested..Paient has the following illness
history - Hypersensitivity reaction.Patient was taken to emergency room. Patient
recovered.